US5874214A - Remotely programmable matrices with memories - Google Patents
Remotely programmable matrices with memories Download PDFInfo
- Publication number
- US5874214A US5874214A US08/538,387 US53838795A US5874214A US 5874214 A US5874214 A US 5874214A US 53838795 A US53838795 A US 53838795A US 5874214 A US5874214 A US 5874214A
- Authority
- US
- United States
- Prior art keywords
- memory
- matrix
- combination
- recording device
- memories
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000015654 memory Effects 0.000 title claims abstract description 412
- 239000011159 matrix material Substances 0.000 claims abstract description 229
- 239000002245 particle Substances 0.000 claims abstract description 201
- 238000000034 method Methods 0.000 claims abstract description 180
- 238000006243 chemical reaction Methods 0.000 claims abstract description 80
- 238000013500 data storage Methods 0.000 claims abstract description 69
- 238000012377 drug delivery Methods 0.000 claims abstract description 12
- 230000003287 optical effect Effects 0.000 claims description 26
- 241001465754 Metazoa Species 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 13
- 230000005670 electromagnetic radiation Effects 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 9
- 238000003860 storage Methods 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 7
- 230000005855 radiation Effects 0.000 claims description 7
- 230000006870 function Effects 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 6
- 239000003792 electrolyte Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 67
- 238000003786 synthesis reaction Methods 0.000 abstract description 56
- 239000000126 substance Substances 0.000 abstract description 31
- 239000007790 solid phase Substances 0.000 abstract description 25
- 238000003018 immunoassay Methods 0.000 abstract description 20
- 238000009396 hybridization Methods 0.000 abstract description 18
- 238000001514 detection method Methods 0.000 abstract description 16
- 238000000746 purification Methods 0.000 abstract description 9
- 229920002521 macromolecule Polymers 0.000 abstract description 6
- 239000012620 biological material Substances 0.000 abstract description 5
- 238000002955 isolation Methods 0.000 abstract description 5
- 230000003612 virological effect Effects 0.000 abstract description 5
- 230000002255 enzymatic effect Effects 0.000 abstract description 4
- 238000007385 chemical modification Methods 0.000 abstract description 3
- 238000006555 catalytic reaction Methods 0.000 abstract description 2
- 239000000356 contaminant Substances 0.000 abstract description 2
- 238000001525 receptor binding assay Methods 0.000 abstract description 2
- 235000001014 amino acid Nutrition 0.000 description 109
- 150000001413 amino acids Chemical class 0.000 description 108
- 108090000765 processed proteins & peptides Proteins 0.000 description 98
- 239000000427 antigen Substances 0.000 description 51
- 102000036639 antigens Human genes 0.000 description 48
- 108091007433 antigens Proteins 0.000 description 48
- 230000008569 process Effects 0.000 description 47
- 238000009739 binding Methods 0.000 description 46
- 150000001875 compounds Chemical class 0.000 description 46
- 230000027455 binding Effects 0.000 description 44
- 239000000203 mixture Substances 0.000 description 44
- -1 antibodies Substances 0.000 description 40
- 239000011324 bead Substances 0.000 description 40
- 230000015572 biosynthetic process Effects 0.000 description 38
- 210000004027 cell Anatomy 0.000 description 37
- 239000012634 fragment Substances 0.000 description 37
- 108090000623 proteins and genes Proteins 0.000 description 37
- KDBDEFYTFKYDHF-UHFFFAOYSA-N 2-(dicarboxymethoxy)propanedioic acid Chemical compound OC(=O)C(C(O)=O)OC(C(O)=O)C(O)=O KDBDEFYTFKYDHF-UHFFFAOYSA-N 0.000 description 36
- 235000018102 proteins Nutrition 0.000 description 35
- 102000004169 proteins and genes Human genes 0.000 description 35
- 239000000523 sample Substances 0.000 description 34
- 238000003556 assay Methods 0.000 description 33
- 230000000692 anti-sense effect Effects 0.000 description 32
- 229920000642 polymer Polymers 0.000 description 32
- 102000039446 nucleic acids Human genes 0.000 description 31
- 108020004707 nucleic acids Proteins 0.000 description 31
- 150000007523 nucleic acids Chemical class 0.000 description 31
- 239000004065 semiconductor Substances 0.000 description 30
- 239000000758 substrate Substances 0.000 description 30
- 239000003446 ligand Substances 0.000 description 28
- 239000007787 solid Substances 0.000 description 28
- 239000000178 monomer Substances 0.000 description 27
- 210000004088 microvessel Anatomy 0.000 description 25
- 102000004196 processed proteins & peptides Human genes 0.000 description 25
- 239000002609 medium Substances 0.000 description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 23
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 23
- 108091034117 Oligonucleotide Proteins 0.000 description 22
- 238000004458 analytical method Methods 0.000 description 22
- 239000011521 glass Substances 0.000 description 22
- 229910052751 metal Inorganic materials 0.000 description 22
- 239000002184 metal Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- 238000005859 coupling reaction Methods 0.000 description 21
- 238000002360 preparation method Methods 0.000 description 21
- 230000008878 coupling Effects 0.000 description 20
- 238000010168 coupling process Methods 0.000 description 20
- 238000012216 screening Methods 0.000 description 20
- 239000004793 Polystyrene Substances 0.000 description 18
- 229920002223 polystyrene Polymers 0.000 description 18
- 102000005962 receptors Human genes 0.000 description 18
- 108020003175 receptors Proteins 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- 230000005540 biological transmission Effects 0.000 description 16
- 238000000576 coating method Methods 0.000 description 16
- 239000003153 chemical reaction reagent Substances 0.000 description 15
- 239000011248 coating agent Substances 0.000 description 15
- 229920000936 Agarose Polymers 0.000 description 13
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 13
- 239000012491 analyte Substances 0.000 description 13
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 12
- 239000011230 binding agent Substances 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- 239000002019 doping agent Substances 0.000 description 11
- 239000000543 intermediate Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 10
- 241000700605 Viruses Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000010408 film Substances 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- 239000000377 silicon dioxide Substances 0.000 description 10
- 239000004743 Polypropylene Substances 0.000 description 9
- 229920001155 polypropylene Polymers 0.000 description 9
- 241000894007 species Species 0.000 description 9
- 239000000470 constituent Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 230000003595 spectral effect Effects 0.000 description 8
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 7
- 238000002965 ELISA Methods 0.000 description 7
- 239000000020 Nitrocellulose Substances 0.000 description 7
- 108010067902 Peptide Library Proteins 0.000 description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 235000010980 cellulose Nutrition 0.000 description 7
- 239000000919 ceramic Substances 0.000 description 7
- 238000010511 deprotection reaction Methods 0.000 description 7
- 229930014626 natural product Natural products 0.000 description 7
- 229920001220 nitrocellulos Polymers 0.000 description 7
- 229910052710 silicon Inorganic materials 0.000 description 7
- 239000010703 silicon Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- 239000004809 Teflon Substances 0.000 description 6
- 229920006362 Teflon® Polymers 0.000 description 6
- 230000009102 absorption Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 238000001261 affinity purification Methods 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920002401 polyacrylamide Polymers 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 238000003491 array Methods 0.000 description 5
- 229920001222 biopolymer Polymers 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 239000002777 nucleoside Substances 0.000 description 5
- 150000003833 nucleoside derivatives Chemical class 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 239000000816 peptidomimetic Substances 0.000 description 5
- 238000002823 phage display Methods 0.000 description 5
- 229940002612 prodrug Drugs 0.000 description 5
- 239000000651 prodrug Substances 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 239000007821 HATU Substances 0.000 description 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 4
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 4
- 102000004330 Rhodopsin Human genes 0.000 description 4
- 108090000820 Rhodopsin Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 150000003862 amino acid derivatives Chemical class 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- 230000005291 magnetic effect Effects 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000002853 nucleic acid probe Substances 0.000 description 4
- 238000006552 photochemical reaction Methods 0.000 description 4
- 229910021420 polycrystalline silicon Inorganic materials 0.000 description 4
- 229920005591 polysilicon Polymers 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 210000004676 purple membrane Anatomy 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 108010032595 Antibody Binding Sites Proteins 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 150000008574 D-amino acids Chemical class 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 238000004166 bioassay Methods 0.000 description 3
- 230000009141 biological interaction Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000007876 drug discovery Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 125000004970 halomethyl group Chemical group 0.000 description 3
- 238000013537 high throughput screening Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 238000000059 patterning Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000010532 solid phase synthesis reaction Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 3
- 239000011135 tin Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CNMAQBJBWQQZFZ-LURJTMIESA-N (2s)-2-(pyridin-2-ylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC1=CC=CC=N1 CNMAQBJBWQQZFZ-LURJTMIESA-N 0.000 description 2
- VYMPLPIFKRHAAC-UHFFFAOYSA-N 1,2-ethanedithiol Chemical compound SCCS VYMPLPIFKRHAAC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102000006306 Antigen Receptors Human genes 0.000 description 2
- 108010083359 Antigen Receptors Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108010082845 Bacteriorhodopsins Proteins 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 229910007277 Si3 N4 Inorganic materials 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
- 238000003277 amino acid sequence analysis Methods 0.000 description 2
- 229910021417 amorphous silicon Inorganic materials 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000005284 basis set Methods 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000000234 capsid Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000012875 competitive assay Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 101150026234 iam gene Proteins 0.000 description 2
- 238000000099 in vitro assay Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 229910052752 metalloid Inorganic materials 0.000 description 2
- 150000002738 metalloids Chemical class 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 102000035118 modified proteins Human genes 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 238000004091 panning Methods 0.000 description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000002186 photoactivation Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 239000011253 protective coating Substances 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 239000012508 resin bead Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 229910052718 tin Inorganic materials 0.000 description 2
- ZPGDWQNBZYOZTI-SFHVURJKSA-N (2s)-1-(9h-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 ZPGDWQNBZYOZTI-SFHVURJKSA-N 0.000 description 1
- ADOHASQZJSJZBT-SANMLTNESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-[1-[(2-methylpropan-2-yl)oxycarbonyl]indol-3-yl]propanoic acid Chemical compound C12=CC=CC=C2N(C(=O)OC(C)(C)C)C=C1C[C@@H](C(O)=O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 ADOHASQZJSJZBT-SANMLTNESA-N 0.000 description 1
- SJVFAHZPLIXNDH-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21)C1=CC=CC=C1 SJVFAHZPLIXNDH-QFIPXVFZSA-N 0.000 description 1
- FODJWPHPWBKDON-IBGZPJMESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 FODJWPHPWBKDON-IBGZPJMESA-N 0.000 description 1
- CBPJQFCAFFNICX-IBGZPJMESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(C)C)C(O)=O)C3=CC=CC=C3C2=C1 CBPJQFCAFFNICX-IBGZPJMESA-N 0.000 description 1
- UMRUUWFGLGNQLI-QFIPXVFZSA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(O)=O)C3=CC=CC=C3C2=C1 UMRUUWFGLGNQLI-QFIPXVFZSA-N 0.000 description 1
- QWXZOFZKSQXPDC-NSHDSACASA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)propanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](C)C(O)=O)C3=CC=CC=C3C2=C1 QWXZOFZKSQXPDC-NSHDSACASA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ZRANNUBDTWQCBC-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,10,10,11,11,11-tricosafluoro-9-isocyanatoundecane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(N=C=O)C(F)(F)C(F)(F)F ZRANNUBDTWQCBC-UHFFFAOYSA-N 0.000 description 1
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 1
- IYAYDWLKTPIEDC-UHFFFAOYSA-N 2-[2-hydroxyethyl(3-triethoxysilylpropyl)amino]ethanol Chemical compound CCO[Si](OCC)(OCC)CCCN(CCO)CCO IYAYDWLKTPIEDC-UHFFFAOYSA-N 0.000 description 1
- FAAYDFBUMOADEP-UHFFFAOYSA-N 3-(2,5-dioxopyrrol-1-yl)-3-hexanoyl-1-hydroxypyrrolidine-2,5-dione Chemical compound O=C1C=CC(=O)N1C1(C(=O)CCCCC)CC(=O)N(O)C1=O FAAYDFBUMOADEP-UHFFFAOYSA-N 0.000 description 1
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical compound ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- MVEOHWRUBFWKJY-UHFFFAOYSA-N 7-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=CC(S(O)(=O)=O)=CC2=CC(O)=CC=C21 MVEOHWRUBFWKJY-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- SNDPXSYFESPGGJ-SCSAIBSYSA-N D-2-aminopentanoic acid Chemical compound CCC[C@@H](N)C(O)=O SNDPXSYFESPGGJ-SCSAIBSYSA-N 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 241000204946 Halobacterium salinarum Species 0.000 description 1
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- GPXJNWSHGFTCBW-UHFFFAOYSA-N Indium phosphide Chemical compound [In]#P GPXJNWSHGFTCBW-UHFFFAOYSA-N 0.000 description 1
- 102000003814 Interleukin-10 Human genes 0.000 description 1
- 108090000174 Interleukin-10 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 101100510757 Pisum sativum LEGK gene Proteins 0.000 description 1
- 229920001054 Poly(ethylene‐co‐vinyl acetate) Polymers 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 102100038358 Prostate-specific antigen Human genes 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 238000010796 Steam-assisted gravity drainage Methods 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical group C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000004018 acid anhydride group Chemical group 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 150000001253 acrylic acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000012042 active reagent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- CSDREXVUYHZDNP-UHFFFAOYSA-N alumanylidynesilicon Chemical compound [Al].[Si] CSDREXVUYHZDNP-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003302 anti-idiotype Effects 0.000 description 1
- 230000002788 anti-peptide Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000000823 artificial membrane Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012911 assay medium Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004666 bacterial spore Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RROBIDXNTUAHFW-UHFFFAOYSA-N benzotriazol-1-yloxy-tris(dimethylamino)phosphanium Chemical compound C1=CC=C2N(O[P+](N(C)C)(N(C)C)N(C)C)N=NC2=C1 RROBIDXNTUAHFW-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- YENOLDYITNSPMQ-UHFFFAOYSA-N carboxysilicon Chemical compound OC([Si])=O YENOLDYITNSPMQ-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000002800 charge carrier Substances 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 150000004697 chelate complex Chemical class 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 238000007878 drug screening assay Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000005519 fluorenylmethyloxycarbonyl group Chemical group 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N furocoumarin Natural products C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- JMANVNJQNLATNU-UHFFFAOYSA-N glycolonitrile Natural products N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000013198 immunometric assay Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- GQYHUHYESMUTHG-UHFFFAOYSA-N lithium niobate Chemical compound [Li+].[O-][Nb](=O)=O GQYHUHYESMUTHG-UHFFFAOYSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- NKAAEMMYHLFEFN-UHFFFAOYSA-M monosodium tartrate Chemical compound [Na+].OC(=O)C(O)C(O)C([O-])=O NKAAEMMYHLFEFN-UHFFFAOYSA-M 0.000 description 1
- 238000011512 multiplexed immunoassay Methods 0.000 description 1
- RAIWYFYCHWDSOE-UHFFFAOYSA-N n,n-di(propan-2-yl)butan-2-amine Chemical compound CCC(C)N(C(C)C)C(C)C RAIWYFYCHWDSOE-UHFFFAOYSA-N 0.000 description 1
- COCAUCFPFHUGAA-MGNBDDOMSA-N n-[3-[(1s,7s)-5-amino-4-thia-6-azabicyclo[5.1.0]oct-5-en-7-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide Chemical compound C=1C=C(F)C([C@@]23N=C(SCC[C@@H]2C3)N)=CC=1NC(=O)C1=CC=C(Cl)C=N1 COCAUCFPFHUGAA-MGNBDDOMSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940099678 norco Drugs 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000000382 optic material Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000863 peptide conjugate Substances 0.000 description 1
- 230000007030 peptide scission Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000002319 phototactic effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical group [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11C—STATIC STORES
- G11C13/00—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
- G11C13/0002—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
- G11C13/0009—RRAM elements whose operation depends upon chemical change
- G11C13/0014—RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
- G11C13/0019—RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material comprising bio-molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00722—Communications; Identification
- G01N35/00732—Identification of carriers, materials or components in automatic analysers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00722—Communications; Identification
- G01N35/00871—Communications between instruments or with remote terminals
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11C—STATIC STORES
- G11C13/00—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
- G11C13/0002—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using resistive RAM [RRAM] elements
- G11C13/0009—RRAM elements whose operation depends upon chemical change
- G11C13/0014—RRAM elements whose operation depends upon chemical change comprising cells based on organic memory material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00281—Individual reactor vessels
- B01J2219/00295—Individual reactor vessels the reactor vessels having pervious side walls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00281—Individual reactor vessels
- B01J2219/00295—Individual reactor vessels the reactor vessels having pervious side walls
- B01J2219/00299—Generally cylindrical reactor vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00306—Reactor vessels in a multiple arrangement
- B01J2219/00308—Reactor vessels in a multiple arrangement interchangeably mounted in racks or blocks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00331—Details of the reactor vessels
- B01J2219/00333—Closures attached to the reactor vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00279—Features relating to reactor vessels
- B01J2219/00331—Details of the reactor vessels
- B01J2219/00333—Closures attached to the reactor vessels
- B01J2219/00344—Caps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00457—Dispensing or evacuation of the solid phase support
- B01J2219/00459—Beads
- B01J2219/00461—Beads and reaction vessel together
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00457—Dispensing or evacuation of the solid phase support
- B01J2219/00459—Beads
- B01J2219/00461—Beads and reaction vessel together
- B01J2219/00463—Directed sorting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/005—Beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00502—Particles of irregular geometry
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00542—Alphanumeric characters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00547—Bar codes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00547—Bar codes
- B01J2219/00549—2-dimensional
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00547—Bar codes
- B01J2219/00551—3-dimensional
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00554—Physical means
- B01J2219/0056—Raised or sunken areas
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00563—Magnetic means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00565—Electromagnetic means
- B01J2219/00567—Transponder chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00565—Electromagnetic means
- B01J2219/00569—EEPROM memory devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/0059—Sequential processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00592—Split-and-pool, mix-and-divide processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00686—Automatic
- B01J2219/00689—Automatic using computers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00695—Synthesis control routines, e.g. using computer programs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0609—Holders integrated in container to position an object
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
-
- G01N15/149—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00722—Communications; Identification
- G01N35/00732—Identification of carriers, materials or components in automatic analysers
- G01N2035/00742—Type of codes
- G01N2035/00782—Type of codes reprogrammmable code
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11C—STATIC STORES
- G11C13/00—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
- G11C13/02—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using elements whose operation depends upon chemical change
- G11C13/025—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using elements whose operation depends upon chemical change using fullerenes, e.g. C60, or nanotubes, e.g. carbon or silicon nanotubes
Definitions
- the present invention relates to the application of data storage technology to molecular tracking and identification and to biological and biochemical assays.
- the nucleic acid in the sample i.e., the target nucleic acid! is hybridized to a detection oligonucleotide.
- a detection oligonucleotide In order to obtain a detectable signal proportional to the concentration of the target nucleic acid, either the target nucleic acid in the sample or the detection oligonucleotide is associated with a signal generating reporter element, such as a radioactive atom, a chromogenic or fluorogenic molecule, or an enzyme such as alkaline phosphatase! that catalyzes a reaction that produces a detectable product. Numerous methods are available for detecting and quantifying the signal.
- the resulting signal-generating hybrid molecules must be separated from unreacted target and detection oligonucleotides.
- many of the commonly used assays immobilize the target nucleic acids or detection oligonucleotides on solid supports.
- Presently available solid supports to which oligonucleotides are linked include nitrocellulose or nylon membranes, activated agarose supports, diazotized cellulose supports and non-porous polystyrene latex solid microspheres. Linkage to a solid support permits fractionation and subsequent identification of the hybridized nucleic acids, since the target nucleic acid may be directly captured by oligonucleotides immobilized on solid supports.
- Immunoassays also detect or quantify very small concentrations of analytes in biological samples.
- Many immunoassays utilize solid supports in which antigen or antibody is covalently, non-covalently, or otherwise, such as via a linker, attached to a solid support matrix. The support-bound antigen or antibody is then used as an analyte in the assay.
- the resulting antibody-antigen complexes or other complexes depending upon the format used, rely on radiolabels or enzyme labels to detect such complexes.
- the use of antibodies to detect and/or quantitate reagents "antigens"! in blood or other body fluids has been widely practiced for many years. Two methods have been most broadly adopted.
- the first such procedure is the competitive binding assay, in which conditions of limiting antibody are established such that only a fraction usually 30-50%! of a labeled e.g., radioisotope, fluorophore or enzyme! antigen can bind to the amount of antibody in the assay medium. Under those conditions, the addition of unlabeled antigen e.g., in a serum sample to be tested! then competes with the labeled antigen for the limiting antibody binding sites and reduces the amount of labeled antigen that can bind.
- a labeled e.g., radioisotope, fluorophore or enzyme! antigen
- the degree to which the labeled antigen is able to bind is inversely proportional to the amount of unlabeled antigen present.
- an antigen present in the assay fluid is specifically bound to a solid substrate and the amount of antigen bound is then detected by a labeled antibody see, e., Miles et al. (1968) Nature 29:186-189; U.S. Pat. No. 3,867,517; U.S. Pat. No. 4,376,110!.
- a labeled antibody see, e., Miles et al. (1968) Nature 29:186-189; U.S. Pat. No. 3,867,517; U.S. Pat. No. 4,376,110!.
- monoclonal antibodies two-site immunometric assays are available see, e.g., U.S. Pat. No. 4,376,110!.
- the "sandwich” assay has been broadly adopted in clinical medicine. With increasing interest in "panels" of diagnostic tests, in which a number of different antigens in a fluid are measured, the need to carry out each immunoassay separately becomes a serious limitation of current quantitative assay
- Drug discovery relies on the ability to identify compounds that interact with a selected target, such as cells, an antibody, receptor, enzyme, transcription factor or the like.
- a selected target such as cells, an antibody, receptor, enzyme, transcription factor or the like.
- Traditional drug discovery involves screening natural products form various sources, or random screening of archived synthetic material. The current trend, however, is to identify such molecules by rational design and/or by screening combinatorial libraries of molecules.
- Combinatorial chemistry is a powerful tool in drug discovery and materials science.
- Methods and strategies for generating diverse libraries have been developed using molecular biology methods and/or simultaneous chemical synthesis methodologies see, e.g., Dower et al. (1991) Annu. Rep. Med. Chem. 26:271-280; Fodor et al. (1991) Science 251:767-773; Jung et al. (1992) Angew. Chem. Ind. Ed. Engl. 31:367-383; Zuckerman et al. (1992) Proc. Natl. Acad. Sci. USA 89:4505-4509; Scott et al.
- the resulting combinatorial libraries potentially contain millions of pharmaceutically relevant compounds and can be rapidly screened to identify compounds that exhibit a selected activity.
- the libraries fall into roughly three categories: fusion-protein-displayed peptide libraries in which random peptides or proteins are presented on the surface of phage particles or proteins expressed from plasmids; support-bound synthetic chemical libraries in which individual compounds or mixtures of compounds are presented on insoluble matrices, such as resin beads see, e.g., Lam et al. (1991) Nature 354:82-84! and cotton supports see, e.g., Eichler et al. (1993) Biochemistry 32:11035-11041!; and methods in which the compounds are used in solution see, e.g., Houghten et al. (1991) Nature 354:84-86, Houghten et al.
- an essential element of the combinatorial discovery process is the ability to extract the information made available during synthesis of the library or identification of the active components of intermediary structures. While there are several techniques for identification of intermediary products and final products, nanosequencing protocols that provide exact structures are only applicable on mass to naturally occurring linear oligomers such as peptides and amino acids. Mass spectrographic MS! analysis is sufficiently sensitive to determine the exact mass and fragmentation patterns of individual synthesis steps, but complex analytical mass spectrographic strategies are not readily automated nor conveniently performed. Also, mass spectrographic analysis provides at best simple connectivity information, but no stereoisomeric information, and generally cannot discriminate among isomeric monomers.
- Combinations of matrix materials with programmable data storage or recording devices, herein referred to as memories and assays using these combinations are provided.
- molecules such as antigens, antibodies, ligands, proteins and nucleic acids, and biological particles, such as phage and viral particles and cells, that are in proximity to or in physical contact with the matrix combination can be electromagnetically tagged by programming the memory with data corresponding to identifying information.
- assays can be monitored, because occurrence of a reaction can be recorded in the memory, if desired, and/or continually monitored in real time.
- an identification code for the particular memory/matrix combination can be permanently recorded, thereby providing a means to identify each such encoded combination.
- the molecules and biological particles that are in proximity to or in physical contact with the matrix combination can be identified and the results of the assays determined by retrieving the stored data points from the memories.
- Combinations of matrix materials, memories, and linked or proximate molecules and biological materials and assays using such combinations are also provided.
- the combinations provided herein have a multiplicity of applications, including combinatorial chemistry, isolation and purification of target macromolecules, capture and detection of macromolecules for analytical purposes, high throughput screening, selective removal of contaminants, enzymatic catalysis, drug delivery, chemical modification, drug delivery, information collection and management and other uses. These combinations are particularly advantageous for use in multianalyte analyses and assays in which a electromagnetic signal is generated by the reactants or products in the assay.
- the combinations are referred to herein as matrices with memories. These combinations contain (i) a miniature recording device that contains one or more programmable data storage devices memories! that can be remotely read and in preferred embodiments also remotely programmed; and (ii) a matrix, such as a particulate support used in chemical syntheses.
- the remote programming and reading is preferably effected using electromagnetic radiation.
- the matrix materials matrices! are any materials that are routinely used in chemical and biochemical synthesis.
- the matrix materials are typically polymeric materials that are compatible with chemical and biological syntheses and assays, and include, glasses, silicates, celluloses, polystyrenes, polysaccharides, polypropylenes, sand, and synthetic resins and polymers, including acrylamides, particularly cross-linked polymers, cotton, and other such materials.
- the matrices may be in the form of particles or may be continuous in design, such as a test tube or microtiter plate or the like.
- the recording device is a miniature device, typically less than 10-20 mm 3 or 10-20 mm in its largest dimension! in size, preferably smaller, that includes at least one data storage unit that includes a remotely programmable and remotely readable, preferably non-volatile, memory. This device with remotely programmable memory is in proximity with or in contact with the matrix.
- the recording device includes a memory device, preferably having non-volatile memory means, for storing a plurality of data points and means for receiving a transmitted signal that is received by the device and for causing a data point corresponding to the data signal to be permanently stored within the memory means; and, if needed, a shell that is non-reactive with and impervious to any processing steps or solutions in which the combination of matrix with recording device is placed, and that is transmissive of read or write signals transmitted to the memory.
- the device may also include at least one support matrix disposed on an outer surface of the shell for retaining molecules or biological particles.
- the recording device containing the memory! is typically coated with at least one layer of material, such as a protective polymer or a glass, including polystyrene, heavy metal-free glass, plastic, ceramic, and may be coated with more than one layers of this and other materials.
- a protective polymer or a glass including polystyrene, heavy metal-free glass, plastic, ceramic
- it may be coated with a ceramic or glass, which is then coated with or linked to the matrix material.
- the glass or ceramic or other coating may serve as the matrix.
- the recording device and the matrix material are in proximity, such as in a container of a size approximately that of the device and matrix material.
- the device is a semiconductor that is approximately 10 mm or less and the matrix material is a bead or the like, such as a polystyrene bead
- the device and beads about 1 mg to about 50 mg, are sealed in a chemically inert porous supports, such as polypropylene formed so that it has pores of a selected size.
- the data storage device or memory is programmed with or encoded with information that identifies molecules or biological particles, either by their process of preparation, their identity, their batch number, category, physical or chemical properties, combinations of any of such information, or other such identifying information.
- the molecules or biological particles are in physical contact, direct or indirect, or in proximity with the matrix, which in turn is in physical contact or in the proximity of the recording device that contains the data storage memory.
- the matrix is on the surface of the recording device and the molecules and biological particles are in physical contact with the matrix material.
- the data storage device or memory can also be programmed by virtue of a reaction in proximity to the matrix with memory.
- memories that also include a photodectector can detect the occurrence of fluorescence or other optical emission. Coupling this emission with an amplifier and providing a voltage to permit data storage in the matrix with memory during the reaction by way of, for example an RF signal transmitted to and received by an antenna/rectifier combination within the data storage device or providing voltage sufficient to write to memory from a battery see, e.g., U.S. Pat. No. U.S. Pat. No. 5,350,645 and U.S. Pat. No. 5,089,877!, permits occurrence of the emission to be recorded in the memory.
- the matrix combinations thus, contain a matrix material, typically in particulate form, in physical contact with a tiny device containing one or more remotely programmable data storage units memories!.
- Contact can be effected by placing the recording device with memory on or in the matrix material or in a solution that is in contact with the matrix material or by linking the device, either by direct or indirect covalent or non-covalent interactions, chemical linkages or by other interactions, to the matrix.
- such contact is effected chemically, by chemically coupling the device with data storage unit to the matrix, or physically by coating the recording device with the matrix material or another material, by physically inserting or encasing the device in the matrix material, by placing the device onto the matrix or by any other means by which the device can be placed in contact with or in proximity to the matrix material.
- matrices with memories are herein referred to as matrices with memories.
- the matrices are either particulate of a size that is roughly about 10 to 20 mm 3 or 10-20 mm in its largest dimension!, preferably about 10 mm 3 or smaller, preferably 1 mm 3 or smaller, or a continuous medium, such as a microtiter plate, or other multi-well plate, or plastic or other solid polymeric vial or glass vial or catheter-tube for drug delivery! or such container or device conventionally used in chemistry and biological syntheses and reactions.
- the data storage device memory! may be placed in, on, or under the matrix medium or may be embedded in the material of the matrix.
- More than one data storage device may be in proximity to or contact with a matrix particle, or more than one matrix particle may be in contact with on device.
- microtiter plates with the recording device containing the data storage unit remotely programmable memory! embedded in each well or vials typically with a 1 ml or smaller capacity! with an embedded recording device may be manufactured.
- the memory device may be linked to or in proximity to more than one matrix particle.
- a single device and a plurality of particles may be sealed in a porous or semi-permeable inert material to produce a microvessel called a "micro-can"!, such as teflon or polypropylene or membrane that is permeable to the components of the medium, or they may be contained in a small closable container that has at least one dimension that is porous or semi-permeable tube.
- a small closable container that has at least one dimension that is porous or semi-permeable tube.
- such tube which preferably has an end that can be opened and sealed or closed tightly, has a volume of about 200-500 mm 3 , with preferred dimensions of about 1-10 mm in diameter and 5 to 20 mm in height, more preferably about 5 mm by 15 mm.
- the porous wall should be non-collapsible with a pore size in the range of 70 ⁇ M to about 100 ⁇ M, but can be selected to be semi-permeable for selected components of the medium in which the microvessel "micro-can" is placed.
- the preferred geometry of these combinations is cylindrical.
- These porous micro-cans may be sealed by heat or may be designed to snap or otherwise close. In some embodiments they are designed to be reused.
- the microvessel "micro-can" with closures may be made out of non-porous material, such as a tube of the shape of an Eppendorf tube, and used as container to hold the matrix particles and device.
- the combination of matrix with memory is used by contacting it with, linking it to, or placing it in proximity with a molecule or biological particle, such as a virus or phage particle, a bacterium or a cell, to produce a second combination of a matrix with memory and a molecule or biological particle.
- a molecule or biological particle such as a virus or phage particle, a bacterium or a cell
- such combinations of matrix with memory or combination of matrix with memory and molecule or biological particle may be prepared when used or may be prepared before use and packaged or stored as such for futures use.
- the recording device with data storage unit is placed in a solution or suspension of the molecule or biological particle of interest.
- the container such as the microtiter plate or test tube or other vial, is the matrix material.
- the recording device is placed in or on the matrix or is embedded, encased or dipped in the matrix material or otherwise place in proximity by enclosing the device and matrix material in a sealed pouch or bag or container herein referred to as a microvessel called a "micro-can"! fabricated from, preferably, porous material, such as teflon or polypropylene prepared with pores, that is inert to the reaction of interest and that have pores of size permeable to desired components of the reaction medium.
- the miniature recording device containing the data storage unit(s) with remotely programmable memory includes, in addition to the remotely programmable memory, means for receiving information for storage in the memory and for retrieving information stored in the memory.
- Such means is typically an antenna, which also serves to provide power in a passive device when combined with a rectifier circuit to convert received RF energy into voltage, that can be tuned to a desired electromagnetic frequency to program the memory.
- Power for operation of the recording device may also be provided by a battery attached directly to the recording device, to create an active device, or by other power sources, including light and chemical reactions, including biological reactions, that generate energy.
- Preferred frequencies are any that do not substantially alter the molecular and biological interactions of interest, such as those that are not substantially absorbed by the molecules or biological particles linked to the matrix or in proximity of the matrix, and that do not alter the support properties of the matrix.
- Radio frequencies are presently preferred, but other frequencies or optical lasers will be used, as long as the selected frequency or optical laser does not interfere with the interactions of the molecules or biological particles of interest.
- information in the form of data points corresponding to such information is stored in and retrieved from the data storage device by application of a selected electromagnetic radiation frequency, which preferably is selected to avoid interference from any background electromagnetic radiation.
- the preferred miniature recording device for use in the combinations herein is a single substrate of a size preferably less than about 10 to 20 mm 3 or 10-20 mm in its largest dimension!, that includes a remotely programmable data storage unit(s) memory!, preferably a non-volatile memory, and an antenna for receiving or transmitting an electromagnetic signal and in some embodiments for supplying power in passive devices when combined with a rectifier circuit! preferably a radio frequency signal; the antenna, rectifier circuit, memory and other components are preferably integrated onto a single substrate, thereby minimizing the size of the device.
- An active device i.e., one that does not rely on external sources for providing voltage for operation of the memory, may include a battery for power, with the battery attached to the substrate, preferably on the back surface of the substrate. Vias through the substrate can then provide conduction paths from the battery to the circuitry on the substrate.
- the device is rapidly or substantially instantaneously programmable, preferably in less than 5 seconds, more preferably in about 1 second, and more preferably in about 50 to 100 milliseconds or less, and most preferably in about 1 millisecond or less.
- the preferred memory is non-volatile, permanent, and relies on antifuse-based architecture or flash memory.
- EEPROMs! electrically programmable erasable read only memories
- EEPROMs! based upon other architectures also can be used in passive devices.
- active recording devices which have batteries to assure continuous power availability
- DRAMS dynamic random access memories
- DRAMS dynamic random access memories
- Containers such as vials, tubes, microtiter plates, capsules and the like, which are in contact with a recording device that includes a data storage unit with programmable memory are also provided.
- the container is typically of a size used in immunoassays or hybridization reactions, generally a liter or less, typically less than 100 ml, and often less than about 10 ml in volume.
- the container can be in the form of a plurality of wells, such as a microtiter plate, each well having about 1 to 1.5 ml or less in volume.
- the container is transmissive to the electromagnetic radiation, such as radio frequencies, infrared wave-lengths, ultraviolet wavelengths, microwave frequencies, visible wavelengths, X-rays or laser light, used to program the recording device.
- Methods for electromagnetically tagging molecules or biological particles are provided. Such tagging is effected by placing the molecules or biological particles of interest in proximity with the recording device or with the matrix with memory, and programming or encoding the identity of the molecule or synthetic history of the molecules or batch number or other identifying information into the memory. The, thus identified molecule or biological particle is then used in the reaction or assay of interest and tracked by virtue of its linkage to the matrix with memory or its proximity to the matrix with memory, which can be queried at will to identify the molecule or biological particle.
- the tagging and/or reaction or assay protocols may be automated.
- methods for tagging constituent members of combinatorial libraries and other libraries or mixtures of diverse molecules and biological particles involve electromagnetically tagging molecules, particularly constituent members of a library, by contacting the molecules or biological particles or bringing such molecules or particles into proximity with a matrix with memory and programming the memory with retrievable information from which the identity, synthesis history, batch number or other identifying information can be retrieved.
- the contact is preferably effected by coating, completely or in part, the recording device with memory with the matrix and then linking, directly or via linkers, the molecule or biological particle of interest to the matrix support.
- the memories can be coated with a protective coating, such as a glass or silicon, which can be readily derivatized for chemical linkage or coupling to the matrix material.
- the memories can be coated with matrix, such as for example dipping the memory into the polymer prior to polymerization, and allowing the polymer to polymerize on the surface of the memory.
- the memory of each particle is addressed and the identity of the added component is encoded in the memory at before, during, or preferably after! each step in the synthesis.
- the memory contains a retrievable record of all of the constituents of the resulting molecule, which can then be used, either linked to the support, or following cleavage from the support in an assay or for screening or other such application. If the molecule is cleaved from the support with memory, the memory must remain in proximity to the molecule or must in some manner be traceable to the molecule. Such synthetic steps may be automated.
- the matrix with memory with linked molecules for biological particles! are mixed and reacted with a sample according to a screening or assay protocol, and those that react are isolated.
- the identity of reacted molecules can then be ascertained by remotely retrieving the information stored in the memory and decoding it to identify the linked molecules.
- compositions containing combinations of matrices with memories and compositions of matrices with memories and molecules or biological particles are also provided.
- coded or electronically tagged libraries of oligonucleotides, peptides, proteins, non-peptide organic molecules, phage display, viruses and cells are provided.
- Particulate matrices, such as polystyrene beads, with attached memories, and continuous matrices, such as microtiter plates or slabs or polymer, with a plurality of embedded or attached memories are provided.
- These combinations of matrix materials with memories and combinations of matrices with memories and molecules or biological particles may be used in any application in which support-bound molecules or biological particles are used. Such applications include, but are not limited to diagnostics, such as immunoassays, drug screening assays, combinatorial chemistry protocols and other such uses.
- These matrices with memories can be used to tag cells for uses in cell sorting, to identify molecules in combinatorial syntheses, to label monoclonal antibodies, to tag constituent members of phage displays, affinity separation procedures, to label DNA and RNA, in nucleic acid amplification reactions see, e.g., U.S. Pat. No. 5,403,484; U.S. Pat. No. 5,386,024; U.S. Pat. No.
- the systems for recording and reading data include: a host computer or other encoder/decoder instrument having a memory for storing data relating to the identity or synthesis of the molecules, and a transmitter means for receiving a data signal and generating a signal for transmitting a data signal; and a recording device that includes a remotely programmable, preferably non-volatile, memory and transmitter means for receiving a data signal and generating at least a transmitted signal and for providing a write signal to the memory in the recording device.
- the systems include means for writing to and reading from the memory device to store and identify each of the indicators that identify or track the molecules and biological particles.
- the systems additionally include the matrix material in physical contact with or proximate to the recording device, and may also include a device for separating matrix particles with memory so that each particle or memory can be separately programmed.
- Methods for tagging molecules and biological particles by contacting, either directly or indirectly, a molecule or biological particle with a recording device; transmitting from a host computer or decoder/encoder instrument to the device electromagnetic radiation representative of a data signal corresponding to an indicator that either specifies one of a series of synthetic steps or the identity or other information for identification of the molecule or biological particle, whereby the data point representing the indicator is written into the memory, are provided.
- Methods for reading identifying information from recording devices linked to or in contact with or in proximity to a electromagnetically tagged molecule or electromagnetically tagged biological particles include the step of exposing the recording device containing the memory in which the data is stored to electromagnetic radiation EM!; and transmitting to a host computer or decoder/encoder instrument an indicator representative of a the identity of a molecule or biological particle or identification of the molecule or biological particle linked to or in proximity to the recording device.
- One, two, three and N-dimensional arrays of the matrices with memories are also provided. Each memory is programmed with its position in the array. Such arrays may be used for blotting, if each matrix particle is coated on one at least one side with a suitable material, such as nitrocellulose. For blotting, each memory is coated on at least one side with the matrix material and arranged contiguously to adjacent memories to form a substantially continuous sheet. After blotting, the matrix particles may be separated and reacted with the analyte of interest e.g., a labeled antibody or oligonucleotide or other ligand!, after which the physical position of the matrices to which analyte binds may be determined.
- the analyte of interest e.g., a labeled antibody or oligonucleotide or other ligand!
- the amount of bound analyte, as well as the kinetics of the binding reaction, may also be quantified. Southern, Northern, Western, dot blot and other such assays using such arrays are provided. Dimensions beyond can refer to additional unique identifying parameters, such as batch number, and simultaneous analysis of multiple blots.
- Immunoassays such as enzyme linked immunosorbent assays ELISAs! in which at least one analyte is linked to a solid support matrix that is combined with a recording device containing a data storage unit with a programmable, preferably remotely programmable and non-volatile, memory are provided.
- Molecular libraries such as phage display libraries, DNA libraries, in which the constituent molecules are combined with a solid support matrix that is combined with a data storage unit with a programmable memory are provided.
- affinity purification protocols in which the affinity resin is combined with a recording device containing a data storage unit with a programmable memory are also provided.
- FIG. 1 depicts combinatorial synthesis of chemical libraries on matrix supports with memories.
- A, B, C, . . . represent the chemical building blocks; a, b, c . . . represent the codes stored in memory that correspond to each of A, B, C, . . . , respectively.
- S a , S b , S c . . . represent respective signals sent to memory.
- FIG. 2 depicts combinatorial synthesis of peptides on a matrix with memory.
- Each amino acid has a corresponding code, a, b, c . . . , in the matrix memory, and L represents a Linker between the memory device and the pharmacophore.
- FIG. 3 depicts combinatorial synthesis of oligonucleotides on matrix supports with memories.
- A, G, T and C represent nucleotides
- a, g, t, and c represent the electronic codes stored in memory that correspond to each of A, G, T and C, respectively.
- the phosphoramidite method of oligonucleotide synthesis is performed by methods known to those of skill in the art see, e.g., Brown et al. (1991) "Modern machine-aided methods of oligodeoxyribonucleotide synthesis" in Oligonucleotides Analogues EDITOR: Eckstein, Fritz (Ed), IRL, Oxford, UK., pp. 1-24, esp. pp. 4-7!.
- FIG. 4 depicts generation of a chemical library, such as a library of organic molecules, in which R 1 , R 2 , R 3 are substituents on selected molecule, such as a pharmacophore monomer, each identified with a different signal, depicted as 1, 2, or 3, from the classes S 1 , S 2 , S 3 , respectively.
- Each matrix memory can be encoded with information that represents the R n added and class S n ! thereby providing a unique code for each library member.
- FIG. 5 is a block diagram of the data storage means and supporting electrical components of a preferred embodiment.
- FIG. 6 is a diagrammatic view of the memory array within the recording device, and the corresponding data stored in the host computer memory.
- FIG. 7 is an illustration of an exemplary apparatus for separating the matrix particles with memories for individual exposure to an EM signal.
- FIG. 8 is an illustration of a second exemplary embodiment of an apparatus for separating matrix particles for individual exposure to an optical signal.
- FIG. 9 is a diagrammatic view of the memory array within the recording device, the corresponding data stored in the host computer memory, and included photodetector with amplifier and gating transistor.
- FIG. 10 is a scheme for the synthesis of the 8 member RF encoded combinatorial decameric peptide library described in EXAMPLE 4. All couplings were carried out in DMF at ambient temperature for 1 h two couplings per amino acid!, using PyBOP and EDIA or DIEA. Deprotection conditions: 20% piperidine in DMF, ambient temperature, 30 min.; Cleavage conditions: 1,2-ethanedithiol:thioanisole:water:phenol:trifluoroacetic acid 1.5:3:3:4.5:88, w/w!, ambient temperature, 1.5 h.
- a matrix refers to any solid or semisolid or insoluble support to which the memory device and/or the molecule of interest, typically a biological molecule, organic molecule or biospecific ligand is linked or contacted.
- Such materials include any materials that are used as affinity matrices or supports for chemical and biological molecule syntheses and analyses, such as, but are not limited to: polystyrene, polycarbonate, polypropylene, nylon, glass, dextran, chitin, sand, pumice, teflon, agarose, polysaccharides, dendrimers, buckyballs, polyacrylamide, silicon, rubber, and other materials used as supports for solid phase syntheses, affinity separations and purifications, hybridization reactions, immunoassays and other such applications.
- the matrix herein may be particulate or may be in the form of a continuous surface, such as a microtiter dish or well, a glass slide, a silicon chip, a nitrocellulose sheet, nylon mesh, or other such materials.
- the particles When particulate, typically the particles have at least one dimension in the 5-10 mm range or smaller.
- Such particles referred collectively herein as "beads", are often, but not necessarily, spherical. Such reference, however, does not constrain the geometry of the matrix, which may be any shape, including random shapes, needles, fibers, elongated, etc. Roughly spherical "beads" are presently preferred.
- the “beads” may include additional components, such as magnetic or paramagnetic particles see, e.g., Dyna beads (Dynal, Oslo, Norway)! for separation using magnets, as long as the additional components do not interfere with chemical reactions, data entry or retrieval from the memory.
- additional components such as magnetic or paramagnetic particles see, e.g., Dyna beads (Dynal, Oslo, Norway)! for separation using magnets, as long as the additional components do not interfere with chemical reactions, data entry or retrieval from the memory.
- matrix particles refer to matrix materials that are in the form of discrete particles.
- the particles have any shape and dimensions, but typically have at least one dimension that is 100 mm or less, preferably 50 mm or less, more preferably 10 mm or less, and typically have a size that is 100 mm 3 or less, preferably 50 mm 3 or less, more preferably 10 mm 3 or less, and most preferably 1 mm 3 or less.
- the matrices may also be continuous surfaces, such as microtiter plates e.g., plates made from polystyrene or polycarbonate or derivatives thereof commercially available from Perkin Elmer Cetus, and Covalink trays Nunc!, microtiter plate lids or a test tube, such as a 1 ml Eppendorf tube.
- microtiter plates e.g., plates made from polystyrene or polycarbonate or derivatives thereof commercially available from Perkin Elmer Cetus, and Covalink trays Nunc!, microtiter plate lids or a test tube, such as a 1 ml Eppendorf tube.
- Matrices that are in the form of containers refers to containers, such as test tubes and microtiter plates and vials that are typically used for solid phase syntheses of combinatorial libraries or as pouches, vessels, bags, and microvessels for screening and diagnostic assays.
- a container used for chemical syntheses refers to a container that typically has a volume of about 1 liter, generally 100 ml, and more often 10 ml or less, 5 ml or less, preferably 1 ml or less, and as small as about 50 ⁇ l-500 ⁇ l, such as 100 ⁇ l or 250 ⁇ l.
- This also refers to multi-well plates, such as microtiter plates.
- the microtiter plate will typically contain a recording device in, on, or otherwise in contact with in each of a plurality of wells.
- a matrix with a memory refers to a combination of a matrix with a miniature recording device that stores multiple bits of data by which the matrix may be identified, preferably in a non-volatile memory that can be written to and read from by transmission of electromagnetic radiation from a remote host, such as a computer.
- miniature is meant of a size less than about 10-20 mm 3 or 10-20 mm in the largest dimension!.
- Preferred memory devices or data storage units are miniature and are preferably smaller than 10-20 mm 3 or 10-20 mm in its largest dimension! dimension, more preferably less than 5 mm 3 , most preferably about 1 mm 3 or smaller.
- a combination named a "micro-can” herein called a microvessel refers to a combination in which a single device or more than one device! and a plurality of particles are sealed in a porous or semi-permeable inert material, such as teflon or polypropylene or membrane that is permeable to the components of the medium, or they are sealed in a small closable container that has at least one dimension that is porous or semi-permeable.
- a porous or semi-permeable inert material such as teflon or polypropylene or membrane that is permeable to the components of the medium, or they are sealed in a small closable container that has at least one dimension that is porous or semi-permeable.
- microvessels micro-cans! which preferably has at least one end that can be opened and sealed or closed tightly, has a volume of about 200-500 mm 3 , with preferred dimensions of about 1-10 mm in diameter and 5 to 20 mm in height, more preferably about 5 mm by 15 mm.
- the porous wall should be non-collapsible with a pore size in the range of 70 ⁇ M to about 100 ⁇ M, but can be selected to be semi-permeable for selected components of the reaction medium.
- a memory is a data storage unit or medium! with programmable memory, preferably a non-volatile memory.
- programming refers to the process by which data or information is entered and stored in a memory.
- a memory that is programmed is a memory that contains retrievable information.
- remotely programmable means that the memory can be programmed without direct physical or electrical contact or can be programmed from a distance, typically at least about 10 mm, although shorter distances may also be used, such as instances in which the information comes from surface or proximal reactions or from an adjacent memory or in instances, such as embodiments in which the memories are very close to each other, as in microtiter plate wells or in an array.
- a recording device is an apparatus that includes the data storage unit with programmable memory, and, if necessary, means for receiving information and for transmitting information that has been recorded. It includes any means needed or used for writing to and reading from the memory.
- the recording devices intended for use herein are miniature devices that preferably are smaller than 10-20 mm 3 or 10-20 mm in their largest dimension!, and more preferably are closer in size to 1 mm 3 or smaller that contain at least one such memory and means for receiving and transmitting data to and from the memory.
- a data storage unit with programmable memory includes any data storage means having the ability to record multiple discrete bits of data, which discrete bits of data may be individually accessed read! after one or more recording operations.
- a matrix with memory is a combination of a matrix material with a miniature data storage unit.
- programmable means capable of storing unique data points.
- Addressable means having unique locations that may be selected for storing the unique data points.
- a host computer or decoder/encoder instrument is an instrument that has been programmed with or includes information i.e., a key! specifying the code used to encode the memory devices.
- This instrument or one linked thereto transmits the information and signals to the recording device and it, or another instrument, receives the information transmitted from the recording device upon receipt of the appropriate signal.
- This instrument thus creates the appropriate signal to transmit to the recording device and can interpret transmitted signals.
- this instrument or computer can determine that this means the linked molecule is, for example, a peptide containing alanine at the N-terminus, an organic group, organic molecule, oligonucleotide, or whatever this information has been predetermined to mean.
- the information sent to and transmitted from the recording device can be encoded into the appropriate form by a person.
- an electromagnetic tag is a recording device that has a memory that contains unique data points that correspond to information that identifies molecules or biological particles linked to, directly or indirectly, in physical contact with or in proximity to the device.
- electromagnetic tagging is the process by which identifying or tracking information is transmitted by any means and to any recording device memory, including optical and magnetic storage media! to the recording device.
- proximity means within a very short distance, generally less than 0.5 inch, typically less than 0.2 inches.
- stating that the matrix material and memory, or the biological particle or molecule and matrix with memory are in proximity means that, they are at least or at least were in the same reaction vessel or, if the memory is removed from the reaction vessel, the identity of the vessel containing the molecules or biological particles with which the memory was proximate or linked is tracked or otherwise known.
- antifuse refers to an electrical device that is initially an open circuit that becomes a closed circuit during programming, thereby providing for non-volatile memory means and, when accompanied by appropriate transceiver and rectification circuitry, permitting remote programming and, hence identification.
- an antifuse is a substantially nonconductive structure that is capable of becoming substantially conductive upon application of a predetermined voltage, which exceeds a threshold voltage.
- An antifuse memory does not require a constant voltage source for refreshing the memory and, therefore, may be incorporated in a passive device.
- Other memories that may be used include, but are not limited to: EEPROMS, DRAMS and flash memories.
- flash memory is memory that retains information when power is removed see, e.g., U.S. Pat. No. 5,452,311, U.S. Pat. No. 5,452,251 and U.S. Pat. No. 5,449,941!. Flash memory can be rewritten by electrically and collectively erasing the stored data, and then by programming.
- passive device refers to an electrical device which does not have its own voltage source and relies upon a transmitted signal to provide voltage for operation.
- electromagnetic EM! radiation refers to radiation understood by skilled artisans to be EM radiation and includes, but is not limited to radiofrequency RF!, infrared IR!, visible, ultraviolet UV!, radiation, sonic waves, X-rays, and laser light.
- information identifying or tracking a biological particle or molecule refers to any information that identifies the molecule or biological particle, such as, but not limited to the identity particle i.e. its chemical formula or name!, its sequence, its type, its class, its purity, its properties, such as its binding affinity for a particular ligand. Tracking means the ability to follow a molecule or biological particle through synthesis and/or process steps.
- the memory devices herein store unique indicators that represent any of this information.
- combinatorial chemistry is a synthetic strategy that produces diverse, usually large, chemical libraries. It is the systematic and repetitive, covalent connection of a set, the basis set, of different monomeric building blocks of varying structure to each other to produce an array of diverse molecules see, e.g., Gallop et al. (1994) J. Medicinal Chemistry 37:1233-1251!. It also encompasses other chemical modifications, such as cyclizations, eliminations, cleavages, etc., that are carried in manner that generates permutations and thereby collections of diverse molecules.
- a biological particle refers to a virus, such as a viral vector or viral capsid with or without packaged nucleic acid, phage, including a phage vector or phage capsid, with or without encapsulated nucleotide acid, a single cell, including eukaryotic and prokaryotic cells or fragments thereof, a liposome or micellar agent or other packaging particle, and other such biological materials.
- a virus such as a viral vector or viral capsid with or without packaged nucleic acid, phage, including a phage vector or phage capsid, with or without encapsulated nucleotide acid, a single cell, including eukaryotic and prokaryotic cells or fragments thereof, a liposome or micellar agent or other packaging particle, and other such biological materials.
- the molecules in the combinations include any molecule, including nucleic acids, amino acids, other biopolymers, and other organic molecules, including peptidomimetics and monomers or polymers of small organic molecular constituents of non-peptidic libraries, that my be identified by the methods here.
- bio-oligomer refers to a biopolymer of less than about 100 subunits.
- a bio-oligomer includes, but is not limited to, a peptide, i.e., containing amino acid subunits, an oligonucleotide, i.e., containing nucleoside subunits, a peptide-oligonucleotide chimera, peptidomimetic, and a polysaccharide.
- sequences of random monomer subunits refers to polymers or oligomers containing sequences of monomers in which any monomer subunit may proceed or follow any other monomer subunit.
- library refers to a collection of substantially random compounds or biological particles expressing random peptides or proteins.
- bio-oligomers biopolymers, or diverse organic compounds or a set of compounds prepared from monomers based on a selected pharmacophore.
- an analyte is any substance that is analyzed or assayed in the reaction of interest.
- analytes include the substrates, products and intermediates in the reaction, as well as the enzymes and cofactors.
- multianalyte analysis is the ability to measure many analytes in a single specimen or to perform multiple tests from a single specimen.
- the methods and combinations herein provide means to identify or track individual analytes from among a mixture of such analytes.
- a peptidomimetic is a compound that mimics the conformation and certain stereochemical features of the biologically active form of a particular peptide.
- peptidomimetics are designed to mimic certain desirable properties of a compound but not the undesirable features, such as flexibility leading to a loss of the biologically active conformation and bond breakdown.
- methylenethio bioisostere CH 2 S! has been used as an amide replacement in enkephalin analogs see, e.g., Spatola, A. F. Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins Weinstein, B., Ed., Vol. 7, pp.
- complete coupling means that the coupling reaction is driven substantially to completion despite or regardless of the differences in the coupling rates of individual components of the reaction, such as amino acids.
- the amino acids, or whatever is being coupled are coupled to substantially all available coupling sites on the solid phase support so that each solid phase support will contain essentially only one species of peptide.
- the biological activity or bioactivity of a particular compound includes any activity induced, potentiated or influenced by the compound in vivo or in vitro. It also includes the abilities, such as the ability of certain molecules to bind to particular receptors and to induce or modulate! a functional response. It may be assessed by in vivo assays or by in vitro assays, such as those exemplified herein.
- pharmaceutically acceptable salts, esters or other derivatives of the compounds include any salts, esters or derivatives that may be readily prepared by those of skill in this art using known methods for such derivatization and that produce compounds that may be administered to animals or humans without substantial toxic effects and that either are pharmaceutically active or are prodrugs.
- hydroxy groups can be esterified or etherified.
- substantially pure means sufficiently homogeneous to appear free of readily detectable impurities as determined by standard methods of analysis, such as thin layer chromatography TLC!, mass spectrometry MS!, size exclusion chromatography, gel electrophoresis, particularly agarose and polyacrylamide gel electrophoresis PAGE! and high performance liquid chromatography HPLC!, used by those of skill in the art to assess such purity, or sufficiently pure such that further purification would not detectably alter the physical and chemical properties, such as enzymatic and biological activities, of the substance.
- Methods for purification of the compounds to produce substantially chemically pure compounds are known to those of skill in the art.
- a substantially chemically pure compound may, however, be a mixture of stereoisomers. In such instances, further purification might increase the specific activity of the compound.
- adequately pure or “pure” per se means sufficiently pure for the intended use of the adequately pure compound.
- biological activity refers to the in vivo activities of a compound or physiological responses that result upon in vivo administration of a compound, composition or other mixture. Biological activity, thus, encompasses therapeutic effects and pharmaceutical activity of such compounds, compositions and mixtures.
- a prodrug is a compound that, upon in vivo administration, is metabolized or otherwise converted to the biologically, pharmaceutically or therapeutically active form of the compound.
- the pharmaceutically active compound is modified such that the active compound will be regenerated by metabolic processes.
- the prodrug may be designed to alter the metabolic stability or the transport characteristics of a drug, to mask side effects or toxicity, to improve the flavor of a drug or to alter other characteristics or properties of a drug.
- amino acids refer to the naturally-occurring amino acids and any other non-naturally occurring amino acids, and also the corresponding D-isomers. It is also understood that certain amino acids may be replaced by substantially equivalent non-naturally occurring variants thereof, such as D-Nva, D-Nle, D-Alle, and others listed with the abbreviations below or known to those of skill in this art.
- hydrophobic amino acids include Ala, Val, Leu, lle, Pro, Phe, Trp, and Met, the non-naturally occurring amino acids and the corresponding D isomers of the hydrophobic amino acids, that have similar hydrophobic properties;
- the polar amino acids include Gly, Ser, Thr, Cys, Tyr, Asn, Gln, the non-naturally occurring amino acids and the corresponding D isomers of the polar amino acids, that have similar properties
- the charged amino acids include Asp, Glu, Lys, Arg, His, the non-naturally occurring amino acids and the corresponding D isomers of these amino acids.
- Southern, Northern, Western and dot blot procedures refer to those in which DNA, RNA and protein patterns, respectively, are transferred for example, from agarose gels, polyacrylamide gels or other suitable medium that constricts convective motion of molecules, to nitrocellulose membranes or other suitable medium for hybridization or antibody or antigen binding are well known to those of skill in this art see, e.g., Southern (1975) J. Mol. Biol. 98:503-517; Ketner et al. (1976) Proc. Natl. Acad. Sci. U.S.A. 73:1102-1106; Towbin et al. (1979) Proc. Natl. Acad. Sci. U.S.A. 76:4350!.
- Fmoc is 9-fluorenylmethoxycarbonyl
- BOP is benzotriazol-1-yloxytris(dimethylamino) phosphonium hexafluorophosphate
- DCC is dicyclohexylcarbodiimide
- DDZ is dimethoxydimethylbenzyloxy
- DMT is dimethoxytrityl
- FMOC is fluorenylmethyloxycarbonyl
- HBTU 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium
- hexafluorophosphate NV is nitroveratryl
- NVOC is 6-nitroveratryloxycarbonyl and other photoremovable groups
- TFA is trifluoroacetic acid
- DMF for N,N-dimethylformamide
- Boc is tert-butoxycarbonyl
- TFA for trifluoroacetic acid
- HF for hydrogen fluoride
- HATU O(7-azabenzotriaol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate
- EDT 1,2-ethanedithiol Protected amino acids are readily available to those of skill in this art.
- Fmoc and Boc protected amino acids can be obtained from Fluka, Bachem, Advanced Chemtech, Sigma, Cambridge Research Biochemical, Bachem, or Peninsula Labs or other chemical companies familiar to those who practice this art.
- Matrices which are generally insoluble materials used to immobilize ligands and other molecules, have application in many chemical syntheses and separations. Matrices are used in affinity chromatography, in the immobilization of biologically active materials, and during chemical syntheses of biomolecules, including proteins, amino acids and other organic molecules and polymers.
- the preparation of matrices is well known to those of skill in this art; there are many such materials and preparations thereof known. For example, naturally-occurring matrix materials, such as agarose and cellulose, may be isolated from their respective sources, and processed according to known protocols, and synthetic materials may be prepared in accord with known protocols.
- Matrices include any material that can act as a support matrix for attachment of the molecules or biological particles of interest and can be in contact with or proximity to with, preferably encasing or coating, the data storage device with programmable memory. Any matrix composed of material that is compatible with and upon or in which chemical syntheses are performed, including biocompatible polymers, is suitable for use herein. The matrix material should be selected so that it does not interfere with the chemistry or biological reaction of interest during the time which the molecule or particle is linked in close proximity thereto see, e.g., U.S. Pat. No. 4,006,403!.
- These matrices thus include any material to which the data storage device with memory can be attached, placed in proximity thereof, impregnated, encased or otherwise connected, linked or physically contacted. Such materials are known to those of skill in this art, and include those that are used as a support matrix.
- These materials include, but are not limited to, inorganics, natural polymers, and synthetic polymers, including, but are not limited to: cellulose, cellulose derivatives, acrylic resins, glass, silica gels, polystyrene, gelatin, polyvinyl pyrrolidone, co-polymers of vinyl and acrylamide, polystyrene cross-linked with divinylbenzene or the like see, Merrifield (1964) Biochemistry 3:1385-1390!, polyacrylamides, latex gels, polystyrene, dextran, polyacrylamides, rubber, silicon, plastics, nitrocellulose, celluloses, natural sponges, and many others.
- polymeric beads such as the TentaGelTM resins and derivatives thereof sold by Rapp Polymere, Tubingen, Germany; see, U.S. Pat. No. 4,908,405 and U.S. Pat. No. 5,292,814; see, also Butz et al. (1994) Peptide Res. 7:20-23; Kleine et al. (1994) Immunobiol. 190:53-66; see, also Piskin et al. (1994), Chapter 18 "Nondegradable and Biodegradable Polymeric Particles" in Diagnostic Biosensor Polymers, ACS Symp.Series 556, Usmani et al.
- Each such "bead” may contain one or more memories.
- the solid phase chemistry and subsequent assaying may be performed on the same bead. All procedures can be automated.
- the matrices are typically insoluble substrates that are solid, porous, deformable, or hard, and have any required structure and geometry, including, but not limited to: beads, pellets, disks, capillaries, hollow fibers, needles, solid fibers, random shapes, thin films and membranes.
- the particles are at least about 10-2000 ⁇ M.
- the support material will encase or be in contact with the data storage device, and, thus, will desirably have at least one dimension on the order of 1 mm 1000 ⁇ M! or more, although smaller particles may be contacted with the data storage devices.
- Each memory will be in contact with or proximity to at least one matrix particle, and may be in contact with more than one.
- the size of the memory and size of the particles can be decreased.
- 0.5 micron semiconductor devices are available.
- Integrated circuits 0.25-micron in size have been described and are being developed using a technology called the Complementary Metal Oxide-Semiconductor process (see, e.g., Investor's Business Daily May 30, 1995).
- larger matrix particles which advantageously provide ease of handling, may be used and may be in contact with or proximity to more than one memory (i.e., one particle may have a plurality of memories in proximity or linked to it; each memory may programmed with different data regarding the matrix particle, linked molecules, synthesis or assay protocol, etc.!.
- macro-beads Rost Polymere, Tubingen, Germany
- Particles of such size can be readily manipulated and the memory can be readily impregnated in or on the bead.
- These beads are also advantageous because of their uniformity in size, which is useful when automating the processes for electronically tagging and assaying the beads.
- Selection of these matrices will be governed, at least in part, by their physical and chemical properties, such as solubility, functional groups, mechanical stability, surface area swelling propensity, hydrophobic or hydrophilic properties and intended use.
- the data storage device with programmable memory may be coated with a material, such as a glass or a plastic, that can be further derivatized and used as the support or it may be encased, partially or completely, in the matrix material, such as during or prior to polymerization of the material.
- a material such as a glass or a plastic
- Such coating may be performed manually or may be automated.
- the coating can be effected manually or using instruments designed for coating such devices. Instruments for this purpose are available see, e.g., the Series C3000 systems for dipping available from Specialty Coating Systems, Inc., Indianapolis, Ind.; and the Series CM 2000 systems for spray coating available from Integrated Technologies, Inc. Acushnet, Mass.!.
- the data storage device with memory may be physically inserted into the matrix material or particle. It also can be manufactured with a coating that is suitable for use as a matrix or that includes regions in the coating that are suitable for use as a matrix. If the matrix material is a porous membrane, it may be placed inside the membrane. It is understood that when the memory device is encased in the matrix or coated with protective material, such matrix or material must be transparent to the signal used to program the memory for writing or reading data. More than one matrix particle may be linked to each data storage device.
- the data storage device with memory is coated with a polymer, which is then treated to contain an appropriate reactive moiety or in some cases the device may be obtained commercially already containing the reactive moiety, and may thereby serve as the matrix support upon which molecules or biological particles are linked.
- Materials containing reactive surface moieties such as amino silane linkages, hydroxyl linkages or carboxysilane linkages may be produced by well established surface chemistry techniques involving silanization reactions, or the like.
- Examples of these materials are those having surface silicon oxide moieties, covalently linked to gamma-aminopropylsilane, and other organic moieties; N- 3-(triethyoxysilyl)propyl!phthelamic acid; and bis-(2-hydroxyethyl)aminopropyltriethoxysilane.
- Exemplary of readily available materials containing amino group reactive functionalities include, but are not limited to, para-aminophenyltriethyoxysilane.
- the data storage device with memory generally should not or cannot be exposed to the reaction solution, and, thus, must be coated with at least a thin layer of a glass or ceramic or other protective coating that does not interfere with the operation of the device.
- These operations include electrical conduction across the device and transmission of remotely transmitted electromagnetic radiation by which data are written and read. It is such coating that may also serve as a matrix upon which the molecules or biological particles may be linked.
- the data storage devices with memory may be coated either directly or following coating with a ceramic, glass or other material, may then be coated with agarose, which is heated, the devices are dipped into the agarose, and then cooled to about room temperature.
- the resulting glass, silica, agarose or other coated memory device may be used as the matrix supports for chemical syntheses and reactions.
- biosensors are chemosensors with a biological detection system, generally biologically active substances, such as enzymes, antibodies, lectins and hormone receptors, which are immobilized on the surface of the sensor electrode or in a thin layer on the sensor electrode!, which measure electrochemical solution parameters, such as pH.
- the combinations herein are not biosensors, which include electrodes that must be in contact with the solution such that molecules in solution directly contact the electrode, and which measure solution parameters.
- the combinations herein are matrix materials with recording devices that contain data storage units that include remotely programmable memories; the recording devices used in solution must be coated with a material that prevents contact between the recording device and the medium, such as the solution or air or gas e.g., nitrogen or oxygen or CO 2 !.
- the devices herein may be combined with biosensors or other such sensor devices and used in connection therewith to monitor information obtained by the biosensor or to transmit information to the biosensor or used to monitor the location of a biosensor or to transmit information from the biosensor if used internally in an animal.
- Naturally-occurring supports include, but are not limited to agarose, other polysaccharides, collagen, celluloses and derivatives thereof, glass, silica, and alumina. Methods for isolation, modification and treatment to render them suitable for use as supports is well known to those of skill in this art see, e.g., Hermanson et al. (1992) Immobilized Affinity Ligand Techniques, Academic Press, Inc., San Diego!. Gels, such as agarose, can be readily adapted for use herein. Natural polymers such as polypeptides, proteins and carbohydrates; metalloids, such as silicon and germanium, that have semiconductive properties, as long as they do not interfere with operation of the data storage device may also be adapted for use herein.
- metals such as platinum, gold, nickel, copper, zinc, tin, palladium, silver, again as long as the combination of the data storage device with memory, matrix support with molecule or biological particle does not interfere with operation of the device with memory, may be adapted for use herein.
- Other matrices of interest include oxides of the metal and metalloids such as Pt--PtO, Si--SiO, Au--AuO, TiO2, Cu--CuO, and the like.
- compound semiconductors such as lithium niobate, gallium arsenide and indium-phosphide, and nickel-coated mica surfaces, as used in preparation of molecules for observation in an atomic force microscope see, e.g., III et al. (1993) Biophys J. 64:919! may be used as matrices. Methods for preparation of such matrix materials are well known.
- U.S. Pat. No. 4,175,183 describes a water insoluble hydroxyalkylated cross-linked regenerated cellulose and a method for its preparation.
- a method of preparing the product using near stoichiometric proportions of reagents is described.
- Use of the product directly in gel chromatography and as an intermediate in the preparation of ion exchangers is also described.
- Synthetic matrices are typically produced by polymerization of functional matrices, or copolymerization from two or more monomers of from a synthetic monomer and naturally occurring matrix monomer or polymer, such as agarose. Before such polymers solidify, they are contacted with the data storage device with memory, which can be cast into the material or dipped into the material. Alternatively, after preparation of particles or larger synthetic matrices, the recording device containing the data storage unit(s) can be manually inserted into the matrix material. Again, such devices can be pre-coated with glass, ceramic, silica or other suitable material.
- Synthetic matrices include, but are not limited to: acrylamides, dextran-derivatives and dextran co-polymers, agarose-polyacrylamide blends, other polymers and co-polymers with various functional groups, methacrylate derivatives and co-polymers, polystyrene and polystyrene copolymers see, e.g., Merrifield (1964) Biochemistry 3:1385-1390; Berg et al. (1990) in Innovation Perspect. Solid Phase Synth. Collect. Pap., Int. Symp., 1st, Epton, Roger (Ed), pp. 453-459; Berg et al. (1989) in Pept., Proc. Eur. Pept.
- Synthetic matrices include those made from polymers and co-polymers such as polyvinylalcohols, acrylates and acrylic acids such as polyethylene-co-acrylic acid, polyethylene-co-methacrylic acid, polyethylene-co-ethylacrylate, polyethylene-co-methyl acrylate, polypropylene-co-acrylic acid, polypropylene-co-methyl-acrylic acid, polypropylene-co-ethylacrylate, polypropylene-co-methyl acrylate, polyethylene-co-vinyl acetate, polypropylene-co-vinyl acetate, and those containing acid anhydride groups such as polyethylene-co-maleic anhydride, polypropylene-co-maleic anhydride and the like.
- Liposomes have also been used as solid supports for affinity purifications Powell et al. (1989) Biotechnol. Bioeng. 33:173!.
- U.S. Pat. No. 5,403,750 describes the preparation of polyurethane-based polymers.
- U.S. Pat. No. 4,241,537 describes a plant growth medium containing a hydrophilic polyurethane gel composition prepared from chain-extended polyols; random copolymerization is preferred with up to 50% propylene oxide units so that the prepolymer will be a liquid at room temperature.
- U.S. Pat. No. 3,939,123 describes lightly crosslinked polyurethane polymers of isocyanate terminated prepolymers containing poly(ethyleneoxy) glycols with up to 35% of a poly(propyleneoxy) glycol or a poly(butyleneoxy) glycol.
- an organic polyamine is used as a crosslinking agent.
- Other matrices and preparation thereof are described in U.S. Pat. Nos. 4,177,038, 4,175,183, 4,439,585, 4,485,227, 4,569,981, 5,092,992, 5,334,640, 5,328,603.
- U.S. Pat. No. 4,162,355 describes a polymer suitable for use in affinity chromatography, which is a polymer of an aminimide and a vinyl compound having at least one pendant halo-methyl group.
- An amine ligand which affords sites for binding in affinity chromatography is coupled to the polymer by reaction with a portion of the pendant halo-methyl groups and the remainder of the pendant halo-methyl groups are reacted with an amine containing a pendant hydrophilic group.
- a method of coating a substrate with this polymer is also described.
- An exemplary aminimide is 1,1-dimethyl-1-(2-hydroxyoctyl)amine methacrylimide and vinyl compound is a chloromethyl styrene.
- U.S. Pat. No. 4,171,412 describes specific matrices based on hydrophilic polymeric gels, preferably of a macroporous character, which carry covalently bonded D-amino acids or peptides that contain D-amino acid units.
- the basic support is prepared by copolymerization of hydroxyalkyl esters or hydroxyalkylamides of acrylic and methacrylic acid with crosslinking acrylate or methacrylate comonomers are modified by the reaction with diamines, aminoacids or dicarboxylic acids and the resulting carboxyterminal or aminoterminal groups are condensed with D-analogs of aminoacids or peptides.
- the peptide containing D-aminoacids also can be synthesized stepwise on the surface of the carrier.
- U.S. Pat. No. 4,178,439 describes a cationic ion exchanger and a method for preparation thereof.
- U.S. Pat. No. 4,180,524 describes chemical syntheses on a silica support.
- Immobilized Artificial Membranes IAMs; see, e.g., U.S. Pat. Nos. 4,931,498 and 4,927,879! may also be used. IAMs mimic cell membrane environments and may be used to bind molecules that preferentially associate with cell membranes see, e.g., Pidgeon et al. (1990) Enzyme Microb. Technol. 12:149!.
- a solution of the protein or other biomolecule is contacted with a support material such as alumina, carbon, an ion-exchange resin, cellulose, glass or a ceramic.
- a support material such as alumina, carbon, an ion-exchange resin, cellulose, glass or a ceramic.
- Fluorocarbon polymers have been used as supports to which biomolecules have been attached by adsorption see, U.S. Pat. No. 3,843,443; Published International PCT Application WO/86 03840!.
- U.S. Pat. No. 5,451,683! A large variety of methods are known for attaching biological molecules, including proteins and nucleic acids, molecules to solid supports see. e.g., U.S. Pat. No. 5,451,683!.
- U.S. Pat. No. 4,681,870 describes a method for introducing free amino or carboxyl groups onto a silica matrix. These groups may subsequently be covalently linked to other groups, such as a protein or other anti-ligand, in the presence of a carbodiimide.
- a silica matrix may be activated by treatment with a cyanogen halide under alkaline conditions. The anti-ligand is covalently attached to the surface upon addition to the activated surface.
- Another method involves modification of a polymer surface through the successive application of multiple layers of biotin, avidin and extenders see, e.g., U.S. Pat. No. 4,282,287!; other methods involve photoactivation in which a polypeptide chain is attached to a solid substrate by incorporating a light-sensitive unnatural amino acid group into the polypeptide chain and exposing the product to low-energy ultraviolet light see, e.g., U.S. Pat. No. 4,762,881!. Oligonucleotides have also been attached using a photochemically active reagents, such as a psoralen compound, and a coupling agent, which attaches the photoreagent to the substrate see, e.g., U.S. Pat. No. 4,542,102 and U.S. Pat. No. 4,562,157!. Photoactivation of the photoreagent binds a nucleic acid molecule to the substrate to give a surface-bound probe.
- Covalent binding of the protein or other biomolecule or organic molecule or biological particle to chemically activated solid matrix supports such as glass, synthetic polymers, and cross-linked polysaccharides is a more frequently used immobilization technique.
- the molecule or biological particle may be directly linked to the matrix support or linked via linker, such as a metal see, e.g., U.S. Pat. No. 4,179,402; and Smith et al. (1992) Methods: A Companion to Methods in Enz. 4:73-78!.
- An example of this method is the cyanogen bromide activation of polysaccharide supports, such as agarose.
- perfluorocarbon polymer-based supports for enzyme immobilization and affinity chromatography is described in U.S. Pat.
- the biomolecule is first modified by reaction with a perfluoroalkylating agent such as perfluorooctylpropylisocyanate described in U.S. Pat. No. 4,954,444. Then, the modified protein is adsorbed onto the fluorocarbon support to effect immobilization.
- a perfluoroalkylating agent such as perfluorooctylpropylisocyanate described in U.S. Pat. No. 4,954,444.
- matrices are well known and may be effected by any such known methods see, e.g., Hermanson et al. (1992) Immobilized Affinity Ligand Techniques, Academic Press, Inc., San Diego!.
- the coupling of the amino acids may be accomplished by techniques familiar to those in the art and provided, for example, in Stewart and Young, 1984, Solid Phase Synthesis, Second Edition, Pierce Chemical Co., Rockford.
- Molecules may also be attached to matrices through kinetically inert metal ion linkages, such as Co(III), using, for example, native metal binding sites on the molecules, such as IgG binding sequences, or genetically modified proteins that bind metal ions see, e.g., Smith et al. (1992) Methods: A Companion to Methods in Enzymology 4, 73 (1992); III et al. (1993) Biophys J. 64:919; Loetscher et al. (1992) J. Chromatography 595:113!.
- kinetically inert metal ion linkages such as Co(III)
- Any remotely programmable data storage device that can be linked to or used in proximity to the solid supports and molecules and biological particles as described herein is intended for use herein.
- Preferred devices are rapidly and readily programmable using penetrating electromagnetic radiation, such as radio frequency or visible light lasers, operate with relatively low power, have fast access preferably 1 sec or less, more preferably 10 2 -10 3 sec!, and are remotely programmable so that information can be stored or programmed and later retrieved from a distance, as permitted by the form of the electromagnetic signal used for transmission.
- the transmitter/receiver system which transfers the data between the recording device and the host computer and which is preferably integrated on the same substrate as the memory, also supplies the power to program and retrieve the data stored in the chip memory. This is effected by integrating a rectifier circuit onto the substrate to convert the received signal into an operating voltage.
- an active device can include a battery see, e.g., U.S. Pat. No. 5,442,940, U.S. Pat. No. 5,350,645, U.S. Pat. No. 5,212,315, U.S. Pat. No. 5,029,214, U.S. Pat. No. 4,960,983! to supply the power to provide an operating voltage to the memory device.
- the memory can be an EEPROM, a DRAM, or other erasable memory requiring continuous power to retain information. It may be desirable to combine the antenna/rectifier circuit combination with a battery to create a passive/active device, with the voltages supplied by each source supplementing each other.
- the transmitted signal could provide the voltage for writing and reading, while the battery, in addition to supplementing this voltage, provides a refresh voltage for a DRAM memory so that data is retained when the transmitted signal is removed.
- the remotely programmable device can be programmed sequentially to be uniquely identifiable during and after stepwise synthesis of macromolecules or before, or during, or after selection of screened molecules.
- the data storage units are information carriers in which the functions of writing data and reading the recorded data are empowered by an electromagnetic signal generated and modulated by a remote host controller.
- the data storage devices are inactive, except when exposed to the appropriate electromagnetic signal.
- the devices may be optically or magnetically programmable read/write devices.
- the programmable devices intended for use herein include any device that can record or store data.
- the preferred device will be remotely programmable and will be small, typically on the order of 10-20 mm 3 or 10-20 mm in its largest dimension! or, preferably smaller. Any means for remote programming and data storage, including semiconductors and optical storage media are intended for use herein.
- the data storage unit includes a semiconductor chip with integrated circuits formed thereon including a memory and its supporting circuitry. These devices can be written to and interrogated from a distance.
- a radiofrequency transmitter/receiver system supplies power to program and retrieve data.
- the data storage unit preferably includes a programmable read only semiconductor memory PROM!, preferably a non-volatile memory or other memory that can store data for future retrieval, that will have information describing or identifying the molecules or biological particles linked to or in proximity to the matrix.
- This information either identifies the molecule or biological particles including a phage and viral particles, bacteria, cells and fragments thereof, provides a history of the synthesis of the molecule, or provides information, such as a batch number, quality control data, reaction number, and/or identity of the linked entity.
- the memory is programmed, before, during or, preferably, after, each step of synthesis and can thereafter be read, thereby identifying the molecule or its components and order of addition, or process of synthesis.
- the memory devices which are about 1-20 mm 3 in size or less, are rapidly programmable 1 sec, preferably 1 msec or less!, can be interrogated from a distance, and are programmable using electromagnetic radiation, preferably frequencies, such as those within the radiofrequency range, that do not alter the assessed activities of the molecules and biological particles of interest.
- a battery may be used as to supply the power to provide an operating voltage to the memory device.
- the memory can be an EEPROM, a DRAM, or other erasable memory requiring continuous power to retain information.
- the transmitted signal could provide the voltage for writing and reading, while the battery, in addition to supplementing this write/read voltage, provides a refresh voltage for a DRAM memory so that data is retained when the transmitted signal is removed.
- An antifuse contains a layer of antifuse material sandwiched between two conductive electrodes.
- the antifuse device is initially an open circuited device in its unprogrammed state and can be irreversibly converted into an essentially short circuited device by the application of a programming voltage across the two electrodes to disrupt the antifuse material and create a low resistance current path between the two electrodes.
- An exemplary antifuse structure for use herein is formed by defining a word line of heavily N-doped polysilicon on an insulating substrate, depositing an antifuse layer of lightly N-doped semiconductor over the polysilicon, and defining a metal address or bit! line upon and in electrical contact with the antifuse layer.
- the semiconductor material used for the antifuse layer is typically selected from among silicon, germanium, carbon and alpha-tin. The properties of the semiconductor material are such that the material is essentially non-conductive as long as the voltage across it does not exceed a threshold level. Once the threshold voltage is exceeded, a conductive filament is formed through the semiconductor so that the resistance between the metal and polysilicon lines at the points at which they cross irreversibly switches from a high resistance state to a relatively low resistance state.
- a voltage of sufficiently high electrical field strength is placed across the antifuse film to create a short circuit.
- the voltage level required to induce breakdown is determined by the level of dopant in the antifuse layer. As breakdown occurs electrical current will flow through one small region of the film. The current is limited by the resistance of the filament itself as well as any series resistance of conductive layers or logic devices transistors! in series with the antifuse.
- U.S. Pat. No. 5,095,362 provides a method for fabricating a layer of programmable material within an antifuse that exhibits relatively lower than normal resistance in its programmed state and also provides a semiconductor device containing an antifuse film of the type composed of semiconductor material having a first electrical state that is characterized by high electrical resistivity and a second electrical state that is characterized by low electrical resistivity.
- the means for selectively decreasing resistivity includes nonactivated conductive dopants that are ion implanted within the otherwise highly resistive semiconductor material.
- the dopants as implanted are in a nonactivated state so that the dopants do not enhance the conduction of carriers in the film. Once activated, the dopants enhance the conduction of carriers in the film.
- Activation of the dopants occurs upon application of a threshold voltage across a predetermined and selected portion of the material in which the dopants are disposed. The selected portion is defined by the crossover point of selected word and bit or address! lines.
- the dopants are N-type, selected from among antimony, phosphorous, arsenic, and others to provide additional charge carriers.
- the implant dosage is used to determine the threshold voltage level that will be required to induce formation of the conductive filament.
- P-type dopants, such as boron may also be used to affect a change in programming voltage.
- a recording device containing a non-volatile electrically-programmable read-only memory ROM! 102 that utilizes antifuse technology or EEPROM or other suitable memory! is combined on a single substrate 100 with a thin-film planar antenna 110 for receiving/transmitting an RF signal 104, a rectifier 112 for deriving a voltage from a received radio frequency RF! signal, an analog-to-digital converter ADC! 114 for converting the voltage into a digital signal for storage of data in the memory, and a digital-to-analog converter DAC! 116 for converting the digital data into a voltage signal for transmission back to the host computer is provided.
- a single substrate 100 is preferred to provide the smallest possible chip, and to facilitate encapsulation of the chip with a protective, polymer shell or shell+matrix or matrix material! 90.
- Shell 90 must be non-reactive with and impervious to the various processes that the recording device is being used to track in order to assure the integrity of the memory device components on the chip.
- Materials for the shell include any such materials that are known to those of skill in the art see, e.g., Hiroshi et al., eds. (1995) Polymeric Materials for Microelectronic Applications: Science and Technology, ACS Symposium Series No. 579!, including glasses, ceramics, plastics and other inert coatings.
- the finished chip on which all of the listed components are integrated is on the order of 1 mm ⁇ 1 mm ⁇ 40 mils ⁇ 40 mils!, with a memory capacity of about 1024 bits, but can have greater or lesser capacity as required or desired. Greater memory capacity, where needed, and smaller chips, however, will be preferred.
- the chip may be larger to accommodate more memory if desired, or may be smaller as design rules permit smaller transistors and higher device densities, i.e., greater memory capacity.
- the individual memory cells are arranged in matrices of orthogonal conductive word and bit lines to obtain the smallest possible memory array size. For example, for 1024 bits of memory, there are 32 word lines and 32 bit lines for a square matrix. Memories with greater capacity may also be used.
- Schottky diodes are formed generally corresponding to the points at which the word and bit lines cross. The word and bit lines are separated by an undoped or lightly-doped semiconductor layer with interstitial doping. The semiconductor layer may also be amorphous silicon with implanted dopants in a nonactivated state. Each of these crossover points is a memory cell and is the equivalent of a programmable switch in series with a Schottky diode.
- an antifuse memory device has all of its switches in the OFF state.
- a switch is turned on by applying a voltage in excess of a pre-determined threshold voltage to one of the word lines while setting a selected bit line to a low logic level.
- the threshold voltage is determined by the impedance of the semiconductor layer, i.e., its doping level.
- the impedance can be less than 200 ohms with a threshold voltage for programming as low as 3 volts. Since in the embodiment described herein the programming voltage is provided solely by the rectified RF signal, a low threshold is preferred.
- Information to be written into the memory need not be detailed since the data stored in the memory is primarily acting as an identification marker that is traceable to a more detailed record stored in the host computer memory 120, independent of the memory associated with the matrix support or tagged molecule or biological particle.
- the RF signal from transmitter 80 that is used to provide the power and the signal to the matrix particle memory need only address a single memory cell to indicate that a nascent oligomer linked to or in proximity to the memory device has been subjected to a given process step or to identify a molecule or biological particle.
- a conventional "push-pull" type of address decoder where only one bit line and one word line are driven high and low, respectively, at any given time, may be used.
- a sophisticated memory addressing system need not be provided on the matrix particle memory chip, and shift registers may be used to control memory addressing.
- a microprocessor which is mask-programmed during the fabrication process for controlling an address bus which connects the ADC 114 and the DAC 116 to the memory array may also be built onto the same substrate on which the memory and other components are integrated.
- Other integrated means for selectively addressing locations within the memory are known and will be apparent to the practitioner skilled in the art.
- antifuse memories are well known in the art. These memories include structures in which the word and bit lines may both be made of either N+ polysilicon or metal aluminum or aluminum-silicon!, separated by silicon dioxide (SiO 2 ), silicon nitride (Si 3 N 4 ), combinations thereof, or amorphous silicon alone or in combination with SiO 2 and/or Si 3 N 4 . In each case, a short circuit is created at locations in the antifuse material corresponding to the crossover location of selected word and bit lines by applying a voltage in excess of a pre-determined threshold voltage.
- non-volatility of the memory or the ability to lock or prevent erasure is preferred since power is applied to the chip only when it is subjected to the RF or other transmission signal for reading or reading and writing. Further considerations are the voltage levels required for writing into memory, since the threshold voltage must be less than the maximum voltage of the rectified RF signal in order to assure that sufficient voltage is always available during the writing process.
- the write voltage may be enhanced by supplementing the RF-supplied voltage with optically-generated voltage, such as a photocell. Photocells on semiconductor substrates are well known in the art and could be easily integrated onto the chip. A laser or other light source could be readily included in the write apparatus to illuminate the chip coincident with transmission of the RF write signal. Similarly, other forms of electromagnetic radiation may be used to provide additional power, if needed.
- antifuse memories are not designed to be erasable, it may be desirable to re-use the devices if the memory becomes full. In such instances, conventional electrically programmable erasable read only memories EEPROMs! may be used instead. Since EEPROMs require higher write voltage levels, it may be desirable to supplement the RF-supplied voltage as described above. In EEPROMs, stored data can be erased by exposing the device to UV light.
- Signal rectifier 112 may be one or more Schottky diode(s), making it readily incorporated into the fabrication process used for the memory array. Other means for signal rectification may be used as are known.
- the ADC 114 and DAC 116 are well-known devices and are readily integrated onto the substrate 100 using the fabrication process described in the references for the memory array. Radio frequency modulation techniques, which are known in the art, for example, pulse code modulation, may be adapted to permit direct digital transmission, in which case the ADC and DAC may not be required.
- Antenna 110 is formed during the fabrication process using conventional photolithographic techniques to provide one or more metal structures, such as aluminum, to receive a pre-determined wavelength RF transmission.
- the antenna may be a simple straight line half-wave antenna which is created by patterning a structure during the second metal process steps so that the structure has a length equal to one-half of the wavelength of the selected RF transmission frequency in free space.
- Another option for formation of the antenna is as a small loop, either on a dedicated portion of the chip, or encircling the other components of the chip, also formed during the second metal step of the fabrication process.
- the first and second metal steps include depositing a layer of aluminum, then patterning the aluminum photolithographically followed by a plasma etch to define the desired features. Except where vias are formed, the two metal layers are separated by a dielectric film. Dipole antennas may be formed by patterning the second metal in a similar manner, with the dimensions of the antenna being selected for the appropriate RF frequency.
- the two metal layers may also be used to form a microstrip antenna structure by selecting the dielectric film between the metal layers such that it has a dielectric constant and thickness appropriate so that the microstrip is resonant at one-half of the RF wavelength.
- the first metal layer provides the ground plane.!
- the metal structures which may be square patches, circles, lines, or other geometries, are defined photolithographically during the normal masking steps of the first and second metal processes.
- Other antenna structures which can be configured as a thin film device for integration onto a common substrate with the memory structure and other components may be used and will be apparent to those skilled in the art.
- a resonant circuit inductor-capacitor! can be readily integrated onto the chip, with the resonant circuit being tuned to the RF carrier signal of the transmitter.
- Frequency tuning of either an antenna or resonant circuit can provide additional coding capability.
- a first group of memory devices can be tuned to receive a carrier wave of a first RF frequency, e.g., f 1
- a second group could be tuned to receive a second frequency f 2 , and so on.
- the separate carrier frequencies could provide additional means for tracking or providing information to the devices, even if the groups become intermixed.
- the RF antenna may, in an alternate embodiment, be formed external to the semiconductor substrate.
- a separate conductive wire which acts as an antenna, will be attached to a bond pad formed on the chip using methods known to those skilled in the art. The wire will then be stabilized when the chip is encased in the protective shell, so that the antenna extends at some angle to the chip.
- the antifuse or other semiconductor memory and supporting circuitry can receive the addressing commands and device power by optical transmission.
- the RF antenna 110 would be replaced by a photocell that generates sufficient write voltage to exceed the threshold voltage.
- the RF transmitter 80 is replaced by a light source, and the commands may be transmitted digitally by pulsing the optical transmitter, which can be a laser, flash lamp or other high intensity light source. It is noted that the light intensity must be sufficient to generate adequate voltage, either singly or in conjunction with a second power generating device, in the photocell to write into memory, but not so high that it damages the metal interconnect on the chip. With digital data transmission analog-to-digital and digital-to-analog conversion circuitry can be eliminated.
- the operation of programming the memory to record the process steps to which the linked or adjacent matrix particle or support and linked or proximate molecule or biological particle is exposed involves placing the memory device reasonably close a distance on the order of about 1 inch 25.4 mm! is presently contemplated, but longer distances should be possible and shorter distances are also contemplated! and can be determined empirically! to RF transmitter 80.
- the RF transmitter 80 emits a carrier wave modulated by a signal generated by host computer 122 using conventional RF technology.
- the carrier wave itself can provide the power to the generate the programming voltage and the operating voltage for the various devices via the rectifier, while the modulation signal provides the address instructions.
- the address signal only has to carry information to turn on a single memory location, while the host computer 122 stores into memory 120 the information linking the process information with the single memory location that was "tagged” to record exposure to the process step.
- FIG. 1 in which chemical building blocks A, C, and E are added to a molecule linked to a matrix with memory, and to FIG. 6, an illustrative example of how information is written onto a particle is provided in Table 1.
- the address signal would increment the x-register 124 one location and increment the y-register 126 eight locations, and then apply the programming voltage.
- the activation of this switch is indicated by an "A" at the selected address, although the actual value stored will be a binary "1", indicating ON.
- the manner in which the programming voltage is applied depends on whether the decoders have depletion or enhancement transistors.!
- the host computer 122 would write into its memory 120 that for process A, the x-,y-address is 1,8. Upon removal of the RF signal after recording process A, the voltage is removed and the registers would reset to 0.
- the address signal would increment the x-register 124 two locations and the y-register 126 four locations, then apply the programming voltage, as indicated by the letter "C".
- the host computer 120 would similarly record in memory that an indication of exposure to process C would be found at x-,y-address 2,4.
- the registers reset to 0 so that when the matrix particle's memory is again exposed to RF following addition of block E, the registers increment 3 and 2 locations, respectively, and the programming voltage is applied to turn on the switch, indicated by "E". Desirably all processing steps are automated.
- the host computer 122 After processing is completed, to read the information that has been recorded in the memory of the data storage unit, the host computer 122 will inquire into the identity of the particle by generating a command signal to the registers to select the appropriate address locations to determine whether the switch is on or off. If the switch is on, i.e., a voltage drop occurs at that point, the computer will create a record that the particle received a particular process step. Alternatively, the host computer can generate an inquiry signal to sequentially look at all memory locations to determine which switches have been turned on, recording all locations at which voltage drops occurred. The computer will then compare the "on" locations to the process steps stored in its memory to identify the steps through which the subject particle was processed.
- individual particles can be identified by reserving certain memory locations for identification only, for example, the first two rows of the x-register. In this case, particles will be passed separately through the RF signal while the x-register is incremented to turn on switches at address locations 0,0, 1,0, 2,0, etc.
- the host computer 122 can first generate a signal to query a matrix particle memory to determine its identity, then write the information with regard to the process performed, saving the process and particle information in the host computer memory 120.
- the tagging of particles which are exposed to a particular process would be performed in the process vessel containing all of the particles.
- the presence, however, of a large number of particles may result in interference or result in an inability to generate a sufficiently high voltage for programming all of the particles simultaneously. This might be remedied by providing an exposure of prolonged duration, e.g., several minutes, while stirring the vessel contents to provide the greatest opportunity for all particles to receive exposure to the RF signal.
- a mechanism for separating the particles may be used in both write and read operations. Also, in instances in which each particle will have a different molecule attached, each particle memory must be addressed separately.
- FIG. 7 An apparatus for separating the particles to allow individual exposure to the RF signal is illustrated in FIG. 7.
- the particles are placed in a vessel 140 which has a funnel 142, or other constricted section, which permits only one particle 150 to pass at a time.
- the particles are, for purposes of exemplification, depicted as spherical.
- the particles can be of any shape, including asymmetric shapes. Where the particles are asymmetric or of other shapes, the size of the funnel exit and tube should be selected to fit the largest diameter of the particles closely. If a particular orientation of the particle is desired or required for effective transmission, the tube and funnel exit should be designed and oriented to permit only particles in the proper alignment with the tube to exit.
- the RF transmitter 80 is positioned adjacent a tube 144 which receives input from funnel 142. When a particle passes through tube 144 the RF transmitter provides a signal to write to or read from the particle's memory.
- Means for initiating the RF transmission may include connection to a mechanical gate or shutter 145 in the funnel 142 which controls the admission of the particle into the tube.
- optical means for detecting the presence of the matrix particle with memory to initiate RF transmission are provided in the form of a laser 146 directed toward the tube 144, which is transparent to the wavelength of the light emitted by the laser. When the laser light impinges upon the particle shown with dashed lines!
- tube 144 has an exemplary three-way splitter and selection means, shown here in dashed lines as mechanical gates, for directing the particles to the desired destination.
- non-volatile memories In addition to antifuse memory devices, other types of electrically-programmable read-only memories, preferably non-volatile memories, which are known in the art, may be used chips, such as those sold by Actel, Mosaic, Lattice Semiconductor, AVID, Anicare, Destron, Rayethon, Altera, ICT, Xilinix, Intel and Signetics see, e.g., U.S. Pat. Nos. 4,652,528, 5,044,623, 5,099,226, 5,218,343, 5,323,704, 4,333,072, 4,321,069, 4,318,658, 5,121,748, 5,214,409, 5,235,326, 5,257,011 and 5,266,926!.
- chips such as those sold by Actel, Mosaic, Lattice Semiconductor, AVID, Anicare, Destron, Rayethon, Altera, ICT, Xilinix, Intel and Signetics see, e.
- Preprogrammed identification tags such as those used for tracking objects or animals see, e.g., U.S. Pat. Nos. 5,257,011, 5,235,326, 5,226,926, 5,214,409, 4,333,072, available from AVID, Norco, Calif.; see, also U.S. Pat. No. 5,218,189, 5,416,486, 4,952,928, 5,359,250!, are also contemplated for use herein.
- Such tags may be used in embodiments such as those in which tracking of linked molecules is desired.
- the matrices or strips attached thereto may be encoded with a pre-programmed identifying bar code.
- Such devices may be used in embodiments in which parameters, such as location in an automated synthesizer, are monitored. The identity of a product or reactant determined by its location or path, which is monitored by reading the chip in each device and storing such information in a remote computer.
- the chips particularly, the IPTT-100, Bio Medic Data Systems, Inc., Maywood, N.J.; see, also U.S. Pat. Nos. 5,422,636, 5,420,579, 5,262,772, 5,252,962 and 5,250,962!.
- These devices which are about 8 mm long, include a recording device, an EEPROM, a passive transponder for receiving an input signal and transmitting an output signal in response.
- the transponder includes a power antenna means see, e.g., U.S. Pat. No. 5,250,944 and U.S. Pat. No. 5,420,579! for receiving the input signal, frequency generator and modulator means for receiving the input signal the receive antenna means and for generating the output signal.
- the output signal has a frequency different from the input frequency, outputs the output signal in response the input signal.
- the input signal having a first frequency
- the output signal has a second frequency that is a multiple of the first frequency, and is greater that the first frequency.
- It also includes a transmitting antenna means for receiving the output signal from the frequency generator and modulator means and that transmit the output signal.
- Data are stored within the transponder within a reprogrammable memory circuit that is programmed by the user see, e.g., U.S. Pat. No. 5,422,636 and EP 0 526 173 A3.!.
- a transponder scanner for scanning and programming the transponder is also available Bio Medic Data Systems Inc. DAS-5001 CONSOLETM System, e.g., U.S. Pat. No. 5,252,962 and U.S. Pat. No. 5,262,772!.
- optical or magnetic means may be used.
- an optical storage means is provided in U.S. Pat. No. 5,136,572, issued Aug. 4, 1992, of Bradley, which is incorporated herein by reference.
- an array of stabilized diode lasers emits fixed wavelengths, each laser emitting light at a different wavelength.
- a tunable diode laser or a tunable dye laser each of which is capable of emitting light across a relatively wide band of wavelengths, may be used.
- the recording medium is photochemically active so that exposure to laser light of the appropriate wavelength will form spectral holes.
- an optical write/read system is configured similar to that of the embodiment of FIG. 7, with a vessel 212 containing a number of the particles which are separated and oriented by passing through a constricted outlet into a write/read path 206 that has an optically-transparent tube i.e., optically transparent to the required wavelength(s)! with a cross-section which orients the particles as required to expose the memory surface to the laser 200 which is capable of emitting a plurality of discrete, stable wavelengths. Gating and detection similar to that described for the previous embodiment may be used and are not shown.
- Computer 202 controls the tuning of laser 200 so that it emits light at a unique wavelength to record a data point.
- Memory within computer 202 stores a record indicating which process step corresponds to which wavelength. For example, for process A, wavelength ⁇ 1 , e.g., 630 nm red!, for process C, ⁇ 2 , e.g., 550 nm yellow!, and for process E, ⁇ 3 , e.g., 480 nm blue!, etc.
- the recording medium 204 is configured to permit orientation to repeatably expose the recording side of the medium to the laser beam each time it passes through tube 206.
- One possible configuration, as illustrated here, is a disc.
- the laser 200 emits light of the selected wavelength to form a spectral hole in the medium.
- the light is focussed by lens 208 to illuminate a spot on recording medium 204.
- the laser power must be sufficient to form the spectral hole.
- the same wavelength is selected at a lower power. Only this wavelength will pass through the spectral hole, where it is detected by detector 210, which provides a signal to computer 202 indicative of the recorded wavelength. Because different wavelengths are used, multiple spectral holes can be superimposed so that the recording medium can be very small for purposes of tagging.
- each different wavelength of light corresponds to an address, so that each laser writes one bit of data.
- the recording media will need to be sufficiently sensitive, and the lasers well-stabilized, to vary only within a narrow band to assure that each bit recorded in the media is distinguishable. Since only a single bit of information is required to tag the particle at any given step, the creation of a single spectral hole at a specific wavelength is capable of providing all of the information needed.
- the host computer then makes a record associating the process performed with a particular laser wavelength.
- the same wavelength laser that was used to create the spectral hole will be the only light transmitted through the hole. Since the spectral holes cannot be altered except by a laser having sufficient power to create additional holes, this type of memory is effectively non-volatile. Further, the recording medium itself does not have any operations occurring within its structure, as is the case in electrical memories, so its structure is quite simple. Since the recording medium is photochemically active, it must be well encased within an optically transmissive to the active optical wavelength(s)!, inert material to prevent reaction with the various processing substances while still permitting the laser light to impinge upon the medium. In many cases, the photochemical recording media may be erased by exposure to broad spectrum light, allowing the memory to be reused.
- Writing techniques can also include the formation of pits in the medium.
- the detector 210 To read these pits, the detector 210 with be positioned on the same side of the write/read tube 206 as the laser 200 to detect light reflected back from the medium.
- Other types of optical data storage and recording media may be used as are known in the art.
- optical discs which are typically plastic-encapsulated metals, such as aluminum, may be miniaturized, and written to and read from using conventional optical disc technology. In such a system, the miniature discs must be aligned in a planar fashion to permit writing and reading.
- a modification of the funnel system, described above, will include a flattened tube to insure the proper orientation.
- the discs can be magnetically oriented.
- optical recording media that may be appropriate for use in the recording devices and combinations herein include, but are not limited to, magneto-optical materials, which provide the advantage of erasability, photochromic materials, photoferroelectric materials, photoconductive electro-optic materials, all of which utilize polarized light for writing and/or reading, as is known in the art.
- magneto-optical materials which provide the advantage of erasability
- photochromic materials photoferroelectric materials
- photoconductive electro-optic materials all of which utilize polarized light for writing and/or reading, as is known in the art.
- Another device that is suitable for use in the matrix with memory combinations are optical memories that employ rhodopsins, particularly bacteriorhodopsin BR!, or other photochromic substances that change between two light absorbing states in response to light of each of two wavelengths see, e.g., U.S. Pat. No. 5,346,789, 5,253,198 and 5,228,001; see, also Birge (1990) Ann. Rev. Phys. Chem 41:683-733!. These substances, particularly BR, exhibit useful photochromic and optoelectrical properties.
- BR for example, has extremely large optical nonlinearities, and is capable of producing photoinduced electrical signals whose polarity depends on the prior exposure of the material to light of various wavelengths as well as on the wavelength of the light used to induce the signal. There properties are useful for information storage and computation. Numerous applications of this material have been designed, including its use as an ultrafast photosignal detector, its use for dynamic holographic recording, and its use for data storage, which is of interest herein.
- the rhodopsins include the visual rhodopsins, which are responsible for the conversion of light into nerve impulses in the image resolving eyes of mollusks, anthropods, and vertebrates, and also bacteriorhodopsin BR!. These proteins also include a class of proteins that serve photosynthetic and phototactic functions.
- the best known BR is the only protein found in nature in a crystalline membrane, called the "purple membrane" of Halobacterium Halobium. This membrane converts light into energy via photon-activated transmembrane proton pumping.
- the BR molecule Upon the absorption of light, the BR molecule undergoes several structural transformations in a well-defined photocycle in which energy is stored in a proton gradient formed upon absorption of light energy. This proton gradient is subsequently utilized to synthesize energy-rich ATP.
- the structural changes that occur in the process of light-induced proton pumping of BR are reflected in alterations of the absorption spectra of the molecule. These changes are cyclic, and under usual physiological conditions bring the molecule back to its initial BR state after the absorption of light in about 10 milliseconds. In less than a picosecond after BR absorbs a photon, the BR produces an intermediate, known as the "J" state, which has a red-shifted absorption maximum. This is the only light-driven event in the photocycle; the rest of the steps are thermally driven processes that occur naturally.
- the first form, or state, following the photon-induced step is called "K", which represents the first form of light-activated BR that can be stabilized by reducing the temperature to 90° K. This form occurs about 3 picoseconds after the J intermediate at room temperature. Two microseconds later there occurs an "L” intermediate state which is, in turn, followed in 50 microseconds by an "M” intermediate state.
- the first is their ability to be photochemically converted back to the basic BR state. Under conditions where a particular intermediate is made stable, illumination with light at a wavelength corresponding to the absorption of the intermediate state in question results in regeneration of the BR state. In addition, the BR state and intermediates exhibit large two-photon absorption processes which can be used to induce interconversions among different states.
- the second important property is light-induced vectorial charge transport within the molecule.
- a charge transport can be detected as an electric signal.
- the electrical polarity of the signal depends on the physical orientation of molecules within the material as well as on the photochemical reaction induced. The latter effect is due to the dependence of charge transport direction on which intermediates including the BR state! are involved in the photochemical reaction of interest.
- the polarity of an electrical signal associated with one BR photochemical reaction is opposite to that associated with a second BR photochemical reaction.
- the latter reaction can be induced by light with a wavelength around 412 nm and is completed in 200 ns.
- the BR molecule and purple membrane! has several intrinsic properties of importance in optics.
- this molecule exhibits a large two-photon absorption cross section.
- the crystalline nature and adaptation to high salt environments makes the purple membrane very resistant to degeneration by environmental perturbations and thus, unlike other biological materials, it does not require special storage. Dry films of purple membrane have been stored for several years without degradation. Furthermore, the molecule is very resistant to photochemical degradation.
- a recording device that can detect the occurrence of a reaction and record a such event in the memory.
- Any of the above devices may be modified to permit such detection.
- the chip with the antifuse memory array with decoder, rectifier components and RF antenna can be modified by addition of a photodetector and accompanying amplifier components as shown in FIG. 9.
- the photodetector will be selected so that it is sensitive to the frequencies of the expected photoemissions from the reactions.
- the photodetector circuitry may use voltage supplied by the same RF signal that is used to write other data to memory, so that no detection of photoemission will occur unless RF or other power is applied to provide bias and drain voltage. If an active device is used, the power supplied by the battery can provide operational voltage to the photodetector circuitry, independent of any transmitted signal.
- the voltage supplied by the photodetector can be used in a number of different ways:
- the threshold voltage for writing to memory will exceed the voltage supplied by the RF signal, which will still contain the address information.
- additional voltage must be provided by the photodetector so that the sum of the voltages exceeds the threshold. (V RF ⁇ V T ⁇ V RF +V PD ). This permits the RF supplied voltage to go to the correct address, however, no writing will occur unless a photoemission has been detected by the detector. Therefore, there will be no record of exposure to a particular process step unless a sufficient reaction has occurred to generate the required photoemission. Since the address signal can still get to the memory array without the extra voltage, reading of recorded data can be achieved without any special circuitry. If the memory device is an active device, a similar mechanism can be used in which only the sum of the voltages is sufficient to record an occurrence.
- the threshold voltage for writing to memory will be provided by the RF signal alone, and the RF signal will include address information. (V T ⁇ V RF ). However, unless voltage from the photodetector is supplied to a "gating" transistor, access to the memory array is prevented so that no writing occurs unless a photoemission is detected. (This embodiment is illustrated.) This will require a special provision for opening the gate during read operations to permit access to the memory array. Since the gating transistor will conduct a signal only in the event of photoemission, this embodiment will work equally well with passive and active memory devices.
- the RF signal provides sufficient voltage to exceed the threshold voltage. (V T ⁇ V RF ). Voltage from the photodetector is used to create a write potential difference at an additional address location which is carried in the RF signal. For example, if the RF signal is addressing column 3, row 3, column 32 could be connected only to the photodetector circuit's output so that, when a photoemission occurs, the write signal will create antifuses or in the case of EEPROM, standard fuses! at addresses 3,3 and 32,3. If no photoemission occurs, only address 3,3 will have an antifuse formed, providing a record of exposure of the matrix to a particular process step even without the occurrence of a detectable reaction.
- the photodetector while still integrated on the same substrate with the basic memory matrix for recording transmitted signals, can be connected to its own independent memory matrix.
- the photodetector's memory matrix can be connected to separate transceiver circuitry with an antenna tuned to a different frequency from that of the basic memory.
- the memory device will be exposed to two different radiofrequency signals, one for the basic memory, the other for the photodetection circuit memory. If only the photoemission information is required, only the corresponding frequency signal need be provided during the read operation.
- sensors may be used in addition to photodetectors, many of which may be capable of generating an electrical signal that can be used as described above for the photodetectors.
- These sensing devices may also be incorporated onto the substrate and electrically connected to the memory device, providing data points within the device's memory under the appropriate write conditions.
- temperature sensing elements can be made from semiconductor liquid crystal and fluorescent crystals, and addition to conventional thermocouples created by placing two different metals in contact at the detection point. It is also possible to include radiation, pH and PCO 2 sensors in a similar manner, using materials that respond to the detected variables by generating a voltage potential that can be conducted to the memory device and recorded.
- the recording device is cast in a selected matrix material during manufacture.
- the devices can be physically inserted into the matrix material, the deformable gel-like materials, or can be placed on the matrix material and attached by a connector, such as a plastic or wax or other such material.
- the device or device(s) may be included in an inert container n proximity to or in contact with matrix material.
- the recording device with memory can be placed onto the inner surface of a vessel, such as a microtiter plate or vial or tube in which the reaction steps are conducted.
- a vessel such as a microtiter plate or vial or tube in which the reaction steps are conducted.
- the device can be incorporated into the vessel material, such into the a wall of each microtiter well or vial or tube in which the reaction is conducted. As long as the molecules or biological particles remain associated with the well, tube or vial, their identity can be tracked.
- one or more recording devices with memory and matrix particles are sealed in a porous non-reactive material, such as polypropylene or teflon net, with a pore size smaller than the particle size of the matrix and the device.
- a porous non-reactive material such as polypropylene or teflon net
- the amount of matrix material is a function of the size of the device and the application in which the resulting matrix with memory is used, and, if necessary can be empirically determined. Generally, smaller sizes are desired, and the amount of material will depend upon the size of the selected recording device.
- microvessels are then encoded, reactions, such as synthetic reactions, performed, and read, and if desired used in desired assays or other methods.
- combinations of matrices with memories and biological particle combinations are prepared.
- libraries e.g., bacteria or bacteriophage, or other virus particles or other particles that contain genetic coding information or other information! can be prepared on the matrices with memories, and stored as such for future use or antibodies can be linked to the matrices with memories and stored for future use.
- the combination of memory with matrix particle may be further linked, such as by welding using a laser or heat, to an inert carrier or other support, such as a teflon strip.
- This strip which can be of any convenient size, such as 1 to 10 mm by about 10 to 100 ⁇ M will render the combination easy to use and manipulate.
- these memories with strips can be introduced into 10 cm culture dishes and used in immunoassays or they can be used to introduce bacteria or phage into cultures and used in selection assays.
- the strip may be encoded or impregnated with a bar code to further provide identifying information.
- the systems include a host computer or decoder/encoder instrument, a transmitter, a receiver and the data storage device.
- the systems also can include a funnel-like device or the like for use in separating and/or tagging single memory devices.
- an EM signal preferably a radio frequency signal is transmitted to the data storage device.
- the antenna or other receiver means in the device detects the signal and transmits it to the memory, whereby the data are written to the memory and stored in a memory location.
- mixtures of the matrix with memory-linked molecules or biological particles may be exposed to the EM signal, or each matrix with memory either before, after or during linkage of the biological particles or molecules! may be individually exposed, using a device, such as that depicted herein, to the EM signal.
- Each matrix with memory will be linked to a plurality of molecules or biological particles, which may be identical or substantially identical or a mixture of molecules or biological particles depending, upon the application and protocol in which the matrix with memory and linked or proximate! molecules or biological particles is used.
- the memory can be programmed with data regarding such parameters.
- the location of the data which when read and transmitted to the host computer or decoder/encoder instrument, corresponds to identifying information about linked or proximate molecules or biological particles.
- the host computer or decoder/encoder instrument can either identify the location of the data for interpretation by a human or another computer or the host computer or the decoder/encoder can be programmed with a key to interpret or decode the data and thereby identify the linked molecule or biological particle.
- the presently preferred system for use are the IPTT-100 transponders and DAS-5001 CONSOLETM Bio Medic Data Systems, Inc., Maywood, N.J.; see, e.g., U.S. Pat. Nos. 5,422,636, 5,420,579, 5,262,772, 5,252,962 and 5,250,962, 5,252,962 and 5,262,772!.
- the matrices with remotely programmable memory(ies) may be used with any methodology that employs molecules or biological particles linked to or combined with matrices. Examples of such methods include, but are not limited to, methods for synthesis and screening of combinatorial libraries and other libraries, described in the following references: U.S. Pat. Nos. 5,403,750, 5,395,750, 5,395,587, 5,384,261, 5,359,115, 5,348,867, 5,338,665, 5,316,922, 5,223,409, 5,223,408, 5,382,513, 5,260,203, 5,258,289, 5,270,170, 5,288,514, 4,631,211, International Application WO 94/28424, which is based on U.S. application Ser. No.
- Such methods also include, cell sorting protocols, enzyme immunoassays, such as ELISAs, which rely on support bound antigens, antibodies or complexes thereof; and assays, such as scintillation proximity, direct fluorescence, FET assays and methods using hybridizations using solid phase-bound nucleic acids.
- ELISAs enzyme immunoassays
- assays such as scintillation proximity, direct fluorescence, FET assays and methods using hybridizations using solid phase-bound nucleic acids.
- Support-bound molecules and biological particles are often used in methods of affinity purification.
- There are innumerable protocols that utilize support-bound ligands of any sort including support-bound antibodies, and support bound nucleic acids.
- the matrices with memories are linked to molecules and particles that are components of libraries to electronically tagged combinatorial libraries.
- Particularly preferred libraries are the combinatorial libraries that containing matrices with memories that employ radiofrequencies for reading and writing.
- One exemplary method for generating a library involves repeating the steps of (1) providing at least two aliquots of a solid phase support; separately introducing a set of subunits to the aliquots of the solid phase support; completely coupling the subunit to substantially all sites of the solid phase support to form a solid phase support/new subunit combination, assessing the completeness of coupling and if necessary, forcing the reaction to completeness; thoroughly mixing the aliquots of solid phase support/new subunit combination; and, after repeating the foregoing steps the desired number of times, removing protecting groups such that the bio-oligomer remains linked to the solid phase support.
- the subunit may be an amino acid, and the bio-oligomer may be a peptide.
- the subunit may be a nucleoside and the bio-oligomer may be an oligonucleotide.
- the nucleoside is deoxyribonucleic acid; in yet another embodiment, the nucleoside is ribonucleic acid.
- the subunit may be an amino acid, oligosaccharide, oligoglycosides or a nucleoside, and the bio-oligomer may be a peptide-oligonucleotide chimera or other chimera.
- Each solid phase support is attached to a single bio-oligomer species and all possible combinations of monomer or multimers in certain embodiments! subunits of which the bio-oligomers are composed are included in the collection.
- the support matrix has a recording device with programmable memory, encased, linked or otherwise attached to the matrix material, and at each step in the synthesis the support matrix to which the nascent polymer is attached is programmed to record the identity of the subunit that is added. At the completion of synthesis of each biopolymer, the resulting biopolymers linked to the supports are mixed.
- the acceptor molecule is one that recognizes and binds to one or more solid phase matrices with memory/bio-oligomer species within the mixture or the substrate molecule will undergo a chemical reaction catalyzed by one or more solid phase matrix with memory/bio-oligomer species within the library.
- the resulting combinations that bind to the acceptor molecule or catalyze reaction are selected.
- the memory in the matrix-memory combination is read and the identity of the active bio-oligomer species is determined.
- FIG. 1! Various schemes for split bead syntheses of polymers FIG. 1!, peptides FIG. 2!, nucleic acids FIG. 3! and organic molecules based on a pharmacophore monomer FIG. 4! are provided.
- Selected matrices with memory particles are placed in a suitable separation system, such as a funnel see, FIG. 5!.
- each particle is scanned i.e., read! as it passes the RF transmitter, and information identifying the added component or class of components is stored in memory.
- a code can be programmed i.e., a 1 at position 1,1 in the memory could, for example, represent alanine at the first position in the peptide!.
- a host computer or decoder/encoder is programmed to send the appropriate signal to a transmitter that results in the appropriate information stored in the memory i.e., for alanine as amino acid 1, a 1 stored at position 1,1!.
- the host computer or decoder/encoder can interpret the signal read from and transmitted from the memory.
- a selected number of beads i.e., particulate matrices with memories matrix particles linked to recording devices!, typically at least 10 3 , more often 10 4 , and desirably at least 10 5 or more up to and perhaps exceeding 10 15 , are selected or prepared.
- the beads are then divided into groups, depending upon the number of choices for the first component of the molecule. They are divided into a number of containers equal to or less than for pooled screening, nested libraries or the other such methods! the number of choices.
- the containers can be microtiter wells, Merrifield synthesis vessels, columns, test tubes, gels, etc.
- each container is scanned with electromagnetic with radiation, preferably high frequency radio waves, to transmit information and encode the memory to identify the first monomer.
- the beads in the second container are so treated.
- the beads are then combined and separated according to the combinatorial protocol, and at each stage of added monomer each separate group is labeled by inputting data specific to the monomer.
- each bead has an oligomer attached and information identifying the oligomer stored in memory in a form that can be retrieved and decoded to reveal the identity of each oligomer.
- An 8-member decapeptide library was designed, synthesized, and screened against an antibody specifically generated against one of the library members using the matrices with memories. Rapid and clean encoding and decoding of structural information using radiofrequency signals, coupling of combinatorial chemical synthesis to biological assay protocols, and potential to sense and measure biodata using suitable biosensors, such as a temperature thermistor, embedded within the devices have been demonstrated.
- the "split and pool” method see, e.g., Furka et al. (19910 Int. J. Pept. Protein Res. 37:487-493; Lam et al. (1991) Nature 354:82-84; and Sebestyen et al. (1993) Bioorg. Med. Chem. Lett.
- a library containing eighteen mixtures, generated from the six permutations of the three monomer sets, times three N-termini was prepared. Each mixture of all combinations of the three sets of amines, four sets of hydrophobic monomers and seventeen diverse monomers was then assayed. The most potent mixture was selected for deconvolution by synthesis of pools of combinatorial mixtures of the components of the selected pool. This process was repeated, until individual compounds were selected.
- each matrix particle with memory will be prepared with sets of the compounds, analogous to the mixtures of compounds.
- the resulting matrix particles with memories and linked compounds can be combined and then assayed.
- the linked compounds molecules or biological particles! can be cleaved from the matrix with memory prior to assaying or anytime thereafter, as long as the cleaved molecules remain in proximity to the device or in some manner can be identified as the molecules or particles that were linked to the device.
- the matrix particle(s) with memories that exhibit the highest affinity bind the greatest amount of sample at equilibrium! are selected and identified by querying the memory to identify the group of compounds. This group of compounds is then deconvoluted and further screened by repeating this process, on or off the matrices with memories, until high affinity compounds are selected.
- the combinations of matrix with memories provided herein permits the simultaneous assay of large numbers of analytes in any format.
- the sample that contains an analyte, such as a ligand or any substance of interest, to be detected or quantitated is incubated with and bound to a protein, such as receptor or antibody, or nucleic acid or other molecule to which the analyte of interest binds.
- the protein or nucleic acid or other molecule to which the analyte of interest binds has been linked to a matrix with memory prior to incubation; in another embodiment, complex of analyte or ligand and protein, nucleic acid or other molecule to which the analyte of interest binds is linked to the matrix with memory after the incubation; and in a third embodiment, incubation to form complexes and attachment of the complexes to the matrix with memory are simultaneous.
- attachment is effected, for example, by direct covalent attachment, by kinetically inert attachment, by noncovalent linkage, or by indirect linkage, such as through a second binding reaction i.e., biotinavidin, Protein A-antibody, antibody-hapten, hybridization to form nucleic acid duplexes of oligonucleotides, and other such reactions and interactions!.
- the complexes are detected and quantitated on the solid phase by virtue of a label, such as radiolabel, fluorescent label, luminophore label, enzyme label or any other such label.
- the information that is encoded in the matrix with memory depends upon the selected embodiment. If, for example, the target molecule, such as the protein or receptor is bound to the solid phase, prior to complexation, the identity of the receptor and/or source of the receptor may be encoded in the memory in the matrix.
- the combinations provided herein are particularly suitable for analyses of multianalytes in a fluid, and particularly for multianalyte immunoassays.
- monoclonal antibodies very specific for carcinoembryonic antigen CEA!, prostate specific antigen PSA!, CA-125, alphafetoprotein AFP!, TGF- ⁇ , IL-2, IL-8 and IL-10 are each covalently attached to a different batch of matrices with memories using well-established procedures and matrices for solid phase antibody assays.
- Each antibody-matrix with memory complex is given a specific identification tag, as described herein.
- a sample of serum from a patient to be screened for the presence or concentration of these antigens is added to a tube containing two of each antibody-matrix with memory complex a total of 16 beads, or duplicates of each kind of bead!.
- a mixture of monoclonal antibodies, previously conjugated to fluorescent dyes, such as fluorescein or phenyl-EDTA-Eu chelate, reactive with different epitopes on each of the antigens is then added.
- the tubes are then sealed and the contents are mixed for sufficient time typically one hour! to allow any antigens present to bind to their specific antibody-matrix with memory-antigen complex to produce antibody-matrix with memory-antigen-labeled antibody complexes.
- these resulting complexes are briefly rinsed and passed through an apparatus, such as that set forth in FIG. 7, but with an additional light source.
- a light source such as a laser emitting at the excitation wavelength of fluorescein, about 494 nm, or 340 nm for the Eu chelate complex
- its fluorescence is measured and quantitated by reading the emitted photons at about 518 nm for fluorescein or 613 nm for phenyl-EDTA-Eu, and as its identity is determined by the specific signal received by the RF detector.
- eight different antigens are simultaneously detected and quantitated in duplicate.
- the electromagnetically tagged matrices with recorded information regarding linked antibodies can be used with other multianalyte assays, such as those described by Ekins et al. (1990) J. Clin. Immunoassay 13:169-181; see, also International PCT Applications Nos. 89/01157 and 93/08472, and U.S. Pat. Nos. 4,745,072, 5,171,695 and 5,304,498!. These methods rely on the use of small concentrations of sensor-antibodies within a few ⁇ m 2 area. Individual memories with matrices, or an array of memories embedded in a matrix are used. Different antibodies are linked to each memory, which is programmed to record the identity of the linked antibody. Alternatively, the antibody can be linked, and its identity or binding sites identified, and the information recorded in the memory.
- antibodies are linked to the matrices with memories.
- the matrices are either in particular form or in the form of a slab with an array of recording devices linked to the matrices or microtiter dish or the like with a recording device in each well.
- Antibodies are then linked either to each matrix particle or to discrete "microspots" on the slab or in the microtiter wells.
- a relatively low affinity anti-idiotype antibody or other species that specifically recognizes the antibody binding site such as a single chain antibody or peptidomimetic! labeled with a fluorophore e.g., Texas Red, see, Ekins et al. (1990) J. Clin.
- Immunoassay 13:169-181! to measure the concentration of and number of available binding sites present on each matrix with memory particle or each microspot, which information is then encoded into each memory for each microspot or each particle. These low affinity antibodies are then eluted, and the matrices can be dried and stored until used.
- the memories in the particles or at each microspot could be programmed with the identity or specificity of the linked antibody, so that after reaction with the test sample and identification of complexed antibodies, the presence and concentration of particular analytes in the sample can be determined. They can be used for multianalyte analyses as described above.
- the matrices with memories are reacted with a second antibody, preferably, although not necessarily, labeled with a different label, such as a different fluorophore, such as fluorescein.
- a second antibody preferably, although not necessarily, labeled with a different label, such as a different fluorophore, such as fluorescein.
- the microspots or each matrix particle is read by passing the particle through a laser scanner such as a confocal microscope, see, e.g., Ekins et al. (1990) J. Clin. Immunoassay 13:169-181; see also U.S. Pat. No. 5,342,633! to determine the fluorescence intensity.
- the memories at each spot or linked to each particle are queried to determine the total number of available binding sites, thereby permitting calculation of the ratio of occupied to unoccupied binding sites.
- Equilibrium dialysis and modifications thereof has been used to study the interaction of antibody or receptor or other protein or nucleic acid with low molecular weight dialyzable molecules that bind to the antibody or receptor or other protein or nucleic acid.
- the antibody, receptor, protein or nucleic acid is linked to solid support (matrix with memory) and is incubated with the dialyzable ligand.
- this method may be used for analysis of multiple binding agents receptors!, linked to matrices with memories, that compete for available ligand, which is present in limiting concentration.
- the matrices with memories linked to the binding agents receptors! with the greatest amount of bound ligand are the binding agents receptors! that have the greatest affinity for the ligand.
- matrices with memories also permits simultaneous determination of K a values of multiple binding agents receptors! or have multiple ligands.
- the mixture is flowed through a reader i.e., a Coulter counter or other such instrument that reads RF and the label! could simultaneously measure the ligand by virtue of the label! and identity of each linked binding agent or linked ligand! as the chip is read.
- a reader i.e., a Coulter counter or other such instrument that reads RF and the label! could simultaneously measure the ligand by virtue of the label! and identity of each linked binding agent or linked ligand! as the chip is read.
- a reader i.e., a Coulter counter or other such instrument that reads RF and the label!
- Phage, viruses, bacteria and other such manipulable hosts and vectors referred to as biological particles! can be modified to express selected antigens peptides or polypeptides! on their surfaces by, for example, inserting DNA encoding the antigen into the host or vector genome, at a site such as in the DNA encoding the coat protein, such that upon expression the antigen peptide or polypeptide! is presented on the surface of the virus, phage or bacterial host. Libraries of such particles that express diverse or families of proteins on their surfaces have been prepared. The resulting library is then screened with a targeted antigen receptor or ligand! and those viruses with the highest affinity for the targeted antigen receptor or ligand! are selected see, e.g., U.S. Pat. Nos. 5,403,484, 5,395,750, 5,382,513, 5,316,922, 5,288,622, 5,223,409, 5,223,408 and 5,348,867!.
- Libraries of antibodies expressed on the surfaces of such packages have been prepared from spleens of immunized and unimmunized animals and from humans.
- a library of phage displaying antibodies from unimmunized human spleens is prepared, it is often of interest to screen this library against a large number of different antigens to identify a number of useful human antibodies for medical applications.
- Phage displaying antibody binding sites derived from single or small numbers of spleen cells can be separately produced, expanded into large batches, and bound to matrices with memories, such as programmable PROM or EEPROM memories, and identified according to phage batch number recorded in the memory.
- Each antigen can then be exposed to a large number of different phage-containing memory devices, and those that bind the antigen can be identified by one of several means, including radiolabeled, fluorescent labeled, enzyme labeled or alternate (e.g., mouse) tagged antibody labeled antigen.
- the encoded information in the thus identified phage-containing devices relates to the batch of phage reactive with the antigen.
- Libraries can also be prepared that contain modified binding sites or synthetic antibodies.
- DNA molecules each encoding proteins containing a family of similar potential binding domains and a structural signal calling for the display of the protein on the outer surface of a selected viral or bacterial or other package, such as a bacterial cell, bacterial spore, phage, or virus are introduced into the bacterial host, virus or phage.
- the protein is expressed and the potential binding domain is displayed on the outer surface of the particle.
- the cells or viruses bearing the binding domains to which target molecules bind are isolated and amplified, and then are characterized.
- one or more of these successful binding domains is used as a model for the design of a new family of potential binding domains, and the process is repeated until a novel binding domain having a desired affinity for the target molecule is obtained.
- libraries of de novo synthesized synthetic antibody library containing antibody fragments expressed on the surface have been prepared.
- DNA encoding synthetic antibodies, which have the structure of antibodies, specifically Fab or Fv fragments, and contain randomized binding sequences that may correspond in length to hypervariable regions CDRs! can be inserted into such vectors and screened with an antigen of choice.
- Synthetic binding site libraries can be manipulated and modified for use in combinatorial type approaches in which the heavy and light chain variable regions are shuffled and exchanged between synthetic antibodies in order to affect specificities and affinities. This enables the production of antibodies that bind to a selected antigen with a selected affinity.
- the approach of constructing synthetic single chain antibodies is directly applicable to constructing synthetic Fab fragments which can also be easily displayed and screened.
- the diversity of the synthetic antibody libraries can be increased by altering the chain lengths of the CDRs and also by incorporating changes in the framework regions that may affect antibody affinity.
- alternative libraries can be generated with varying degrees of randomness or diversity by limiting the amount of degeneracy at certain positions within the CDRs.
- the synthetic binding site can be modified further by varying the chain lengths of the CDRs and adjusting amino acids at defined positions in the CDRs or the framework region which may affect affinities.
- Antibodies identified from the synthetic antibody library can easily be manipulated to adjust their affinity and or effector functions.
- the synthetic antibody library is amenable to use in other combinatorial type approaches.
- nucleic acid amplification techniques have made it possible to engineer humanized antibodies and to clone the immunoglobulin antibody! repertoire of an immunized mouse from spleen cells into phage expression vectors and identify expressed antibody fragments specific to the antigen used for immunization see, e.g., U.S. Pat. No. 5,395,750!.
- the phage or other particles, containing libraries of modified binding sites can be prepared in batches and linked to matrices that identify the DNA that has been inserted into the phage.
- the matrices are then mixed and screened with labeled antigen e.g., fluorescent or enzymatic! or hapten, using an assay carried out with limiting quantities of the antigen, thereby selecting for higher affinity phage.
- libraries of phage linked to matrix particles with memories can be prepared.
- the matrices are encoded to identify the batch number of the phage, a sublibrary, or to identify a unique sequence of nucleotides or amino acids in the antibody or antibody fragment expressed on its surface.
- the library is then screened with labeled antigens.
- the antigens are labeled with enzyme labels or radiolabels or with the antigen bound with a second binding reagent, such as a second antibody specific for a second epitope to which a fluorescent antigen binds.
- the matrix particle can be queried and the identity of the phage or expressed surface protein or peptide determined.
- the resulting information represents a profile of the sequence that binds to the antigen. This information can be analyzed using methods known to those of skill in this art.
- fused cells are plated into, for example, microtiter wells with the matrices with memory-tagged antibody binding reagent such as protein A!.
- the solid phase is removed, pooled and processed batchwise to identify the cells that produce antibodies that are the greatest binders see, e.g., U.S. Pat. No. 5,324,633 for methods and device for measuring the binding affinity of a receptor to a ligand; or the above method by which phage libraries are screened for highest K A phage, i.e., limiting labeled antigen!.
- nucleic acid probes linked to the matrices with memories can be used for screening in assays that heretofore had to be done with one probe at a time or with mixtures of probes followed by sequencing the hybridizing probes.
- assays see, e.g., U.S. Pat. No. 5,292,874, "Nucleic acid probes to Staphylococcus aureus” to Milliman, and U.S. Pat. No. 5,232,831, "Nucleic acid probes to Streptococcus pyogenes" to Milliman, et al.; see, also, U.S. Pat. Nos.
- U.S. Pat. No. 5,232,831 provides probes for the detection of particular Streptococcus species from among related species and methods using the probes. These probes are based on regions of Streptococcus rRNA that are not conserved among related Streptococcus species. Particular species are identified by hybridizing with mixtures of probes and ascertaining which probe(s) hybridize. By virtue of the instant matrices with memories, following hybridization, the identity of the hybridizing probes can be determined by querying the memories, and thereby identifying the hybridizing probe.
- nucleic acid probes are of a length shorter than a target, which is hybridized to the probes under conditions such that only those probes having an exact complementary sequence are hybridized maximally, but those with mismatches in specific locations hybridize with a reduced affinity, as can be determined by conditions necessary to dissociate the pairs of hybrids.
- Alignment of overlapping sequences from the hybridizing probes reconstructs the complement of the target see, EP 0 535 242 A1, International PCT Application WO 95/00530, and Khrapko et al. (1989) FEBS Lttrs. 256:118-122!.
- the target fragment with the sequence of interest is hybridized, generally under highly stringent conditions that tolerate no mismatches or as described below a selected number of mismatches, with mixtures of oligonucleotides typically a mixture of octomers of all possible sequences! that are each immobilized on a matrix with memory that is encoded with the sequence of the probe.
- hybridizing probes are identified by routine methods, such as OD or using labeled probe, and the sequences of the hybridizing probes can be determined by retrieving the sequences from the linked memories.
- sequence of the target can then be determined by aligning overlapping sequences of the hybridizing probes.
- the chips After hybridization in batch mode with the gene segment to be sequenced, usually amplified by a method such as PCR, using appropriate primers, and labeled with a detectable such as fluorescent! tag, the chips can be passed through a detector, such as described above for processing multiplexed immunoassays, and the degree of binding to each oligomer can be determined. After exposing the batch to varying degrees of dissociating conditions, the devices can again be assayed for degree of binding, and the strength of binding to related sequences will relate the sequence of the gene segment see, e.g., International PCT Application WO 95/00530!.
- matrices with memory combinations linked for example, to peptides, such as antigens or antibody fragments or receptors, of selected and known sequences or specificities, or to other biologically active compounds, such as neurotransmitters, cell surface receptors, enzymes, or any other identified biological target of interest.
- peptides such as antigens or antibody fragments or receptors
- other biologically active compounds such as neurotransmitters, cell surface receptors, enzymes, or any other identified biological target of interest.
- Mixtures of these peptides linked to memory matrices can be introduced into the natural product mixture.
- Individual binding matrices, detected by an indicator, such as a fluorometric dye can be isolated and the memory queried to determine which linked molecule or biological particle is bound to a natural product.
- Each memory in the form of a rectangle or other suitable, is linked or coated on one surface with material, such as nitrocellulose, to which or the analyte of interest binds or with which it reacts.
- the chips are arranged in an array, such as in strips that can be formed into rectangles or suitable other shapes, circles, or in other geometries, and the respective x-y coordinate or other position-identifying coordinate(s), and, if needed, sheet number and/or other identifying information, is programmed into each memory. Alternatively, they may be programmed with this identification, then positioned robotically or manually into an array configuration.
- the memories are separated and mixed for reaction with a traditionally labeled, such as a fluorescent label, detection nucleic acid, protein, antibody or receptor of interest. Complexes are identified, and their origin in the blot determined by retrieving the stored information in each chip. Quantitation may also be effected based on the amount of label bound.
- the transfer medium i.e., the nitrocellulose or other such medium! may be part of the surface of the chip or array of chips that can bind to the separated species subsequent to separation.
- the separation system such as the agarose or polyacrylamide gel, can be included on the surface(s) of the matrix with memories in the array. After separation the surface will be activated with a photactivatable linker or suitable activating agent to thereby covalently linked, such as by a photoflash, the separated molecules to the matrices in the array.
- Such support bound analytes may also be used to analyze the kinetics of binding by continuously passing the supports through a label reading device during the reaction, and identify the labeled complexes.
- the binding agents can be eluted, either in a kinetically readable manner or in batch.
- the recording devices may also include components that record reaction conditions, such as temperature and pH, kinetics, which are temperature and pH dependent, may be accurately calculated.
- the support bound analytes may be identified to analyze kinetics of binding to the binding agent.
- binding and elution protocols may also be adapted to affinity purification methodologies.
- the devices herein may also be used in methods of cell sorting.
- the memory with matrix combinations are linked to selected antigens, information regarding the antigens is encoded into the memories, the resulting combinations are used in multi-analyte analyses of cells.
- each agent such as an antibody, capable of binding specifically to one of many different surface markers is bound to a different matrix with a memory.
- the nature of the recognized marker is recorded in the memory of each matrix-binding agent complex, and the mixture of binding-agent-matrix memory complexes is reacted with a mixture of cells.
- the cell-matrix complexes that result from binding agents attaching cells to the surfaces of the respective matrices are then reacted with a labeled for example, fluorescent! reagent or mixture of reagents which also reacts with the cells.
- labeled reagents can be the same or different from those coupled to the memory matrices.
- the matrices are passed through a reader to read the label and the memory!, those that have bound cells can be identified and if necessary isolated.
- This application is particularly useful for screening for rare cells, for example stem cells in a bone marrow or peripheral lymphocyte sample, for detecting tumor cells in a bone marrow sample to be used for autologous transplantation, or for fetal cells in a maternal circulation.
- the memory with matrices herein can be counted and read with instruments, such as a Coulter counter, that are designed to count cells or particles.
- instruments such as a Coulter counter
- a Coulter Counter a suspension of cells or particles is sucked through a minute hole in a glass tube.
- One electrode is placed within the tube and another is outside of the tube in the suspension.
- the passage of a particle through the hole temporarily interrupts the current; the number of interruptions is determined by a conventional scaling unit.
- such instruments are modified by including an RF reader or other reader if another frequency or memory means is selected! so that the identity of the particle or cell or antigen on the cell or other encoded information! can be determined as the particle or cell passes through the hole and interrupts the current.
- the RF reader will read the memory in the matrix that is linked to the particle.
- the particles also may be counted concurrently with the determination of the identity of the particle.
- this device and method is a means to sort multiple types of cells at once.
- Memories may also be combined with biocompatible supports and polymers that are used internally in the bodies of animals, such as drug delivery devices see, e.g., U.S. Pat. Nos. 5,447,533, 5,443,953, 5,383,873, 5,366,733, 5,324,324, 5,236,355, 5,114,719, 4,786,277, 4,779,806, 4,705,503, 4,702,732, 4,657,543, 4,542,025, 4,530,840, 4,450,150 and 4,351,337! or other biocompatible support see, U.S. Pat. No. 5,217,743 and U.S. Pat. No. 4,973,493, which provide methods for enhancing the biocompatibility of matrix polymers!.
- biocompatible polymers include matrices of poly(ethylene-co-vinyl acetate) and matrices of a polyanhydride copolymer of a stearic acid dimer and sebacic acid see, e.g., Sherwood et al. (1992) Bio/Technology 10:1446-1449!.
- the biocompatible drug delivery device in combination with the memory is introduced into the body.
- the device generally by virtue of combination with a biosensor or other sensor, also monitors pH, temperature, electrolyte concentrations and other such physiological parameters and in response to preprogrammed changes, directs the drug delivery device to release or not release drugs or can be queried, whereby the change is detected and drug delivered or administered.
- the device provided in combination with a biocompatible support and biosensor, such that the information determined by the biosensor can be stored in the device memory.
- the combination of device and biosensor is introduced into the body and is used to monitor internal conditions, such as glucose level, which level is written to memory.
- the internal condition such as glucose level, electrolytes, particularly potassium, pH, hormone levels, and other such level, can then be determined by querying the device.
- the device preferably one containing a non-volatile memory that is read to and written using RF, linked to a biosensor
- a biosensor see, e.g., U.S. Pat. No. 5,384,028 which provides a biosensor with a data memory that stores data! that can detect a change in an internal condition, such as glucose or electrolyte, and store or report that change via RF to the linked matrix with memory, which records such change as a data point in the memory, which can then be queried.
- the animal is then scanned with RF and the presence of the data point is indicative of a change.
- the memory with matrix with linked biosensor is introduced into a site in the body, and can be queried externally.
- a glass surface of any conformation beads for exemplification purposes (1)! that contain a selected memory device that coat the device or that can be used in proximity to the device or subsequently linked to the device is coated with a layer of polystyrene that is derivatized so that it contains a cleavable linker, such as an acid cleavable linker.
- a bead for example, is coated with a layer of a solution of styrene, chloromethylated styrene, divinyl benzene, benzoyl peroxide 88/10/1/1/, molar ratio! and heated at 70° C. for 24 h. The result is a cross-linked chloromethylated polystyrene on glass (2).
- the resulting coated beads with memories are then used as solid support for molecular syntheses or for linkage of any desired substrate.
- a matrix with memory was constructed from (a) and (b) as follows:
- the memory device is a transponder IPTT-100, Bio Medic Data Systems, Inc., Maywood, N.J.! that includes a remotely addressable memory EEPROM!.
- the transponder receives, stores and emits radiofrequency signals of different frequencies so that it can be remotely programmed with information regarding synthetic steps and the constituents of linked or proximate molecules or biological particles.
- the transponder was encoded and read with a device that emits and reads RF frequencies Bio Medic Data Systems Inc. DAS-5001 CONSOLETM System, see, also U.S. Pat. No. 5,252,962!.
- EEPROM Electrical, Erasable, Programmable, Read-Only Memory
- flash a temperature sensing device able to accept or emit information at any time.
- encoding information is sent from a distance in the form of radiofrequency pulses at 145 kHz and stored until decoding is needed.
- the radiofrequency signals are retrieved using a specially assembled apparatus capable of reading the radiofrequency code from a distance DAS-5001 CONSOLETM from Bio Medic Data Systems, Inc., Maywood, N.J.; see, e.g., U.S. Pat. Nos. 5,422,636, 5,420,579, 5,262,772, 5,252,962 and 5,250,962, 5,252,962 and 5,262,772!.
- a pool of the matrices with memories prepared as in EXAMPLE 2 was split into two equal groups. Each group was then addressed and write-encoded with a unique radiofrequency signal corresponding to the building block, in this instance an amino acid, to be added to that group.
- the matrices with memories were then pooled, and common reactions and manipulations such as washing and drying, were performed.
- the pool was then re-split and each group was encoded with a second set of radiofrequency signals corresponding to the next set of building blocks to be introduced, and the reactions were performed accordingly. This process was repeated until the synthesis was completed.
- the semiconductor devices also recorded temperature and can be modified to record other reaction conditions and parameters for each synthetic step for storage and future retrieval.
- Each matrix with memory in the 96-member pool was decoded using a specifically designed radiofrequency memory retrieving device Bio Medic Data Systems Inc. DAS-5001 CONSOLETM System, see, also U.S. Pat. No. 5,252,962 and U.S. Pat No. 5,262,772! the identity of the peptide on each matrix with memory Table 2!.
- the structural identity of each peptide was confirmed by mass spectrometry and 1 H NMR spectroscopy.
- the content of peptide in each crude sample was determined by HPLC to be higher than 90% prior to any purification and could be increased further by standard chromatographic techniques.
- the matrix with memory microvessels were placed in a flat-bottomed flask. Enough DMF v r ml, 0.75 ml per microvessel! was added to completely cover all the matrix with memory microvessels. Fmoc-amino acid, EDIA, and PyBOP or HATU for the hindered amino acids Pro and lle! were added sequentially with final concentrations of 0.1, 0.2, and 0.1M, respectively. The flask was sealed and shaken gently at ambient temperature for 1 h. The solution was removed and the matrix with memory microvessels were washed with DMF 4 ⁇ v r !, and resubjected to the same coupling conditions with half the amount of reagents. They ere finally washed with DMF 4 ⁇ v r !, MeOH 4 ⁇ v 4 !, DCM 4 ⁇ v 4 !, and dried under vacuum at ambient temperature.
- the matrix with memory microvessels were placed in a flat bottomed flash. Enough 20% piperidine solution in DMF v r ml, 0.75 ml/matrix with memory microvessel! was added to completely cover the microvessels. The flask was sealed and gently shaken at ambient temperature for 30 min. Aliquots were removed and the UV absorption of the solution was measured at 302 nm to determine the Fmoc number. The matrix with memory microvessels were then washed with DMF 6 ⁇ v r ! and DCM 6 ⁇ v r ! and dried under vacuum at ambient temperature.
- the TentaGel® beads 20-120 mg! from each matrix with memory microvessel were treated with 1 ml of TFA cleavage mixture EDT:thioanisole; H 2 O:PhOH:TFA, 1.5:3:3:4.5:88, w/w! at ambient temperature for 1.5 hours.
- the resin beads were removed by filtration through a glass-wool plug, the solution was concentrated, diluted with water 2 ml!, extracted with diethyl ether 8 ⁇ 2 ml!, and lyophilized to yield the peptide as a white powder 4-20 mg!.
- the peptide (SEQUENCE ID No. 25) with a cysteine at the N-terminus was synthesized by standard solid phase methods using an automated Applied Biosystems 430A peptide synthesizer see, Sakakibara (1971) Chemistry and Biochemistry of Amino Acids, Peptides and Proteins, Weinstein, ed, Vol. 1, Marcel Dekker, N.Y., pp. 51-85!.
- the synthetic peptide was conjugated to keyhole limpet hemocyanin using maleimidohexanoyl-N-hydroxysuccinimide as a cross-linking agent see, Ishikawa et al. (1983) J. Immunoassay 4:209-237!.
- Rabbits were injected at multiple dorsal intradermal sites with 500 ⁇ g peptide emulsified with complete Freund's adjuvant. The animals were boosted regularly at 3-6 week intervals with 200 ⁇ g of peptide conjugate emulsified in incomplete Freund's adjuvant. The titer of the antisera after a few booster injections was approximately 1:50,000 to 1:100,000 as determined by ELISA using the unconjugated peptide as the antigen.
- Plates were coated with 100 ⁇ l/well of a 0.5 ⁇ g/ ⁇ l solution of peptides diluted in phosphate buffered saline PBS! by incubating them overnight at 4° C. The plates were washed extensively with PBS and incubated with 200 ⁇ l of 0.1% bovine serum albumin BSA! in PBS for 1 h at room temperature. The plates were then washed with PBS and 100 ⁇ l of prebleed or rabbit anti-peptide peptide of SEQ ID No. 25! antibody (1:100,000) was added to the duplicate wells.
- the plates were washed with PBS and 100 ⁇ l of peroxidase-goat-antirabbit IgG diluted in PBS supplemented with 0.1% BSA was added. After incubation for another hour at ambient temperature, the plates were extensively washed with PBS and 100 ⁇ l of peroxidase substrate solution was added to each well. The plates were then incubated for 15 minutes at ambient temperature. The peroxidase reaction was measured by the increase in absorbance at 405 nm.
- the library included the peptide having the sequence Met-Leu-Asp-Ser-lle-Trp-Lys-Pro-Asp-Leu MLDSIWKPDL; SEQ ID NO. 25!, against which an antibody had been generated in rabbits the peptide used for rabbits had an additional N-terminal Cys residue for linking!, and seven other peptides differing at residues L, P, and/or I SEQ ID NOs. 26-32 and the Scheme set forth in FIG. 10).
- the matrix with memory microvessels loaded with TentaGel® beads carrying PAL linkers (20 mg each) were split into two equal groups. Each group was encoded with the radiofrequency code L or A the one-letter symbols for amino acids leucine and alanine, respectively! and the first coupling was carried out separately using Fmoc-Leu-OH or Fmoc-Ala-OH, respectively and ByBOP, or HATU for the sterically hindered amino acids STEP 1, FIG. 10!.
- microvessels were then pooled, deprotected with 20% piperidine in DMF Fmoc removal!, encoded with the code D and subjected to coupling with Fmoc-Asp(OtBu)-OH and deprotection as above STEP 2!.
- the microvessels were then re-split into two equal and fully randomized groups and encoding was performed on each group with the codes P or F and amino acid derivatives Fmoc-Pro-OH or Fmoc-Phe-OH were coupled, respectively STEP 3!.
- the microvessels were pooled again and amino acid derivatives Fmoc-Lys (Boc)-OH and Fmoc-Trp(Boc)-OH were coupled sequentially with appropriate encoding and deprotection procedures STEPS 4 and 5!, and then were re-split into two equal groups, encoded appropriately and the amino acid derivatives Fmoc-lle-OH or Fmoc-Gly-OH were coupled separately STEP 6!.
- the matrix with memory microvessels were pooled, the amino groups deprotected and the remaining amino acids Ser, Asp, Leu and Met! were sequentially introduced with appropriate encoding and deprotections using suitably protected Fmoc derivatives STEPS 7-10!.
- the introduction of each amino acid was performed by double couplings at every step. The coupling efficiency for each step was generally over 90% as measured by Fmoc number determination after Fmoc deprotection UV spectroscopy!.
- TentaGel® beads from matrices with memories with identical codes were pooled together and the peptides were cleaved from the resin separately with EDT:thioanisole:H 2 O:PhOH:TFA (1.5:3:3:4.5:88m, w/w).
- the work-up and isolation procedures involved filtration, evaporation, dilution with water, thorough extraction with diethyl ether, and lyophilization.
- the fully deprotected peptides were obtained as white solids, their structures were confirmed by mass spectroscopy, and their purity was determined by HPLC analysis.
- the peptide sequence in entry 2, SEQ ID NO. 26! was confirmed by peptide amino acid sequence analysis.
- Ambient reactor temperature was also measured at specific synthesis steps by the on-board temperature thermistor.
- a rabbit polyclonal antibody generated specifically against the peptide SEQ ID NO. 25 was used to detect this specific sequence in the RECTM peptide library by the ELISA method.
- the ELISA assay correctly identified the library member with the SEQ ID NO. 25 100% binding!.
- the sequence of this peptide was also confirmed by the radiofrequency code, mass spectroscopy, and amino acid sequence analysis.
Abstract
Description
TABLE 1 ______________________________________ PROCESS STEP X-REGISTER ADDRESS Y-REGISTER ADDRESS ______________________________________ A 1 8C 2 4E 3 2 ______________________________________
TABLE 2 ______________________________________ Radiofrequency Encoded Combinatorial 24-member peptide library # of matrices Entry RF with Mass (SEQ ID) code Peptide memories.sup.a,b (Actual).sup.c ______________________________________ 1 LAGD Leu--Ala--Gly--Asp 3 372 (372.2) 2 LEGD Leu--Glu--Gly--Asp 4 432 (432.2) 3 SAGD Ser--Ala--Gly--Asp 5 348 (348.1) 4 SEGD Ser--Glu--Gly--Asp 5 406 (406.1) 5 LAVD Leu--Ala--Val--Asp 4 416 (416.2) 6 LEVD Leu--Glu--Val--Asp 6 474 (474.2) 7 SAVD Ser--Ala--Val--Asp 2 390 (390.2) 8 SEVD Ser--Glu--Val--Asp 3 446 (446.2) 9 LAGF Leu--Ala--Gly--Phe 5 406 (406.2) 10 LEGF Leu--Glu--Gly--Phe 5 464 (464.2) 11 SAGF Ser--Ala--Gly--Phe 5 380 (380.2) 12 SEGF Ser--Glu--Gly--Phe 6 438 (438.2) 13 LAVF Leu--Ala--Val--Phe 6 448 (448.3) 14 LEVF Leu--Glu--Val--Phe 2 xxx 15 SAVF Ser--Ala--Val--Phe 2 xxx 16 SEVF Ser--Glu--Val--Phe 1 480 (480.2) 17 LAGK Leu--Ala--Gly--Lys 2 387 (387.3) 18 LEGK Leu--Glu--Gly--Lys 1 445 (445.3) 19 SAGK Ser--Ala--Gly--Lys 4 361 (361.2) 20 SEGK Ser--Glu--Gly--Lys 3 419 (419.2) 21 LAVK Leu--Ala--Val--Lys 4 429 (429.3) 22 LEVK Leu--Glu--Val--Lys 6 487 (487.3) 23 SAVK Ser--Ala--Val--Lys 6 403 (403.3) 24 SEVK Ser--Glu--Val--Lys 6 461 (461.3) ______________________________________ .sup.a This is the number of packets of each matrix with memory containin the same peptide. .sup.b The ambient temperature was recorded by the sensor device of the chip in the matrices with memories at various points during the synthetic pathway. .sup.c Mass refers to (M + H) except1 and 8 which refer to (M - H) Since each peptide has a unique mass, the mass spectrum confirms its structure. .sup.d HPLC conditions: Shimadzu SCL 10A with a MICROSORBMV ™ C18 column (5 μM, 100 Å; isocratic elution with acetonitrile/water. entry
__________________________________________________________________________ SEQUENCE LISTING (1) GENERAL INFORMATION: (iii) NUMBER OF SEQUENCES: 32 (2) INFORMATION FOR SEQ ID NO:1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1: LeuAlaGlyAsp (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: LeuGluGlyAsp 1 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: SerAlaGlyAsp 1 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: SerGluGlyAsp 1 (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: LeuAlaValAsp 1 (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: LeuGluValAsp 1 (2) INFORMATION FOR SEQ ID NO:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: SerAlaValAsp 1 (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: SerGluValAsp 1 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: LeuAlaGlyPhe 1 (2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: LeuGluGlyPhe 1 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: SerAlaGlyPhe 1 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: SerGluGlyPhe 1 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: LeuAlaValPhe 1 (2) INFORMATION FOR SEQ ID NO:14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: LeuGluValPhe 1 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: SerAlaValPhe 1 (2) INFORMATION FOR SEQ ID NO:16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16: SerGluValPhe 1 (2) INFORMATION FOR SEQ ID NO:17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17: LeuAlaGlyLys 1 (2) INFORMATION FOR SEQ ID NO:18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18: LeuGluGlyLys 1 (2) INFORMATION FOR SEQ ID NO:19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19: SerAlaGlyLys 1 (2) INFORMATION FOR SEQ ID NO:20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20: SerGluGlyLys 1 (2) INFORMATION FOR SEQ ID NO:21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21: LeuAlaValLys 1 (2) INFORMATION FOR SEQ ID NO:22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22: LeuGluValLys 1 (2) INFORMATION FOR SEQ ID NO:23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23: SerAlaValLys 1 (2) INFORMATION FOR SEQ ID NO:24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24: SerGluValLys 1 (2) INFORMATION FOR SEQ ID NO:25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25: MetLeuAspSerIleTrpLysProAspLeu 1510 (2) INFORMATION FOR SEQ ID NO:26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: MetLeuAspSerGlyTrpLysProAspLeu 1510 (2) INFORMATION FOR SEQ ID NO:27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:27: MetLeuAspSerIleTrpLysProAspAla 1510 (2) INFORMATION FOR SEQ ID NO:28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:28: MetLeuAspSerIleTrpLysPheAspLeu 1510 (2) INFORMATION FOR SEQ ID NO:29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:29: MetLeuAspSerGlyTrpLysPheAspLeu 1510 (2) INFORMATION FOR SEQ ID NO:30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:30: MetLeuAspSerGlyTrpLysProAspAla 1510 (2) INFORMATION FOR SEQ ID NO:31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:31: MetLeuAspSerIleTrpLysPheAspAla 1510 (2) INFORMATION FOR SEQ ID NO:32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (v) FRAGMENT TYPE: internal (vi) ORIGINAL SOURCE: (xi) SEQUENCE DESCRIPTION: SEQ ID NO:32: MetLeuAspSerGlyTrpLysPheAspAla 1510 __________________________________________________________________________
Claims (31)
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/538,387 US5874214A (en) | 1995-04-25 | 1995-10-03 | Remotely programmable matrices with memories |
US08/567,746 US6025129A (en) | 1995-04-25 | 1995-12-05 | Remotely programmable matrices with memories and uses thereof |
JP8530562A JPH11511238A (en) | 1995-04-25 | 1996-04-25 | Matrix with remotely programmable memory and use thereof |
KR1019970707576A KR19990008052A (en) | 1995-04-25 | 1996-04-25 | Remotely programmable matrix with storage device and uses thereof |
DE69630881T DE69630881T2 (en) | 1995-04-25 | 1996-04-25 | REMOTE PROGRAMMABLE MATRICES WITH STORAGE AND USES THEREOF |
EA199700257A EA199700257A1 (en) | 1995-04-25 | 1996-04-25 | MATRIX WITH MEMORY PROGRAMMED AT A DISTANCE, AND THEIR USE |
EP96916437A EP0822861B1 (en) | 1995-04-25 | 1996-04-25 | Remotely programmable matrices with memories and uses thereof |
CN96193374A CN1181720A (en) | 1995-04-25 | 1996-04-25 | Remotely programmable matrices with memories and uses thereof |
PCT/US1996/006145 WO1996036436A1 (en) | 1995-04-25 | 1996-04-25 | Remotely programmable matrices with memories and uses thereof |
AT96916437T ATE254965T1 (en) | 1995-04-25 | 1996-04-25 | REMOTE PROGRAMMABLE MATRICES WITH STORAGE AND USES THEREOF |
CA002216645A CA2216645A1 (en) | 1995-04-25 | 1996-04-25 | Remotely programmable matrices with memories and uses thereof |
AU59185/96A AU707444B2 (en) | 1995-04-25 | 1996-04-25 | Remotely programmable matrices with memories and uses thereof |
US08/633,410 US6100026A (en) | 1995-04-25 | 1996-06-10 | Matrices with memories and uses thereof |
US08/669,252 US6319668B1 (en) | 1995-04-25 | 1996-06-24 | Method for tagging and screening molecules |
US08/711,426 US6284459B1 (en) | 1995-04-25 | 1996-09-05 | Solid support matrices with memories and combinatorial libraries therefrom |
US08/723,423 US5961923A (en) | 1995-04-25 | 1996-09-30 | Matrices with memories and uses thereof |
PCT/US1996/015999 WO1997012680A2 (en) | 1995-10-03 | 1996-10-03 | Matrices with memories, sensors with memories and uses thereof |
AU72573/96A AU7257396A (en) | 1995-10-03 | 1996-10-03 | Matrices with memories, sensors with memories and uses thereof |
EP96934064A EP0853497B1 (en) | 1995-10-03 | 1996-10-03 | Matrices with memories and uses thereof |
US09/051,022 US6340588B1 (en) | 1995-04-25 | 1996-10-03 | Matrices with memories |
AT96934064T ATE362397T1 (en) | 1995-10-03 | 1996-10-03 | MATRICES WITH STORAGE AND USES THEREOF |
DE69637085T DE69637085D1 (en) | 1995-10-03 | 1996-10-03 | MATRICES WITH SAVINGS AND USES THEREOF |
US08/912,998 US6329139B1 (en) | 1995-04-25 | 1997-08-11 | Automated sorting system for matrices with memory |
US09/098,122 US6372428B1 (en) | 1995-04-25 | 1998-06-16 | Remotely programmable matrices with memories |
US11/011,452 US7935659B2 (en) | 1995-04-25 | 2004-12-14 | Multiplexed assays using encoded solid supports |
US13/099,198 US8219327B2 (en) | 1995-04-25 | 2011-05-02 | Multiplexed assay using encoded solid support matrices |
US13/158,302 US20110237459A1 (en) | 1995-04-25 | 2011-06-10 | Multiplexed Assay Using Encoded Solid Support Matrices |
US13/478,689 US20120238466A1 (en) | 1995-04-25 | 2012-05-23 | Multiplexed Assay Using Encoded Solid Support Matrices |
US13/708,778 US20130090260A1 (en) | 1995-04-25 | 2012-12-07 | Multiplexed Assay Using Spectrally-Encoded Solid Support Matrices |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/428,662 US5741462A (en) | 1995-04-25 | 1995-04-25 | Remotely programmable matrices with memories |
US08/480,196 US5925562A (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/484,504 US5751629A (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/480,147 US6352854B1 (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/473,660 US6331273B1 (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/484,486 US6416714B1 (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/538,387 US5874214A (en) | 1995-04-25 | 1995-10-03 | Remotely programmable matrices with memories |
Related Parent Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/428,662 Continuation-In-Part US5741462A (en) | 1995-04-25 | 1995-04-25 | Remotely programmable matrices with memories |
US08/480,147 Continuation-In-Part US6352854B1 (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/473,660 Continuation-In-Part US6331273B1 (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/480,196 Continuation-In-Part US5925562A (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/484,504 Continuation-In-Part US5751629A (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
US08/484,486 Continuation-In-Part US6416714B1 (en) | 1995-04-25 | 1995-06-07 | Remotely programmable matrices with memories |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/567,746 Continuation-In-Part US6025129A (en) | 1995-04-25 | 1995-12-05 | Remotely programmable matrices with memories and uses thereof |
PCT/US1996/006145 Continuation-In-Part WO1996036436A1 (en) | 1995-04-25 | 1996-04-25 | Remotely programmable matrices with memories and uses thereof |
US08/723,423 Continuation-In-Part US5961923A (en) | 1995-04-25 | 1996-09-30 | Matrices with memories and uses thereof |
US09/098,122 Continuation US6372428B1 (en) | 1995-04-25 | 1998-06-16 | Remotely programmable matrices with memories |
Publications (1)
Publication Number | Publication Date |
---|---|
US5874214A true US5874214A (en) | 1999-02-23 |
Family
ID=27559978
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/538,387 Expired - Fee Related US5874214A (en) | 1995-04-25 | 1995-10-03 | Remotely programmable matrices with memories |
US09/098,122 Expired - Lifetime US6372428B1 (en) | 1995-04-25 | 1998-06-16 | Remotely programmable matrices with memories |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/098,122 Expired - Lifetime US6372428B1 (en) | 1995-04-25 | 1998-06-16 | Remotely programmable matrices with memories |
Country Status (1)
Country | Link |
---|---|
US (2) | US5874214A (en) |
Cited By (130)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030581A (en) * | 1997-02-28 | 2000-02-29 | Burstein Laboratories | Laboratory in a disk |
WO2000075664A1 (en) * | 1999-06-09 | 2000-12-14 | Ljl Biosystems, Inc. | Improvements in luminescence polarization assays |
US6245511B1 (en) | 1999-02-22 | 2001-06-12 | Vialogy Corp | Method and apparatus for exponentially convergent therapy effectiveness monitoring using DNA microarray based viral load measurements |
US20010022279A1 (en) * | 2000-02-11 | 2001-09-20 | Denyer Jonathan Stanley Harold | Controlling drug delivery apparatus |
US6297018B1 (en) | 1998-04-17 | 2001-10-02 | Ljl Biosystems, Inc. | Methods and apparatus for detecting nucleic acid polymorphisms |
US6319668B1 (en) | 1995-04-25 | 2001-11-20 | Discovery Partners International | Method for tagging and screening molecules |
WO2001094016A1 (en) * | 2000-06-06 | 2001-12-13 | Glaxo Group Limited | Sample container with radiofrequency identifier tag |
US6340588B1 (en) | 1995-04-25 | 2002-01-22 | Discovery Partners International, Inc. | Matrices with memories |
US6352854B1 (en) | 1995-04-25 | 2002-03-05 | Discovery Partners International, Inc. | Remotely programmable matrices with memories |
US6361950B1 (en) | 1995-11-30 | 2002-03-26 | Pharmaseq, Inc. | Multiplex assay for nucleic acids employing transponders |
US6372428B1 (en) | 1995-04-25 | 2002-04-16 | Discovery Partners International, Inc. | Remotely programmable matrices with memories |
US6376187B1 (en) * | 1995-11-30 | 2002-04-23 | Pharmaseq, Inc. | Electronically-indexed solid-phase assay for biomolecules |
US6387623B1 (en) | 1995-11-30 | 2002-05-14 | Pharmaseq | Screening of drugs from chemical combinatorial libraries employing transponders |
US6387273B1 (en) | 1999-08-27 | 2002-05-14 | Scynexis Chemistry & Automation, Inc. | Sample preparation for high throughput purification |
US6413431B1 (en) | 1999-08-10 | 2002-07-02 | Scynexis Chemistry & Automation, Inc. | HPLC method for purifying organic compounds |
US20020084329A1 (en) * | 1997-07-16 | 2002-07-04 | Kaye Paul H. | Coded items for labeling objects |
US20020094537A1 (en) * | 2000-12-29 | 2002-07-18 | Ellson Richard N. | Device and method for tracking conditions in an assay |
US6454759B2 (en) * | 2000-02-28 | 2002-09-24 | The Regents Of The University Of California | Microfabricated injectable drug delivery system |
US6464687B1 (en) * | 1999-03-09 | 2002-10-15 | Ball Semiconductor, Inc. | Implantable drug delivery system |
US20020155490A1 (en) * | 2001-04-18 | 2002-10-24 | Skinner Nigel G. | Particle based assay system |
US6500609B1 (en) | 1999-02-11 | 2002-12-31 | Scynexis Chemistry & Automation, Inc. | Method and apparatus for synthesizing characterizing and assaying combinatorial libraries |
US20030008323A1 (en) * | 1999-04-15 | 2003-01-09 | Ilya Ravkin | Chemical-library composition and method |
US6506342B1 (en) * | 1997-06-19 | 2003-01-14 | Robert D. Frankel | Tracking apparatus and method for use with combinatorial synthesis processes |
US20030011476A1 (en) * | 2000-02-26 | 2003-01-16 | Godfrey James William | Medicament dispenser |
US20030036096A1 (en) * | 1999-04-15 | 2003-02-20 | Ilya Ravkin | Chemical-library composition and method |
US6524863B1 (en) | 1999-08-04 | 2003-02-25 | Scynexis Chemistry & Automation, Inc. | High throughput HPLC method for determining Log P values |
US20030059764A1 (en) * | 2000-10-18 | 2003-03-27 | Ilya Ravkin | Multiplexed cell analysis system |
US20030081574A1 (en) * | 2001-10-25 | 2003-05-01 | Ntt Docomo, Inc. | Radio base station and method of controlling radio communications |
US20030119021A1 (en) * | 2001-07-16 | 2003-06-26 | Hubert Koster | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US20030129654A1 (en) * | 1999-04-15 | 2003-07-10 | Ilya Ravkin | Coded particles for multiplexed analysis of biological samples |
US20030127609A1 (en) * | 1998-08-31 | 2003-07-10 | Amer El-Hage | Sample analysis systems |
US20030134330A1 (en) * | 1999-04-15 | 2003-07-17 | Ilya Ravkin | Chemical-library composition and method |
US20030143612A1 (en) * | 2001-07-18 | 2003-07-31 | Pointilliste, Inc. | Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening |
US20030146095A1 (en) * | 1999-11-08 | 2003-08-07 | Nanogen, Inc. | Methods for the electronic, Homogeneous assembly and fabrication of devices |
US20030153092A1 (en) * | 2000-04-19 | 2003-08-14 | Skinner Nigel Guy | Method of fabricating coded particles |
US20030162296A1 (en) * | 1998-05-13 | 2003-08-28 | Lawandy Nabil M. | Micro-lasing beads and structures for combinatorial chemistry and other applications, and techniques for fabricating the structures and for detecting information encoded by the structures |
GB2385850A (en) * | 1999-04-30 | 2003-09-03 | Agilent Technologies Inc | Biopolymer array fabrication and use |
US20030166015A1 (en) * | 1999-04-15 | 2003-09-04 | Zarowitz Michael A. | Multiplexed analysis of cell-substrate interactions |
US20030183226A1 (en) * | 2000-07-15 | 2003-10-02 | Brand Peter John | Medicament dispenser |
WO2003083905A2 (en) * | 2002-03-26 | 2003-10-09 | Derhsing Lai | Novel integrated circuit chip for bioassays_____________________ |
US20030203390A1 (en) * | 1995-10-26 | 2003-10-30 | Kaye Paul H. | Coded particles for process sequence tracking in combinatorial compound library preparation |
US20030207249A1 (en) * | 1999-04-15 | 2003-11-06 | Beske Oren E. | Connection of cells to substrates using association pairs |
US6653151B2 (en) | 1999-07-30 | 2003-11-25 | Large Scale Proteomics Corporation | Dry deposition of materials for microarrays using matrix displacement |
US6652808B1 (en) * | 1991-11-07 | 2003-11-25 | Nanotronics, Inc. | Methods for the electronic assembly and fabrication of devices |
US20030219800A1 (en) * | 2001-10-18 | 2003-11-27 | Beske Oren E. | Multiplexed cell transfection using coded carriers |
US6660832B1 (en) | 1999-08-20 | 2003-12-09 | Isis Pharmaceuticals, Inc. | Macrocyclic compounds and preparation methods thereof |
US20030235594A1 (en) * | 1999-09-14 | 2003-12-25 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
US6686461B1 (en) | 2000-03-22 | 2004-02-03 | Solulink Bioscience, Inc. | Triphosphate oligonucleotide modification reagents and uses thereof |
US20040048311A1 (en) * | 2002-01-24 | 2004-03-11 | Dana Ault-Riche | Use of collections of binding sites for sample profiling and other applications |
US6706473B1 (en) | 1996-12-06 | 2004-03-16 | Nanogen, Inc. | Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides |
US6713309B1 (en) | 1999-07-30 | 2004-03-30 | Large Scale Proteomics Corporation | Microarrays and their manufacture |
WO2004030616A2 (en) | 2002-09-17 | 2004-04-15 | Antigen Express, Inc. | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES |
US20040096911A1 (en) * | 1999-04-15 | 2004-05-20 | Oleg Siniaguine | Particles with light-polarizing codes |
US20040111219A1 (en) * | 1999-02-22 | 2004-06-10 | Sandeep Gulati | Active interferometric signal analysis in software |
US20040126773A1 (en) * | 2002-05-23 | 2004-07-01 | Beske Oren E. | Assays with coded sensor particles to sense assay conditions |
US20040132005A1 (en) * | 2002-09-10 | 2004-07-08 | Jing-Hsiang Hsu | Method of forming biochip and application thereof |
US20040191770A1 (en) * | 2003-02-17 | 2004-09-30 | Midwest Research Institute, Inc. | Biological particulate matter analogue |
US20040197817A1 (en) * | 1999-04-30 | 2004-10-07 | Caren Michael P. | Polynucleotide array fabrication |
US20040209255A1 (en) * | 2002-03-11 | 2004-10-21 | Hk Pharmaceuticals, Inc. | Compounds and methods for analyzing the proteome |
US20040209282A1 (en) * | 2002-10-30 | 2004-10-21 | Dana Ault-Riche | Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
US20040241748A1 (en) * | 2003-02-10 | 2004-12-02 | Dana Ault-Riche | Self-assembling arrays and uses thereof |
US20040241752A1 (en) * | 1998-02-03 | 2004-12-02 | Anderson Emory V. | Point of care diagnostic systems |
US20040249586A1 (en) * | 1997-09-15 | 2004-12-09 | Annegret Boge | Molecular modification assays |
US20050042771A1 (en) * | 2003-01-16 | 2005-02-24 | Hubert Koster | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US6873593B1 (en) * | 1997-05-21 | 2005-03-29 | Eugen Pavel | Three-Dimensional optical memory with fluorescent photosensitive vitreous material read and written to by laser |
US20050084914A1 (en) * | 2003-09-15 | 2005-04-21 | Foulkes J. G. | Assays with primary cells |
US20050084423A1 (en) * | 2003-09-15 | 2005-04-21 | Zarowitz Michael A. | Systems for particle manipulation |
US20050095648A1 (en) * | 2003-10-30 | 2005-05-05 | Mario Geysen | Method for designing linear epitopes and algorithm therefor and polypeptide epitopes |
US20050100937A1 (en) * | 2003-09-11 | 2005-05-12 | Holmes Elizabeth A. | Medical device for analyte monitoring and drug delivery |
US20050203289A1 (en) * | 2000-03-22 | 2005-09-15 | Schwartz David A. | Functional biopolymer modification reagents and uses thereof |
US20050205673A1 (en) * | 2004-03-19 | 2005-09-22 | Applera Corporation | Methods and systems for using RFID in biological field |
US20050225751A1 (en) * | 2003-09-19 | 2005-10-13 | Donald Sandell | Two-piece high density plate |
US20050227294A1 (en) * | 1997-09-15 | 2005-10-13 | Molecular Devices Corporation | Molecular modification assays involving lipids |
US20050242963A1 (en) * | 2004-03-19 | 2005-11-03 | Applera Corporation | Sample carrier device incorporating radio frequency identification, and method |
US20050276728A1 (en) * | 2004-04-08 | 2005-12-15 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US20050280811A1 (en) * | 2003-09-19 | 2005-12-22 | Donald Sandell | Grooved high density plate |
US20060002947A1 (en) * | 1999-09-14 | 2006-01-05 | Robert Humphreys | Ii-key/antigenic epitope hybrid peptide vaccines |
WO2006002641A1 (en) * | 2004-07-02 | 2006-01-12 | Versamatrix A/S | Spherical radiofrequency-encoded beads |
US20060018911A1 (en) * | 2004-01-12 | 2006-01-26 | Dana Ault-Riche | Design of therapeutics and therapeutics |
US7009517B2 (en) | 2000-05-24 | 2006-03-07 | Glaxo Group Limited | Method for monitoring objects with transponders |
US20060053005A1 (en) * | 2004-09-02 | 2006-03-09 | Sandeep Gulati | Detecting events of interest using quantum resonance interferometry |
US20060058099A1 (en) * | 2004-09-09 | 2006-03-16 | Soukup Thomas E | System and method for awarding an incentive award |
US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US20060098745A1 (en) * | 2004-11-09 | 2006-05-11 | Yu-Pin Chou | Apparatus and method for evaluating data transmission |
US20060121544A1 (en) * | 1997-09-15 | 2006-06-08 | Annegret Boge | Molecular modification assays |
US20060127369A1 (en) * | 2002-09-27 | 2006-06-15 | Carlsberg A/S | Spatially encoded polymer matrix |
US20060264780A1 (en) * | 2005-05-09 | 2006-11-23 | Holmes Elizabeth A | Systems and methods for conducting animal studies |
US7179638B2 (en) | 1999-07-30 | 2007-02-20 | Large Scale Biology Corporation | Microarrays and their manufacture by slicing |
US7179645B2 (en) | 2002-09-24 | 2007-02-20 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
WO2007044711A1 (en) * | 2005-10-07 | 2007-04-19 | University Of Florida Research Foundation, Inc. | Multiple component nanoparticles for multiplexed signaling and optical encoding |
US20070138024A1 (en) * | 2004-09-21 | 2007-06-21 | Swanson Paul D | Electrode based patterning of thin film self-assembled nanoparticles |
WO2007079752A2 (en) * | 2006-01-11 | 2007-07-19 | Novo Nordisk A/S | Improved spherical encoded beads |
US20070178094A1 (en) * | 1999-09-14 | 2007-08-02 | Humphreys Robert E | Hybrid peptides modulate the immune response |
US20070224084A1 (en) * | 2006-03-24 | 2007-09-27 | Holmes Elizabeth A | Systems and Methods of Sample Processing and Fluid Control in a Fluidic System |
US7276336B1 (en) | 1999-07-22 | 2007-10-02 | Agilent Technologies, Inc. | Methods of fabricating an addressable array of biopolymer probes |
US20070266826A1 (en) * | 2006-04-28 | 2007-11-22 | Angel Sanjurjo | Methods for producing consolidated materials |
US20080233341A1 (en) * | 2005-08-26 | 2008-09-25 | Evonik Degussa Gmbh | Special Aminoalkylsilane Compounds as Binders for Composite Materials |
US20080238627A1 (en) * | 2005-03-22 | 2008-10-02 | Applera Corporation | Sample carrier device incorporating radio frequency identification, and method |
US20080288178A1 (en) * | 2001-08-24 | 2008-11-20 | Applera Corporation | Sequencing system with memory |
US20080311681A1 (en) * | 2004-12-23 | 2008-12-18 | Ib Johannsen | Antibody Binding Affinity Ligands |
US20100248277A1 (en) * | 2006-11-14 | 2010-09-30 | Ian Gibbons | Detection and quantification of analytes in bodily fluids |
US20100310591A1 (en) * | 2009-01-28 | 2010-12-09 | Robert Humphreys | Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA |
US20100307921A1 (en) * | 2001-09-19 | 2010-12-09 | Life Technologies Corporation | Microdevice with integrated memory |
WO2011032181A2 (en) | 2009-09-14 | 2011-03-17 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr3 designs |
US20110093249A1 (en) * | 2009-10-19 | 2011-04-21 | Theranos, Inc. | Integrated health data capture and analysis system |
US7935659B2 (en) | 1995-04-25 | 2011-05-03 | Nexus Biosystems, Inc. | Multiplexed assays using encoded solid supports |
US20110118147A1 (en) * | 2008-03-13 | 2011-05-19 | Ladner Robert C | Libraries of genetic packages comprising novel hc cdr3 designs |
US20110172125A1 (en) * | 2008-04-24 | 2011-07-14 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs |
US8007999B2 (en) | 2006-05-10 | 2011-08-30 | Theranos, Inc. | Real-time detection of influenza virus |
US8158430B1 (en) | 2007-08-06 | 2012-04-17 | Theranos, Inc. | Systems and methods of fluidic sample processing |
US20130006479A1 (en) * | 2009-07-30 | 2013-01-03 | Anderson Gerald G | Microchip System and Method for Operating a Locking Mechanism and for Cashless Transactions |
US8967248B2 (en) | 2011-08-23 | 2015-03-03 | Harris Corporation | Method for hydrocarbon resource recovery including actuator operated positioning of an RF sensor and related apparatus |
US8997864B2 (en) | 2011-08-23 | 2015-04-07 | Harris Corporation | Method for hydrocarbon resource recovery including actuator operated positioning of an RF applicator and related apparatus |
US9376709B2 (en) | 2010-07-26 | 2016-06-28 | Biomatrica, Inc. | Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures |
US20160245759A1 (en) * | 2007-06-30 | 2016-08-25 | Shane M. Popp | Pharmaceutical dosage forms fabricated with nanomaterials |
US9610597B1 (en) | 2011-10-27 | 2017-04-04 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
US9626620B2 (en) | 2013-06-05 | 2017-04-18 | Haemonetics Corporation | Frangible RFID tag and method of producing same |
US9725703B2 (en) | 2012-12-20 | 2017-08-08 | Biomatrica, Inc. | Formulations and methods for stabilizing PCR reagents |
US9845489B2 (en) | 2010-07-26 | 2017-12-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
US9928457B2 (en) | 2013-06-18 | 2018-03-27 | Haemonetics Corporation | RFID tag and method of securing same to object |
US10064404B2 (en) | 2014-06-10 | 2018-09-04 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
US20190139603A1 (en) * | 2016-04-29 | 2019-05-09 | Johannes Kepler Universität Linz | Storage of codes in molecularly imprinted polymers |
US10568317B2 (en) | 2015-12-08 | 2020-02-25 | Biomatrica, Inc. | Reduction of erythrocyte sedimentation rate |
US10700273B2 (en) * | 2017-09-20 | 2020-06-30 | Research & Business Foundation Sungkyunkwan University | Protein-based nonvolatile memory device and method for manufacturing the same |
US10829541B2 (en) | 2000-04-17 | 2020-11-10 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
US10973226B2 (en) | 2018-10-05 | 2021-04-13 | TMRW Life Sciences, Inc. | Apparatus to preserve and identify biological samples at cryogenic conditions |
US11112416B2 (en) | 2018-01-30 | 2021-09-07 | Life Technologies Corporation | Instruments, devices and consumables for use in a workflow of a smart molecular analysis system |
US11287421B2 (en) | 2006-03-24 | 2022-03-29 | Labrador Diagnostics Llc | Systems and methods of sample processing and fluid control in a fluidic system |
USD951481S1 (en) | 2020-09-01 | 2022-05-10 | TMRW Life Sciences, Inc. | Cryogenic vial |
USD963194S1 (en) | 2020-12-09 | 2022-09-06 | TMRW Life Sciences, Inc. | Cryogenic vial carrier |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6815390B2 (en) * | 2000-07-12 | 2004-11-09 | Merck Patent Gmbh | Supported fluorous biphasic catalyst system |
US7125523B2 (en) * | 2002-04-29 | 2006-10-24 | Agilent Technologies, Inc. | Holders for arrays |
US7164533B2 (en) | 2003-01-22 | 2007-01-16 | Cyvera Corporation | Hybrid random bead/chip based microarray |
WO2004019276A1 (en) * | 2002-08-20 | 2004-03-04 | Cyvera Corporation | Diffraction grating-based optical identification element |
US7508608B2 (en) | 2004-11-17 | 2009-03-24 | Illumina, Inc. | Lithographically fabricated holographic optical identification element |
US7923260B2 (en) | 2002-08-20 | 2011-04-12 | Illumina, Inc. | Method of reading encoded particles |
US7900836B2 (en) | 2002-08-20 | 2011-03-08 | Illumina, Inc. | Optical reader system for substrates having an optically readable code |
US20050227252A1 (en) * | 2002-08-20 | 2005-10-13 | Moon John A | Diffraction grating-based encoded articles for multiplexed experiments |
US7872804B2 (en) | 2002-08-20 | 2011-01-18 | Illumina, Inc. | Encoded particle having a grating with variations in the refractive index |
US7441703B2 (en) * | 2002-08-20 | 2008-10-28 | Illumina, Inc. | Optical reader for diffraction grating-based encoded optical identification elements |
US7619819B2 (en) | 2002-08-20 | 2009-11-17 | Illumina, Inc. | Method and apparatus for drug product tracking using encoded optical identification elements |
US7901630B2 (en) | 2002-08-20 | 2011-03-08 | Illumina, Inc. | Diffraction grating-based encoded microparticle assay stick |
EP1535242A1 (en) * | 2002-08-20 | 2005-06-01 | Cyvera Corporation | Diffraction grating-based encoded micro-particles for multiplexed experiments |
CA2499046A1 (en) * | 2002-09-12 | 2004-03-25 | Cyvera Corporation | Diffraction grating-based encoded micro-particles for multiplexed experiments |
WO2004025561A1 (en) * | 2002-09-12 | 2004-03-25 | Cyvera Corporation | Chemical synthesis using diffraction grating-based encoded optical elements |
EP1540592A1 (en) * | 2002-09-12 | 2005-06-15 | Cyvera Corporation | Method and apparatus for labeling using diffraction grating-based encoded optical identification elements |
WO2004024328A1 (en) * | 2002-09-12 | 2004-03-25 | Cyvera Corporation | Method and apparatus for aligning elongated microbeads in order to interrogate the same |
US20100255603A9 (en) | 2002-09-12 | 2010-10-07 | Putnam Martin A | Method and apparatus for aligning microbeads in order to interrogate the same |
AU2003270655A1 (en) * | 2002-09-12 | 2004-04-30 | Cyvera Corporation | Assay stick comprising coded microbeads |
US7092160B2 (en) | 2002-09-12 | 2006-08-15 | Illumina, Inc. | Method of manufacturing of diffraction grating-based optical identification element |
US8073626B2 (en) * | 2003-01-31 | 2011-12-06 | Agilent Technologies, Inc. | Biopolymer array reading |
US7433123B2 (en) | 2004-02-19 | 2008-10-07 | Illumina, Inc. | Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein |
US7407816B2 (en) * | 2004-05-07 | 2008-08-05 | Gentius, Inc | Isoelectric particles and uses thereof |
WO2006055736A1 (en) | 2004-11-16 | 2006-05-26 | Illumina, Inc. | And methods and apparatus for reading coded microbeads |
US20060128031A1 (en) * | 2004-12-15 | 2006-06-15 | Robotti Karla M | Addressable recovery of bound analytes from an evanescent wave sensor |
US7544330B2 (en) * | 2005-09-28 | 2009-06-09 | Idexx Laboratories, Inc. | Microplate sample tracking system |
US7623624B2 (en) * | 2005-11-22 | 2009-11-24 | Illumina, Inc. | Method and apparatus for labeling using optical identification elements characterized by X-ray diffraction |
US7830575B2 (en) | 2006-04-10 | 2010-11-09 | Illumina, Inc. | Optical scanner with improved scan time |
US8012744B2 (en) | 2006-10-13 | 2011-09-06 | Theranos, Inc. | Reducing optical interference in a fluidic device |
EP3181228B1 (en) | 2007-10-02 | 2020-07-29 | Labrador Diagnostics LLC | Modular point-of-care devices and uses thereof |
BR112013018656B1 (en) | 2011-01-21 | 2021-03-02 | Labrador Diagnostics Llc | method for detecting the presence or concentration of an analyte in a sample of fluid contained in a container, and, method of measuring the concentration of analyte in a sample of fluid |
Citations (288)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2866723A (en) * | 1953-09-16 | 1958-12-30 | Minnesota Mining & Mfg | Process for marking halogenated polymers, and resulting article |
US3047421A (en) * | 1960-06-08 | 1962-07-31 | Continental Diamond Fibre Corp | Method of making cementable fluorocarbons, such as polytetrafluoro-ethylene and the like and the product |
US3119099A (en) * | 1960-02-08 | 1964-01-21 | Wells Gardner Electronics | Molecular storage unit |
US3469848A (en) * | 1966-04-11 | 1969-09-30 | Tri Point Ind Inc | Fluorocarbon sound record |
FR2110030A5 (en) | 1970-10-19 | 1972-05-26 | Astec Inc | |
US3692498A (en) * | 1970-10-12 | 1972-09-19 | Lab Aids Inc | Chemical testing apparatus |
US3704952A (en) * | 1969-12-29 | 1972-12-05 | Environment One Corp | Fluid medium source tracer method |
US3715856A (en) * | 1971-08-19 | 1973-02-13 | Borel J & Co | Packaging method |
US3781120A (en) * | 1970-09-14 | 1973-12-25 | Technicon Instr | Self-locating sample receptacle having integral identification label |
DE2344930A1 (en) | 1972-09-27 | 1974-04-04 | Johannes Dr Bancsich | SAMPLE CARRIERS AND DEVICE FOR WRITING AND READING THE SAME |
US3843443A (en) * | 1973-03-30 | 1974-10-22 | J Fishman | Polypeptide materials bound to fluorocarbon polymers |
US3867517A (en) * | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
US3920124A (en) * | 1974-12-09 | 1975-11-18 | Deering Milliken Res Corp | Fabric roll sorting method |
US3930924A (en) * | 1971-12-08 | 1976-01-06 | Satoshi Oka | Process for making identification cards |
US3935427A (en) * | 1973-12-26 | 1976-01-27 | Sun Electric Corporation | Car diagnosis system |
US3939123A (en) * | 1974-06-18 | 1976-02-17 | Union Carbide Corporation | Lightly cross-linked polyurethane hydrogels based on poly(alkylene ether) polyols |
US4006117A (en) * | 1973-01-24 | 1977-02-01 | Hooker Chemicals & Plastics Corporation | Amine phosphite antioxidants |
US4006403A (en) * | 1975-04-11 | 1977-02-01 | Clayton Manufacturing Company | Engine performance analyzer |
US4133642A (en) * | 1978-03-10 | 1979-01-09 | Terumo Corporation | Pipetting apparatus for automatic analyzer |
US4154795A (en) * | 1976-07-23 | 1979-05-15 | Dynatech Holdings Limited | Microtest plates |
US4162355A (en) * | 1976-06-30 | 1979-07-24 | Board Of Regents, For And On Behalf Of The University Of Florida | Copolymers of (a) aminimides and (b) vinyl pendant primary halomethy monomers useful for affinity chromatography |
US4171412A (en) * | 1974-04-25 | 1979-10-16 | Ceskoslovenska Akademie Ved | Specific sorbent having D-aminoacid moiety covalently bonded to solid particulate hydrophilic polymeric carrier |
US4175183A (en) * | 1977-03-01 | 1979-11-20 | Development Finance Corporation Of New Zealand | Hydroxyalkylated cross-linked regenerated cellulose and method of preparation thereof |
US4176260A (en) * | 1977-05-16 | 1979-11-27 | Ward Danny W | Inventory control system |
US4177038A (en) * | 1976-05-18 | 1979-12-04 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschafen E.V. | Method for the production of a vehicle substance which is capable of covalent bonding with biologically active matter |
US4178439A (en) * | 1976-03-04 | 1979-12-11 | Development Finance Corporation Of New Zealand | Sulphated ion exchanger and method for preparation thereof |
US4179402A (en) * | 1978-05-15 | 1979-12-18 | Shell Oil Company | Resin-metal-ligand composition |
US4180524A (en) * | 1978-02-16 | 1979-12-25 | Phillips Petroleum Company | Disproportionation/double-bond isomerization of olefins |
US4241537A (en) * | 1979-05-10 | 1980-12-30 | W. R. Grace & Co. | Plant growth media utilizing polyurethane hydrogel |
US4282287A (en) * | 1980-01-24 | 1981-08-04 | Giese Roger W | Biochemical avidin-biotin multiple-layer system |
US4318658A (en) * | 1979-05-30 | 1982-03-09 | Mcintyre Raeburn C | Tilting deck vehicle |
US4321069A (en) * | 1979-10-26 | 1982-03-23 | Ritter Robert A | Multiple vessel cascade gas enrichment system |
US4333072A (en) * | 1979-08-06 | 1982-06-01 | International Identification Incorporated | Identification device |
US4351337A (en) * | 1973-05-17 | 1982-09-28 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery device, and process for preparing and using the same |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4424579A (en) * | 1981-02-23 | 1984-01-03 | Burroughs Corporation | Mask programmable read-only memory stacked above a semiconductor substrate |
US4439585A (en) * | 1980-11-12 | 1984-03-27 | Tyndale Plains-Hunter, Ltd. | Polyurethane diacrylate compositions as carrier for pharmacological agents |
US4442507A (en) * | 1981-02-23 | 1984-04-10 | Burroughs Corporation | Electrically programmable read-only memory stacked above a semiconductor substrate |
US4450150A (en) * | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
US4476149A (en) * | 1981-08-27 | 1984-10-09 | Boehringer Mannheim Gmbh | Process for the production of an analysis test strip |
US4485227A (en) * | 1983-06-16 | 1984-11-27 | Howmedica, Inc. | Biocompatible poly-(ether-urethane-urea) and process for its preparation |
US4507230A (en) * | 1982-05-12 | 1985-03-26 | Research Corporation | Peptide synthesis reagents and method of use |
US4530840A (en) * | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
FR2526169B1 (en) | 1982-04-28 | 1985-08-30 | Mochida Pharm Co Ltd | CONTAINER FOR IMMUNOLOGICAL ASSAY |
US4542025A (en) * | 1982-07-29 | 1985-09-17 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
US4542102A (en) * | 1983-07-05 | 1985-09-17 | Molecular Diagnostics, Inc. | Coupling of nucleic acids to solid support by photochemical methods |
US4562157A (en) * | 1983-05-25 | 1985-12-31 | National Research Development Corporation | Diagnostic device incorporating a biochemical ligand |
US4569981A (en) * | 1980-07-18 | 1986-02-11 | Bayer Aktiengesellschaft | Solid, water-dispersible plastics precursors containing isocyanate groups, a process for the production of aqueous plastics dispersions using such plastics precursors |
FR2555744B1 (en) | 1983-11-30 | 1986-05-09 | Philips Ind Commerciale | SPECIMEN WITH MEANS FOR STORING ANALYSIS RESULTS |
US4588880A (en) * | 1982-09-16 | 1986-05-13 | Robert Bosch Gmbh | Non-contacting code recognition system for code carriers on production line workpieces |
US4598386A (en) * | 1984-04-18 | 1986-07-01 | Roesner Bruce B | Reduced-area, read-only memory |
US4631211A (en) * | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
US4646266A (en) * | 1984-09-28 | 1987-02-24 | Energy Conversion Devices, Inc. | Programmable semiconductor structures and methods for using the same |
US4652528A (en) * | 1984-08-13 | 1987-03-24 | Halogen Insulator & Seal Corp. | Information carrier and method of use |
US4654512A (en) * | 1981-09-19 | 1987-03-31 | Erwin Gardosi | Machine readable information carrier |
US4657543A (en) * | 1984-07-23 | 1987-04-14 | Massachusetts Institute Of Technology | Ultrasonically modulated polymeric devices for delivering compositions |
US4681870A (en) * | 1985-01-11 | 1987-07-21 | Imre Corporation | Protein A-silica immunoadsorbent and process for its production |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4702732A (en) * | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
US4705503A (en) * | 1986-02-03 | 1987-11-10 | Regents Of The University Of Minnesota | Metabolite sensor including a chemical concentration sensitive flow controller for a drug delivery system |
US4745072A (en) * | 1983-06-23 | 1988-05-17 | Ekins Roger Philip | Immunoassay and immunometric assay of free ligand concentrations in biological fluids |
US4762881A (en) * | 1987-01-09 | 1988-08-09 | E. I. Du Pont De Nemours And Company | Photoreactive benzoylphenylalanines and related peptides |
US4777019A (en) * | 1985-04-12 | 1988-10-11 | Thomas Dandekar | Biosensor |
US4779806A (en) * | 1984-07-23 | 1988-10-25 | Massachusetts Institute Of Technology | Ultrasonically modulated polymeric devices for delivering compositions |
US4783776A (en) * | 1986-01-22 | 1988-11-08 | Hitachi, Ltd. | Method of recording and reproducing digital information and apparatus therefor |
US4786277A (en) * | 1986-11-21 | 1988-11-22 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation |
US4791285A (en) * | 1985-07-03 | 1988-12-13 | Koatsu Gas Kogyo Co., Ltd. | Read/write method by a non-contact system and between a storage substrate and read/write unit |
US4796074A (en) * | 1987-04-27 | 1989-01-03 | Instant Circuit Corporation | Method of fabricating a high density masked programmable read-only memory |
US4807140A (en) * | 1983-11-10 | 1989-02-21 | Saulnier Dominique C | Electronic label information exchange system |
US4855909A (en) * | 1987-11-20 | 1989-08-08 | Hewlett-Packard Company | Forensic sample tracking system and print station therefor |
US4857893A (en) * | 1986-07-18 | 1989-08-15 | Bi Inc. | Single chip transponder device |
US4870574A (en) * | 1986-06-27 | 1989-09-26 | Thomson Semiconducteurs | Method for the programming of data in an electrically programmable read-only memory |
US4876668A (en) * | 1985-07-31 | 1989-10-24 | California Institute Of Technology | Thin film memory matrix using amorphous and high resistive layers |
US4885250A (en) * | 1987-03-02 | 1989-12-05 | E. I. Du Pont De Nemours And Company | Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports |
US4889800A (en) * | 1985-08-12 | 1989-12-26 | Scripps Clinic And Research Foundation | Synthetic polypeptides and receptor molecules derived therefrom and methods of use |
US4908405A (en) * | 1985-01-04 | 1990-03-13 | Ernst Bayer | Graft copolymers of crosslinked polymers and polyoxyethylene, processes for their production, and their usage |
US4908813A (en) * | 1986-12-10 | 1990-03-13 | Hitachi, Ltd. | Wavelength multiplexing optical recording apparatus |
US4908694A (en) * | 1982-04-30 | 1990-03-13 | Fujitsu Limited | Semiconductor device |
US4927879A (en) * | 1988-02-25 | 1990-05-22 | Purdue Research Foundation | Method for solid phase membrane mimetics |
US4931498A (en) * | 1988-02-25 | 1990-06-05 | Purdue Research Foundation | Immobilized artificial membranes |
US4933285A (en) * | 1986-10-07 | 1990-06-12 | Environmental Technologies Group, Inc. | Multiple monolayers of polymeric linkages on a solid phase for immobilizing macromolecules |
US4952531A (en) * | 1988-03-17 | 1990-08-28 | Olin Corporation | Sealing glass for matched sealing of copper and copper alloys |
US4952928A (en) * | 1988-08-29 | 1990-08-28 | B. I. Incorporated | Adaptable electronic monitoring and identification system |
US4954444A (en) * | 1987-03-02 | 1990-09-04 | E. I. Du Pont De Nemours And Company | Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports |
US4958452A (en) * | 1989-09-27 | 1990-09-25 | Zoecon Corporation | Animal identification ear tag assembly |
US4960983A (en) * | 1987-09-28 | 1990-10-02 | Mitsubishi Denki Kabushiki Kaisha | Noncontact type IC card and system for noncontact transfer of information using the same |
US4973493A (en) * | 1982-09-29 | 1990-11-27 | Bio-Metric Systems, Inc. | Method of improving the biocompatibility of solid surfaces |
US4990756A (en) * | 1988-07-25 | 1991-02-05 | Telsor Corporation | Apparatus and method for emulating bar codes |
US4991719A (en) * | 1989-03-03 | 1991-02-12 | Speed Sort, Inc. | Method and apparatus for sorting randomly positioned items minimizing sorting conveyor movement |
US5002548A (en) * | 1986-10-06 | 1991-03-26 | Bio Medic Data Systems, Inc. | Animal marker implanting system |
US5004606A (en) * | 1986-09-24 | 1991-04-02 | Hybritech Incorporated | Non-covalent antibody-anthracycline immunocomplexes |
US5012236A (en) * | 1989-05-26 | 1991-04-30 | Trovan Limited | Electromagnetic energy transmission and detection apparatus |
US5024747A (en) * | 1979-12-21 | 1991-06-18 | Varian Associates, Inc. | Wafer coating system |
US5029214A (en) * | 1986-08-11 | 1991-07-02 | Hollander James F | Electronic speech control apparatus and methods |
US5028918A (en) * | 1989-12-18 | 1991-07-02 | Dairy Equipment Company | Identification transponder circuit |
US5030807A (en) * | 1990-01-16 | 1991-07-09 | Amtech Corporation | System for reading and writing data from and into remote tags |
US5033623A (en) * | 1989-04-15 | 1991-07-23 | W. Schlafhorst & Co. | Method and apparatus for associating information with a textile package |
US5043222A (en) * | 1988-03-17 | 1991-08-27 | Olin Corporation | Metal sealing glass composite with matched coefficients of thermal expansion |
US5044623A (en) * | 1988-11-21 | 1991-09-03 | Eastman Kodak Company | Apparatus for stacking sheets |
US5047371A (en) * | 1988-09-02 | 1991-09-10 | Olin Corporation | Glass/ceramic sealing system |
US5055659A (en) * | 1990-02-06 | 1991-10-08 | Amtech Technology Corp. | High speed system for reading and writing data from and into remote tags |
US5056056A (en) * | 1989-02-02 | 1991-10-08 | Systems Research Laboratories, Inc. | Data recorder including a recirculating non-volatile memory |
US5063417A (en) | 1988-07-18 | 1991-11-05 | California Institute Of Technology | Molecular shift register based on electron transfer |
US5064767A (en) | 1990-06-21 | 1991-11-12 | The Board Of Trustees Of The Leland Stanford Junior University | Carboxyl-terminal protein sequencing method and kit |
US5073703A (en) | 1990-03-30 | 1991-12-17 | Datakey, Inc. | Apparatus for encoding electrical identification devices by means of selectively fusible links |
US5074318A (en) | 1986-10-06 | 1991-12-24 | Bio Medic Data Systems, Inc. | Animal marker |
US5087570A (en) | 1988-05-10 | 1992-02-11 | Weissman Irving L | Homogeneous mammalian hematopoietic stem cell composition |
US5089391A (en) | 1989-01-10 | 1992-02-18 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
US5089877A (en) | 1990-06-06 | 1992-02-18 | Sgs-Thomson Microelectronics, Inc. | Zero power ic module |
US5092992A (en) | 1989-06-07 | 1992-03-03 | J. T. Baker Inc. | Polyethyleneimine matrixes for affinity chromatography |
US5095362A (en) | 1990-10-23 | 1992-03-10 | Instant Circuit Corporation | Method for reducing resistance for programmed antifuse |
US5099226A (en) | 1991-01-18 | 1992-03-24 | Interamerican Industrial Company | Intelligent security system |
US5100626A (en) | 1990-05-24 | 1992-03-31 | Levin Andrew E | Binding assay device with removable cassette and manifold |
US5105190A (en) | 1986-04-22 | 1992-04-14 | N.V. Nederlandsche Apparatenfabriek Nedap | Electromagnetic identification system |
US5114719A (en) | 1987-04-29 | 1992-05-19 | Sabel Bernhard A | Extended drug delivery of small, water-soluble molecules |
US5119163A (en) | 1990-06-22 | 1992-06-02 | Sharp Kabushiki Kaisha | Semiconductor device |
US5120662A (en) | 1989-05-09 | 1992-06-09 | Abbott Laboratories | Multilayer solid phase immunoassay support and method of use |
US5120642A (en) | 1989-11-28 | 1992-06-09 | Coulter Corporation | Monoclonal antibody which distinguishes helper inducer and suppressor inducer cd4+ lymphocytes |
US5121748A (en) | 1990-05-12 | 1992-06-16 | Schott Glaswerke | Biocompatible infused absorption glass containing feo |
US5134277A (en) | 1983-11-07 | 1992-07-28 | Australian Meat And Live-Stock Corporation | Remote data transfer system with ambient light insensitive circuitry |
US5136572A (en) | 1990-09-10 | 1992-08-04 | Tacan Corporation | Optical data storage using temperature stabilizer lasers |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5148256A (en) | 1981-02-23 | 1992-09-15 | Unisys Corporation | Digital computer having an interconnect mechanism stacked above a semiconductor substrate |
US5148404A (en) | 1990-10-09 | 1992-09-15 | Texas Instruments Incorporated | Transponder and method for the production thereof |
US5171695A (en) | 1986-08-06 | 1992-12-15 | Multilyte Limited | Determination of analyte concentration using two labelling markers |
US5200051A (en) | 1988-11-14 | 1993-04-06 | I-Stat Corporation | Wholly microfabricated biosensors and process for the manufacture and use thereof |
US5201728A (en) | 1991-05-03 | 1993-04-13 | Giampapa Vincent C | Subcutaneous implantable multiple-agent delivery system |
US5211165A (en) | 1991-09-03 | 1993-05-18 | General Electric Company | Tracking system to follow the position and orientation of a device with radiofrequency field gradients |
US5212315A (en) | 1983-11-03 | 1993-05-18 | Merrell Dow Pharmaceuticals Inc. | Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones |
US5212050A (en) | 1988-11-14 | 1993-05-18 | Mier Randall M | Method of forming a permselective layer |
US5214409A (en) | 1991-12-03 | 1993-05-25 | Avid Corporation | Multi-memory electronic identification tag |
US5215899A (en) | 1989-11-09 | 1993-06-01 | Miles Inc. | Nucleic acid amplification employing ligatable hairpin probe and transcription |
US5216143A (en) | 1991-06-28 | 1993-06-01 | Gen-Probe Products Company | Nucleic acid probes to mycobacterium gordonae |
US5218189A (en) | 1991-09-09 | 1993-06-08 | Checkpoint Systems, Inc. | Binary encoded multiple frequency rf indentification tag |
US5217743A (en) | 1992-02-07 | 1993-06-08 | Paradigm Biotechnologies Partnership | Biomaterials of enhanced biocompatibility |
US5217870A (en) | 1989-04-28 | 1993-06-08 | Biogen, Inc. | Monoclonal antibodies against CDX |
US5218343A (en) | 1990-02-05 | 1993-06-08 | Anatoli Stobbe | Portable field-programmable detection microchip |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5223408A (en) | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
US5228001A (en) | 1991-01-23 | 1993-07-13 | Syracuse University | Optical random access memory |
US5232831A (en) | 1991-06-28 | 1993-08-03 | Gen-Probe Incorporated | Nucleic acid probes to streptococcus pyogenes |
DE9308204U1 (en) | 1993-06-01 | 1993-08-05 | Hecht, Manfred, 90765 Fuerth, De | |
US5235326A (en) | 1991-08-15 | 1993-08-10 | Avid Corporation | Multi-mode identification system |
US5236355A (en) | 1988-12-22 | 1993-08-17 | American Cyanamid Company | Apparatus for the treatment of periodontal disease |
US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
US5248863A (en) | 1991-10-01 | 1993-09-28 | Ncr Corporation | Switch actuator mechanism |
US5250944A (en) | 1990-10-29 | 1993-10-05 | Bio Medic Data Systems, Inc. | Antenna and driving circuit for transmitting and receiving images to and from a passive transponder |
US5250459A (en) | 1992-04-14 | 1993-10-05 | Micron Technology, Inc. | Electrically programmable low resistive antifuse element |
US5250962A (en) | 1991-10-16 | 1993-10-05 | Xerox Corporation | Movable ink jet priming station |
US5251635A (en) | 1991-09-03 | 1993-10-12 | General Electric Company | Stereoscopic X-ray fluoroscopy system using radiofrequency fields |
US5252743A (en) | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5252962A (en) | 1990-08-03 | 1993-10-12 | Bio Medic Data Systems | System monitoring programmable implantable transponder |
US5253198A (en) | 1991-12-20 | 1993-10-12 | Syracuse University | Three-dimensional optical memory |
US5257011A (en) | 1991-12-03 | 1993-10-26 | Avid Corporation | Data altering means for multi-memory electronic identification tag |
US5255680A (en) | 1991-09-03 | 1993-10-26 | General Electric Company | Automatic gantry positioning for imaging systems |
US5256469A (en) | 1991-12-18 | 1993-10-26 | General Electric Company | Multi-layered, co-fired, ceramic-on-metal circuit board for microelectronic packaging |
US5258289A (en) | 1990-09-05 | 1993-11-02 | Davis Claude G | Method for the selecting of genes encoding catalytic antibodies |
US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
US5262772A (en) | 1989-08-16 | 1993-11-16 | Bio Medic Data Systems, Inc. | Transponder scanner |
US5266926A (en) | 1991-05-31 | 1993-11-30 | Avid Marketing, Inc. | Signal transmission and tag power consumption measurement circuit for an inductive reader |
US5265610A (en) | 1991-09-03 | 1993-11-30 | General Electric Company | Multi-planar X-ray fluoroscopy system using radiofrequency fields |
US5268371A (en) | 1990-01-10 | 1993-12-07 | Cis Bio International | Derivatives of porphyrin and metalloporphyrins optionally coupled to a biologically active molecule and pharmaceutical composition containing them |
US5270251A (en) | 1993-02-25 | 1993-12-14 | Massachusetts Institute Of Technology | Incoherent radiation regulated voltage programmable link |
US5270170A (en) | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
US5271400A (en) | 1992-04-01 | 1993-12-21 | General Electric Company | Tracking system to monitor the position and orientation of a device using magnetic resonance detection of a sample contained within the device |
US5272666A (en) | 1991-10-18 | 1993-12-21 | Lattice Semiconductor Corporation | Programmable semiconductor antifuse structure and method of fabricating |
US5273927A (en) | 1990-12-03 | 1993-12-28 | Micron Technology, Inc. | Method of making a ferroelectric capacitor and forming local interconnect |
US5277724A (en) | 1991-12-18 | 1994-01-11 | General Electric Co. | Method of minimizing lateral shrinkage in a co-fired, ceramic-on-metal circuit board |
US5282158A (en) | 1992-08-21 | 1994-01-25 | Micron Technology, Inc. | Transistor antifuse for a programmable ROM |
US5284747A (en) | 1991-12-18 | 1994-02-08 | Gen-Probe Incorporated | Nucleic acid probes to Coccidioides immitis |
US5288476A (en) | 1988-11-25 | 1994-02-22 | Cis Bio International | Radiopharmaceutical product more particularly having a cardiac tropism incorporating a nitride complex of a transition metal and its preparation process |
US5288291A (en) | 1992-08-12 | 1994-02-22 | Datapet, Inc. | Method and apparatus for simultaneously injecting a liquid and a transponder into an animal |
US5288622A (en) | 1983-03-03 | 1994-02-22 | Genentech, Inc. | Human nerve growth factor by recombinant technology |
US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
US5290734A (en) | 1991-06-04 | 1994-03-01 | Vlsi Technology, Inc. | Method for making anti-fuse structures |
US5292814A (en) | 1987-04-29 | 1994-03-08 | Ernst Bayer | Process for the preparation of monodispersed polymer beads |
US5292874A (en) | 1991-09-04 | 1994-03-08 | Gen-Probe Incorporated | Nucleic acid probes to Staphylococcus aureus |
US5296122A (en) | 1989-03-29 | 1994-03-22 | Teruaki Katsube | Apparatus for forming thin film |
US5300278A (en) | 1988-03-09 | 1994-04-05 | Cis Bio International | Process for the preparation of 99m Tc, 186 Re or 188 Re nitride complexes usable as radiopharmaceutical products |
US5300456A (en) | 1993-06-17 | 1994-04-05 | Texas Instruments Incorporated | Metal-to-metal antifuse structure |
US5304498A (en) | 1982-03-19 | 1994-04-19 | Ekins Roger Philip | Method and composition for free ligand assay |
US5306466A (en) | 1993-05-19 | 1994-04-26 | California South Pacific Investors | Detection of contaminants in food |
US5308967A (en) | 1990-10-26 | 1994-05-03 | Reinhard Jurisch | Data carrier for identification systems |
US5307808A (en) | 1992-04-01 | 1994-05-03 | General Electric Company | Tracking system and pulse sequences to monitor the position of a device using magnetic resonance |
US5311039A (en) | 1990-04-24 | 1994-05-10 | Seiko Epson Corporation | PROM and ROM memory cells |
US5310686A (en) | 1987-03-10 | 1994-05-10 | Ares Serono Research & Development Limited Partnership | Polymer-coated optical structures |
US5314829A (en) | 1992-12-18 | 1994-05-24 | California Institute Of Technology | Method for imaging informational biological molecules on a semiconductor substrate |
US5316971A (en) | 1992-09-18 | 1994-05-31 | Actel Corporation | Methods for programming antifuses having at least one metal electrode |
US5316922A (en) | 1992-04-15 | 1994-05-31 | The United States Of America As Represented By Department Of Health And Human Services | Method for indentifying and expressing proteins that recognize and adhere to specific probes |
US5319181A (en) | 1992-03-16 | 1994-06-07 | Symbol Technologies, Inc. | Method and apparatus for decoding two-dimensional bar code using CCD/CMD camera |
US5318354A (en) | 1992-05-20 | 1994-06-07 | C. W. Lisk Company, Inc. | Proportional control valve with differential sensing area |
US5322812A (en) | 1991-03-20 | 1994-06-21 | Crosspoint Solutions, Inc. | Improved method of fabricating antifuses in an integrated circuit device and resulting structure |
US5324324A (en) | 1992-10-13 | 1994-06-28 | Siemens Pacesetter, Inc. | Coated implantable stimulation electrode and lead |
US5323704A (en) | 1992-07-30 | 1994-06-28 | Heidelberg-Harris Gmbh | Device for the identification of a flexible roller shell |
US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
US5324483A (en) | 1992-10-08 | 1994-06-28 | Warner-Lambert Company | Apparatus for multiple simultaneous synthesis |
US5324591A (en) | 1987-03-06 | 1994-06-28 | Geo-Centers, Inc. | Deep ultraviolet photolithographically defined ultra-thin films for selective cell adhesion and outgrowth and method of manufacturing the same and devices containing the same |
US5326449A (en) | 1991-12-31 | 1994-07-05 | Abbott Laboratories | Composite membrane |
US5326696A (en) | 1992-03-09 | 1994-07-05 | Tanox Biosystems, Inc. | Selecting low frequency antigen-specific single B lymphocytes |
US5329153A (en) | 1992-04-10 | 1994-07-12 | Crosspoint Solutions, Inc. | Antifuse with nonstoichiometric tin layer and method of manufacture thereof |
US5328603A (en) | 1990-03-20 | 1994-07-12 | The Center For Innovative Technology | Lignocellulosic and cellulosic beads for use in affinity and immunoaffinity chromatography of high molecular weight proteins |
US5334640A (en) | 1992-04-08 | 1994-08-02 | Clover Consolidated, Ltd. | Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods |
US5335219A (en) | 1991-01-18 | 1994-08-02 | Ovshinsky Stanford R | Homogeneous composition of microcrystalline semiconductor material, semiconductor devices and directly overwritable memory elements fabricated therefrom, and arrays fabricated from the memory elements |
US5334880A (en) | 1991-04-30 | 1994-08-02 | International Business Machines Corporation | Low voltage programmable storage element |
US5342772A (en) | 1990-09-21 | 1994-08-30 | E. I. Du Pont De Nemours And Company | Process for enzyme immobilization on a fluorocarbon surface |
US5347283A (en) | 1989-06-14 | 1994-09-13 | Hughes Aircraft Company | Frequency agile radar |
US5347263A (en) | 1993-02-05 | 1994-09-13 | Gnuco Technology Corporation | Electronic identifier apparatus and method utilizing a single chip microcontroller and an antenna coil |
US5346789A (en) | 1991-12-06 | 1994-09-13 | Cornell Research Foundation, Inc. | Oriented biological material for optical information storage and processing |
US5349173A (en) | 1991-04-23 | 1994-09-20 | Siemens Aktiengesellschaft | Apparatus for contactless data and energy transmission |
US5348867A (en) | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
US5348705A (en) | 1992-04-10 | 1994-09-20 | B.M.L., Inc. | Automatic clinical sample dispensing system |
US5351052A (en) | 1992-09-28 | 1994-09-27 | Texas Instruments Incorporated | Transponder systems for automatic identification purposes |
US5350645A (en) | 1993-06-21 | 1994-09-27 | Micron Semiconductor, Inc. | Polymer-lithium batteries and improved methods for manufacturing batteries |
US5352579A (en) | 1991-06-28 | 1994-10-04 | Gen Probe, Inc. | Nucleic acid probes to histoplasma capsulatum |
US5353795A (en) | 1992-12-10 | 1994-10-11 | General Electric Company | Tracking system to monitor the position of a device using multiplexed magnetic resonance detection |
US5359250A (en) | 1992-03-04 | 1994-10-25 | The Whitaker Corporation | Bulk wave transponder |
US5359115A (en) | 1992-03-26 | 1994-10-25 | Affymax Technologies, N.V. | Methods for the synthesis of phosphonate esters |
US5361385A (en) | 1992-08-26 | 1994-11-01 | Reuven Bakalash | Parallel computing system for volumetric modeling, data processing and visualization |
US5362899A (en) | 1993-09-09 | 1994-11-08 | Affymax Technologies, N.V. | Chiral synthesis of alpha-aminophosponic acids |
US5364797A (en) | 1993-05-20 | 1994-11-15 | Mobil Oil Corp. | Sensor device containing mesoporous crystalline material |
US5366733A (en) | 1988-12-22 | 1994-11-22 | American Cyanamid Company | Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, and composition of matter therefor |
US5374718A (en) | 1992-08-26 | 1994-12-20 | Gen-Probe Incorporated | Nucleic acid probes to chlamydia pneumoniae |
US5377678A (en) | 1991-09-03 | 1995-01-03 | General Electric Company | Tracking system to follow the position and orientation of a device with radiofrequency fields |
US5381035A (en) | 1992-09-23 | 1995-01-10 | Chen; Wenn-Jei | Metal-to-metal antifuse including etch stop layer |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5384028A (en) | 1992-08-28 | 1995-01-24 | Nec Corporation | Biosensor with a data memory |
US5384481A (en) | 1991-01-17 | 1995-01-24 | Crosspoint Solutions, Inc. | Antifuse circuit structure for use in a field programmable gate array and method of manufacture thereof |
US5383873A (en) | 1992-12-09 | 1995-01-24 | Regents Of The University Of Minnesota | Smooth muscle chemical pacemaker |
US5386024A (en) | 1993-02-10 | 1995-01-31 | Gen-Probe Incorporated | Method to prepare nucleic acids from a biological sample using low pH and acid protease |
US5389769A (en) | 1992-03-27 | 1995-02-14 | Shinko Electric Co., Ltd. | ID recognizing system in semiconductor manufacturing system |
US5389534A (en) | 1992-03-23 | 1995-02-14 | Siemens Aktiengesellschaft | Biosensor containing a biochemical substance immobilized on a layer of an olefinic-unsaturated, epoxyfunctional polyether |
US5389449A (en) | 1991-01-04 | 1995-02-14 | Perseptive Biosystems, Inc. | Sulfonamide bonded hydrophilic coatings |
US5391463A (en) | 1988-04-14 | 1995-02-21 | The United States Of America As Represented By The Secretary Of The Navy | Surface modification to create regions resistant to adsorption of biomolecules |
US5395750A (en) | 1992-02-28 | 1995-03-07 | Hoffmann-La Roche Inc. | Methods for producing proteins which bind to predetermined antigens |
US5395587A (en) | 1993-07-06 | 1995-03-07 | Smithkline Beecham Corporation | Surface plasmon resonance detector having collector for eluted ligate |
US5397939A (en) | 1991-07-31 | 1995-03-14 | Quicklogic Corporation | Programming of antifuses |
US5400136A (en) | 1992-01-16 | 1995-03-21 | Martin Marietta Energy Systems, Inc. | Surface-enhanced Raman scattering (SERS) dosimeter and probe |
US5399339A (en) | 1990-07-04 | 1995-03-21 | Cis Bio International | Process for the preparation of nitride complexes of transition metals |
US5401378A (en) | 1991-03-27 | 1995-03-28 | Australian Membrane & Biotechnology Research Institute | Ionic reservoir at electrode surface |
US5403750A (en) | 1991-03-06 | 1995-04-04 | W. R. Grace & Co.-Conn. | Biocompatible, low protein adsorption affinity matrix |
US5408037A (en) | 1991-01-17 | 1995-04-18 | Zymogenetics, Inc. | Methods for detecting glucagon antagonists |
US5410155A (en) | 1993-03-11 | 1995-04-25 | Packard Instrument, B.V. | Scintillation counting medium and process |
US5412593A (en) | 1994-01-12 | 1995-05-02 | Texas Instruments Incorporated | Fuse and antifuse reprogrammable link for integrated circuits |
USRE34936E (en) * | 1986-10-06 | 1995-05-09 | Bio Medic Data Systems, Inc. | Animal marker implanting system |
US5416486A (en) | 1993-11-08 | 1995-05-16 | Apti, Inc. | Identification/security tag system employing electronic doppler shifting and/or rectenna structure |
US5416193A (en) | 1993-04-30 | 1995-05-16 | Pfizer Inc. | Coupling reagent and method |
US5420328A (en) | 1992-09-11 | 1995-05-30 | Affymax Technologies, N.V. | Methods for the synthesis of phosphonate esters |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5432018A (en) | 1990-06-20 | 1995-07-11 | Affymax Technologies N.V. | Peptide library and screening systems |
US5435937A (en) | 1992-02-14 | 1995-07-25 | Amersham International Plc | Fluorescent compounds |
US5438439A (en) | 1993-08-13 | 1995-08-01 | Mok; Fai | Non-destructive readout mechanism for volume holograms using two wavelengths |
US5437277A (en) | 1991-11-18 | 1995-08-01 | General Electric Company | Inductively coupled RF tracking system for use in invasive imaging of a living body |
US5440511A (en) | 1993-06-15 | 1995-08-08 | Fujitsu Limited | Semiconductor memory device |
US5442584A (en) | 1993-09-14 | 1995-08-15 | Goldstar Electron Co., Ltd. | Semiconductor memory device and method for fabricating the same dynamic random access memory device construction |
US5442212A (en) | 1993-08-31 | 1995-08-15 | Mitsubishi Denki Kabushiki Kaisha | Semiconductor memory device |
US5443066A (en) | 1991-11-18 | 1995-08-22 | General Electric Company | Invasive system employing a radiofrequency tracking system |
US5443953A (en) | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
US5443816A (en) | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
US5442940A (en) | 1991-10-24 | 1995-08-22 | Hewlett-Packard Company | Apparatus and method for evaluating the fetal condition |
US5447533A (en) | 1992-09-03 | 1995-09-05 | Pacesetter, Inc. | Implantable stimulation lead having an advanceable therapeutic drug delivery system |
US5449941A (en) | 1991-10-29 | 1995-09-12 | Semiconductor Energy Laboratory Co., Ltd. | Semiconductor memory device |
US5452251A (en) | 1992-12-03 | 1995-09-19 | Fujitsu Limited | Semiconductor memory device for selecting and deselecting blocks of word lines |
US5452311A (en) | 1992-10-30 | 1995-09-19 | Intel Corporation | Method and apparatus to improve read reliability in semiconductor memories |
US5451896A (en) | 1992-05-13 | 1995-09-19 | Mitsubishi Denki Kabushiki Kaisha | Semiconductor integrated circuit device with an internal voltage-down converter |
US5453633A (en) | 1992-10-29 | 1995-09-26 | Samsung Electronics Co., Ltd. | Dynamic random access memory device and a manufacturing method thereof |
US5457184A (en) | 1991-08-30 | 1995-10-10 | Cis Bio International | Rare earth macrocyclic complexes and use thereof for reduction of disturbances in an assay using fluorescence |
US5463564A (en) | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
US5489678A (en) | 1989-06-07 | 1996-02-06 | Affymax Technologies N.V. | Photolabile nucleoside and peptide protecting groups |
US5491074A (en) | 1993-04-01 | 1996-02-13 | Affymax Technologies Nv | Association peptides |
US5503805A (en) | 1993-11-02 | 1996-04-02 | Affymax Technologies N.V. | Apparatus and method for parallel coupling reactions |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US5541061A (en) | 1992-04-29 | 1996-07-30 | Affymax Technologies N.V. | Methods for screening factorial chemical libraries |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5549974A (en) | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
US5552721A (en) | 1995-06-05 | 1996-09-03 | International Business Machines Corporation | Method and system for enhanced drive in programmmable gate arrays |
US5556762A (en) | 1990-11-21 | 1996-09-17 | Houghten Pharmaceutical Inc. | Scanning synthetic peptide combinatorial libraries: oligopeptide mixture sets having a one predetermined residue at a single, predetermined position, methods of making and using the same |
US5565324A (en) | 1992-10-01 | 1996-10-15 | The Trustees Of Columbia University In The City Of New York | Complex combinatorial chemical libraries encoded with tags |
US5572410A (en) | 1991-02-25 | 1996-11-05 | Gustafson; Ake | Integrated circuit device having a winding connected to an integrated circuit solely by a wire |
US5583819A (en) | 1995-01-27 | 1996-12-10 | Single Chip Holdings, Inc. | Apparatus and method of use of radiofrequency identification tags |
US5609826A (en) | 1995-04-17 | 1997-03-11 | Ontogen Corporation | Methods and apparatus for the generation of chemical libraries |
US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
US5639603A (en) | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
EP0535242B1 (en) | 1991-03-18 | 1997-09-03 | Institut Molekulyarnoi Biologii Im. V.A.Engelgardta Rossiiskoi Akademii Nauk | Method and device for determining nucleotide sequence of dna |
GB2306484B (en) | 1995-10-26 | 1997-09-24 | Univ Hertfordshire | Coded particles for process sequence tracking in combinatorial compound library preparation |
US5679773A (en) | 1995-01-17 | 1997-10-21 | Affymax Technologies N.V | Reagants and methods for immobilized polymer synthesis and display |
US5708153A (en) | 1991-09-18 | 1998-01-13 | Affymax Technologies N.V. | Method of synthesizing diverse collections of tagged compounds |
US5736332A (en) | 1995-11-30 | 1998-04-07 | Mandecki; Wlodek | Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3882318A (en) | 1974-01-21 | 1975-05-06 | Hycel Inc | Detector means for an automatic chemical testing apparatus |
JPS5716359A (en) | 1980-07-03 | 1982-01-27 | Olympus Optical Co Ltd | Sample container |
US4935875A (en) | 1987-12-02 | 1990-06-19 | Data Chem, Inc. | Chemical analyzer |
US5075077A (en) | 1988-08-02 | 1991-12-24 | Abbott Laboratories | Test card for performing assays |
SE8804657D0 (en) | 1988-12-27 | 1988-12-27 | Gerald Potter Colin | SUPPORT STRUCTURE FOR USE IN A PROXIMITY ASSEY |
JP2881826B2 (en) | 1989-07-24 | 1999-04-12 | 東ソー株式会社 | Automatic analyzer |
US5474796A (en) | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
DE69220888T2 (en) | 1991-11-05 | 1998-01-29 | Perkin Elmer Corp | Device and method for producing biopolymers |
US5605662A (en) | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
NL9200207A (en) | 1992-02-05 | 1993-09-01 | Nedap Nv | IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION. |
JP3164403B2 (en) | 1992-03-27 | 2001-05-08 | オリンパス光学工業株式会社 | Automatic analyzer |
DE4313807C2 (en) | 1992-04-28 | 1995-03-09 | Olympus Optical Co | Reagent container system for the immunological analysis of a sample in an automatic analyzer |
US5585275A (en) | 1992-09-02 | 1996-12-17 | Arris Pharmaceutical Corporation | Pilot apparatus for peptide synthesis and screening |
EP0672255A1 (en) | 1992-12-04 | 1995-09-20 | Eurogenetics N.V. | Method and automated device for performing immunological tests |
DE4306563A1 (en) | 1993-03-03 | 1994-09-08 | Jan Lichtenberg | Specimen container for specimens to be analysed |
US6087186A (en) | 1993-07-16 | 2000-07-11 | Irori | Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
US5397709A (en) | 1993-08-27 | 1995-03-14 | Becton Dickinson And Company | System for detecting bacterial growth in a plurality of culture vials |
DE9416270U1 (en) | 1994-10-10 | 1994-12-08 | Grieb Reinhard | Laboratory sample container |
US5751629A (en) | 1995-04-25 | 1998-05-12 | Irori | Remotely programmable matrices with memories |
US5874214A (en) | 1995-04-25 | 1999-02-23 | Irori | Remotely programmable matrices with memories |
US5741462A (en) | 1995-04-25 | 1998-04-21 | Irori | Remotely programmable matrices with memories |
US5925562A (en) | 1995-04-25 | 1999-07-20 | Irori | Remotely programmable matrices with memories |
US5961923A (en) | 1995-04-25 | 1999-10-05 | Irori | Matrices with memories and uses thereof |
US5641634A (en) | 1995-11-30 | 1997-06-24 | Mandecki; Wlodek | Electronically-indexed solid-phase assay for biomolecules |
US6355490B1 (en) | 1996-09-13 | 2002-03-12 | Jill Edie Hochlowski | Attached tags for use in combinatorial chemistry synthesis |
GB9707744D0 (en) | 1997-04-17 | 1997-06-04 | Zeneca Ltd | Method |
GB9707743D0 (en) | 1997-04-17 | 1997-06-04 | Zeneca Ltd | Analysis |
GB9707742D0 (en) | 1997-04-17 | 1997-06-04 | Zeneca Ltd | Methods |
-
1995
- 1995-10-03 US US08/538,387 patent/US5874214A/en not_active Expired - Fee Related
-
1998
- 1998-06-16 US US09/098,122 patent/US6372428B1/en not_active Expired - Lifetime
Patent Citations (303)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2866723A (en) * | 1953-09-16 | 1958-12-30 | Minnesota Mining & Mfg | Process for marking halogenated polymers, and resulting article |
US3119099A (en) * | 1960-02-08 | 1964-01-21 | Wells Gardner Electronics | Molecular storage unit |
US3047421A (en) * | 1960-06-08 | 1962-07-31 | Continental Diamond Fibre Corp | Method of making cementable fluorocarbons, such as polytetrafluoro-ethylene and the like and the product |
US3469848A (en) * | 1966-04-11 | 1969-09-30 | Tri Point Ind Inc | Fluorocarbon sound record |
US3704952A (en) * | 1969-12-29 | 1972-12-05 | Environment One Corp | Fluid medium source tracer method |
US3781120A (en) * | 1970-09-14 | 1973-12-25 | Technicon Instr | Self-locating sample receptacle having integral identification label |
US3692498A (en) * | 1970-10-12 | 1972-09-19 | Lab Aids Inc | Chemical testing apparatus |
FR2110030A5 (en) | 1970-10-19 | 1972-05-26 | Astec Inc | |
US3713985A (en) * | 1970-10-19 | 1973-01-30 | Kantor F | Device and method for testing potency of biological control reagents |
US3715856A (en) * | 1971-08-19 | 1973-02-13 | Borel J & Co | Packaging method |
US3930924A (en) * | 1971-12-08 | 1976-01-06 | Satoshi Oka | Process for making identification cards |
US3867517A (en) * | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
GB1423185A (en) | 1972-09-27 | 1976-01-28 | Bancsich J Hadrian W | Specimen holder and arrangement for registration and read out thereof |
DE2344930A1 (en) | 1972-09-27 | 1974-04-04 | Johannes Dr Bancsich | SAMPLE CARRIERS AND DEVICE FOR WRITING AND READING THE SAME |
US4006117A (en) * | 1973-01-24 | 1977-02-01 | Hooker Chemicals & Plastics Corporation | Amine phosphite antioxidants |
US3843443A (en) * | 1973-03-30 | 1974-10-22 | J Fishman | Polypeptide materials bound to fluorocarbon polymers |
US4351337A (en) * | 1973-05-17 | 1982-09-28 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery device, and process for preparing and using the same |
US4450150A (en) * | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
US3935427A (en) * | 1973-12-26 | 1976-01-27 | Sun Electric Corporation | Car diagnosis system |
US4171412A (en) * | 1974-04-25 | 1979-10-16 | Ceskoslovenska Akademie Ved | Specific sorbent having D-aminoacid moiety covalently bonded to solid particulate hydrophilic polymeric carrier |
US3939123A (en) * | 1974-06-18 | 1976-02-17 | Union Carbide Corporation | Lightly cross-linked polyurethane hydrogels based on poly(alkylene ether) polyols |
US3920124A (en) * | 1974-12-09 | 1975-11-18 | Deering Milliken Res Corp | Fabric roll sorting method |
US4006403A (en) * | 1975-04-11 | 1977-02-01 | Clayton Manufacturing Company | Engine performance analyzer |
US4178439A (en) * | 1976-03-04 | 1979-12-11 | Development Finance Corporation Of New Zealand | Sulphated ion exchanger and method for preparation thereof |
US4177038A (en) * | 1976-05-18 | 1979-12-04 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschafen E.V. | Method for the production of a vehicle substance which is capable of covalent bonding with biologically active matter |
US4162355A (en) * | 1976-06-30 | 1979-07-24 | Board Of Regents, For And On Behalf Of The University Of Florida | Copolymers of (a) aminimides and (b) vinyl pendant primary halomethy monomers useful for affinity chromatography |
US4154795A (en) * | 1976-07-23 | 1979-05-15 | Dynatech Holdings Limited | Microtest plates |
US4175183A (en) * | 1977-03-01 | 1979-11-20 | Development Finance Corporation Of New Zealand | Hydroxyalkylated cross-linked regenerated cellulose and method of preparation thereof |
US4176260A (en) * | 1977-05-16 | 1979-11-27 | Ward Danny W | Inventory control system |
US4180524A (en) * | 1978-02-16 | 1979-12-25 | Phillips Petroleum Company | Disproportionation/double-bond isomerization of olefins |
US4133642A (en) * | 1978-03-10 | 1979-01-09 | Terumo Corporation | Pipetting apparatus for automatic analyzer |
US4179402A (en) * | 1978-05-15 | 1979-12-18 | Shell Oil Company | Resin-metal-ligand composition |
US4241537A (en) * | 1979-05-10 | 1980-12-30 | W. R. Grace & Co. | Plant growth media utilizing polyurethane hydrogel |
US4318658A (en) * | 1979-05-30 | 1982-03-09 | Mcintyre Raeburn C | Tilting deck vehicle |
US4333072A (en) * | 1979-08-06 | 1982-06-01 | International Identification Incorporated | Identification device |
US4321069A (en) * | 1979-10-26 | 1982-03-23 | Ritter Robert A | Multiple vessel cascade gas enrichment system |
US5024747A (en) * | 1979-12-21 | 1991-06-18 | Varian Associates, Inc. | Wafer coating system |
US4282287A (en) * | 1980-01-24 | 1981-08-04 | Giese Roger W | Biochemical avidin-biotin multiple-layer system |
US4569981A (en) * | 1980-07-18 | 1986-02-11 | Bayer Aktiengesellschaft | Solid, water-dispersible plastics precursors containing isocyanate groups, a process for the production of aqueous plastics dispersions using such plastics precursors |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4439585A (en) * | 1980-11-12 | 1984-03-27 | Tyndale Plains-Hunter, Ltd. | Polyurethane diacrylate compositions as carrier for pharmacological agents |
US5296722A (en) | 1981-02-23 | 1994-03-22 | Unisys Corporation | Electrically alterable resistive component stacked above a semiconductor substrate |
US4442507A (en) * | 1981-02-23 | 1984-04-10 | Burroughs Corporation | Electrically programmable read-only memory stacked above a semiconductor substrate |
US4424579A (en) * | 1981-02-23 | 1984-01-03 | Burroughs Corporation | Mask programmable read-only memory stacked above a semiconductor substrate |
US5148256A (en) | 1981-02-23 | 1992-09-15 | Unisys Corporation | Digital computer having an interconnect mechanism stacked above a semiconductor substrate |
US4476149A (en) * | 1981-08-27 | 1984-10-09 | Boehringer Mannheim Gmbh | Process for the production of an analysis test strip |
US4654512A (en) * | 1981-09-19 | 1987-03-31 | Erwin Gardosi | Machine readable information carrier |
US5304498A (en) | 1982-03-19 | 1994-04-19 | Ekins Roger Philip | Method and composition for free ligand assay |
FR2526169B1 (en) | 1982-04-28 | 1985-08-30 | Mochida Pharm Co Ltd | CONTAINER FOR IMMUNOLOGICAL ASSAY |
GB2129551B (en) | 1982-04-28 | 1986-02-26 | Mochida Pharm Co Ltd | Immunoassay vessel conveying analysis information |
US4908694A (en) * | 1982-04-30 | 1990-03-13 | Fujitsu Limited | Semiconductor device |
US4507230A (en) * | 1982-05-12 | 1985-03-26 | Research Corporation | Peptide synthesis reagents and method of use |
US4542025A (en) * | 1982-07-29 | 1985-09-17 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
US4530840A (en) * | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
US4588880A (en) * | 1982-09-16 | 1986-05-13 | Robert Bosch Gmbh | Non-contacting code recognition system for code carriers on production line workpieces |
US4973493A (en) * | 1982-09-29 | 1990-11-27 | Bio-Metric Systems, Inc. | Method of improving the biocompatibility of solid surfaces |
US5288622A (en) | 1983-03-03 | 1994-02-22 | Genentech, Inc. | Human nerve growth factor by recombinant technology |
US4562157A (en) * | 1983-05-25 | 1985-12-31 | National Research Development Corporation | Diagnostic device incorporating a biochemical ligand |
US4485227A (en) * | 1983-06-16 | 1984-11-27 | Howmedica, Inc. | Biocompatible poly-(ether-urethane-urea) and process for its preparation |
US4745072A (en) * | 1983-06-23 | 1988-05-17 | Ekins Roger Philip | Immunoassay and immunometric assay of free ligand concentrations in biological fluids |
US4542102A (en) * | 1983-07-05 | 1985-09-17 | Molecular Diagnostics, Inc. | Coupling of nucleic acids to solid support by photochemical methods |
US5212315A (en) | 1983-11-03 | 1993-05-18 | Merrell Dow Pharmaceuticals Inc. | Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones |
US5134277A (en) | 1983-11-07 | 1992-07-28 | Australian Meat And Live-Stock Corporation | Remote data transfer system with ambient light insensitive circuitry |
US4807140A (en) * | 1983-11-10 | 1989-02-21 | Saulnier Dominique C | Electronic label information exchange system |
FR2555744B1 (en) | 1983-11-30 | 1986-05-09 | Philips Ind Commerciale | SPECIMEN WITH MEANS FOR STORING ANALYSIS RESULTS |
US4598386A (en) * | 1984-04-18 | 1986-07-01 | Roesner Bruce B | Reduced-area, read-only memory |
US4657543A (en) * | 1984-07-23 | 1987-04-14 | Massachusetts Institute Of Technology | Ultrasonically modulated polymeric devices for delivering compositions |
US4779806A (en) * | 1984-07-23 | 1988-10-25 | Massachusetts Institute Of Technology | Ultrasonically modulated polymeric devices for delivering compositions |
US4652528A (en) * | 1984-08-13 | 1987-03-24 | Halogen Insulator & Seal Corp. | Information carrier and method of use |
US4646266A (en) * | 1984-09-28 | 1987-02-24 | Energy Conversion Devices, Inc. | Programmable semiconductor structures and methods for using the same |
US4702732A (en) * | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
US4908405A (en) * | 1985-01-04 | 1990-03-13 | Ernst Bayer | Graft copolymers of crosslinked polymers and polyoxyethylene, processes for their production, and their usage |
US4681870A (en) * | 1985-01-11 | 1987-07-21 | Imre Corporation | Protein A-silica immunoadsorbent and process for its production |
US4631211A (en) * | 1985-03-25 | 1986-12-23 | Scripps Clinic & Research Foundation | Means for sequential solid phase organic synthesis and methods using the same |
US4683202B1 (en) * | 1985-03-28 | 1990-11-27 | Cetus Corp | |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4777019A (en) * | 1985-04-12 | 1988-10-11 | Thomas Dandekar | Biosensor |
US4791285A (en) * | 1985-07-03 | 1988-12-13 | Koatsu Gas Kogyo Co., Ltd. | Read/write method by a non-contact system and between a storage substrate and read/write unit |
US4876668A (en) * | 1985-07-31 | 1989-10-24 | California Institute Of Technology | Thin film memory matrix using amorphous and high resistive layers |
US4889800A (en) * | 1985-08-12 | 1989-12-26 | Scripps Clinic And Research Foundation | Synthetic polypeptides and receptor molecules derived therefrom and methods of use |
US4783776A (en) * | 1986-01-22 | 1988-11-08 | Hitachi, Ltd. | Method of recording and reproducing digital information and apparatus therefor |
US4705503A (en) * | 1986-02-03 | 1987-11-10 | Regents Of The University Of Minnesota | Metabolite sensor including a chemical concentration sensitive flow controller for a drug delivery system |
US5105190A (en) | 1986-04-22 | 1992-04-14 | N.V. Nederlandsche Apparatenfabriek Nedap | Electromagnetic identification system |
US4870574A (en) * | 1986-06-27 | 1989-09-26 | Thomson Semiconducteurs | Method for the programming of data in an electrically programmable read-only memory |
US4857893A (en) * | 1986-07-18 | 1989-08-15 | Bi Inc. | Single chip transponder device |
US5171695A (en) | 1986-08-06 | 1992-12-15 | Multilyte Limited | Determination of analyte concentration using two labelling markers |
US5029214A (en) * | 1986-08-11 | 1991-07-02 | Hollander James F | Electronic speech control apparatus and methods |
US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
US5004606A (en) * | 1986-09-24 | 1991-04-02 | Hybritech Incorporated | Non-covalent antibody-anthracycline immunocomplexes |
US5074318A (en) | 1986-10-06 | 1991-12-24 | Bio Medic Data Systems, Inc. | Animal marker |
USRE34936E (en) * | 1986-10-06 | 1995-05-09 | Bio Medic Data Systems, Inc. | Animal marker implanting system |
US5002548A (en) * | 1986-10-06 | 1991-03-26 | Bio Medic Data Systems, Inc. | Animal marker implanting system |
US4933285A (en) * | 1986-10-07 | 1990-06-12 | Environmental Technologies Group, Inc. | Multiple monolayers of polymeric linkages on a solid phase for immobilizing macromolecules |
US4786277A (en) * | 1986-11-21 | 1988-11-22 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation |
US4908813A (en) * | 1986-12-10 | 1990-03-13 | Hitachi, Ltd. | Wavelength multiplexing optical recording apparatus |
US4762881A (en) * | 1987-01-09 | 1988-08-09 | E. I. Du Pont De Nemours And Company | Photoreactive benzoylphenylalanines and related peptides |
US4954444A (en) * | 1987-03-02 | 1990-09-04 | E. I. Du Pont De Nemours And Company | Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports |
US4885250A (en) * | 1987-03-02 | 1989-12-05 | E. I. Du Pont De Nemours And Company | Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports |
US5324591A (en) | 1987-03-06 | 1994-06-28 | Geo-Centers, Inc. | Deep ultraviolet photolithographically defined ultra-thin films for selective cell adhesion and outgrowth and method of manufacturing the same and devices containing the same |
US5310686A (en) | 1987-03-10 | 1994-05-10 | Ares Serono Research & Development Limited Partnership | Polymer-coated optical structures |
US4796074A (en) * | 1987-04-27 | 1989-01-03 | Instant Circuit Corporation | Method of fabricating a high density masked programmable read-only memory |
US5292814A (en) | 1987-04-29 | 1994-03-08 | Ernst Bayer | Process for the preparation of monodispersed polymer beads |
US5114719A (en) | 1987-04-29 | 1992-05-19 | Sabel Bernhard A | Extended drug delivery of small, water-soluble molecules |
US4960983A (en) * | 1987-09-28 | 1990-10-02 | Mitsubishi Denki Kabushiki Kaisha | Noncontact type IC card and system for noncontact transfer of information using the same |
US4855909A (en) * | 1987-11-20 | 1989-08-08 | Hewlett-Packard Company | Forensic sample tracking system and print station therefor |
US4931498A (en) * | 1988-02-25 | 1990-06-05 | Purdue Research Foundation | Immobilized artificial membranes |
US4927879A (en) * | 1988-02-25 | 1990-05-22 | Purdue Research Foundation | Method for solid phase membrane mimetics |
US5300278A (en) | 1988-03-09 | 1994-04-05 | Cis Bio International | Process for the preparation of 99m Tc, 186 Re or 188 Re nitride complexes usable as radiopharmaceutical products |
US5043222A (en) * | 1988-03-17 | 1991-08-27 | Olin Corporation | Metal sealing glass composite with matched coefficients of thermal expansion |
US4952531A (en) * | 1988-03-17 | 1990-08-28 | Olin Corporation | Sealing glass for matched sealing of copper and copper alloys |
US5391463A (en) | 1988-04-14 | 1995-02-21 | The United States Of America As Represented By The Secretary Of The Navy | Surface modification to create regions resistant to adsorption of biomolecules |
US5087570A (en) | 1988-05-10 | 1992-02-11 | Weissman Irving L | Homogeneous mammalian hematopoietic stem cell composition |
US5063417A (en) | 1988-07-18 | 1991-11-05 | California Institute Of Technology | Molecular shift register based on electron transfer |
US4990756A (en) * | 1988-07-25 | 1991-02-05 | Telsor Corporation | Apparatus and method for emulating bar codes |
US4952928A (en) * | 1988-08-29 | 1990-08-28 | B. I. Incorporated | Adaptable electronic monitoring and identification system |
US5047371A (en) * | 1988-09-02 | 1991-09-10 | Olin Corporation | Glass/ceramic sealing system |
US5403484A (en) | 1988-09-02 | 1995-04-04 | Protein Engineering Corporation | Viruses expressing chimeric binding proteins |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5200051A (en) | 1988-11-14 | 1993-04-06 | I-Stat Corporation | Wholly microfabricated biosensors and process for the manufacture and use thereof |
US5212050A (en) | 1988-11-14 | 1993-05-18 | Mier Randall M | Method of forming a permselective layer |
US5044623A (en) * | 1988-11-21 | 1991-09-03 | Eastman Kodak Company | Apparatus for stacking sheets |
US5288476A (en) | 1988-11-25 | 1994-02-22 | Cis Bio International | Radiopharmaceutical product more particularly having a cardiac tropism incorporating a nitride complex of a transition metal and its preparation process |
US5366733A (en) | 1988-12-22 | 1994-11-22 | American Cyanamid Company | Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, and composition of matter therefor |
US5236355A (en) | 1988-12-22 | 1993-08-17 | American Cyanamid Company | Apparatus for the treatment of periodontal disease |
US5089391A (en) | 1989-01-10 | 1992-02-18 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
US5056056A (en) * | 1989-02-02 | 1991-10-08 | Systems Research Laboratories, Inc. | Data recorder including a recirculating non-volatile memory |
US4991719A (en) * | 1989-03-03 | 1991-02-12 | Speed Sort, Inc. | Method and apparatus for sorting randomly positioned items minimizing sorting conveyor movement |
US5296122A (en) | 1989-03-29 | 1994-03-22 | Teruaki Katsube | Apparatus for forming thin film |
US5033623A (en) * | 1989-04-15 | 1991-07-23 | W. Schlafhorst & Co. | Method and apparatus for associating information with a textile package |
US5217870A (en) | 1989-04-28 | 1993-06-08 | Biogen, Inc. | Monoclonal antibodies against CDX |
US5120662A (en) | 1989-05-09 | 1992-06-09 | Abbott Laboratories | Multilayer solid phase immunoassay support and method of use |
US5012236A (en) * | 1989-05-26 | 1991-04-30 | Trovan Limited | Electromagnetic energy transmission and detection apparatus |
US5405783A (en) | 1989-06-07 | 1995-04-11 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of an array of polymers |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5092992A (en) | 1989-06-07 | 1992-03-03 | J. T. Baker Inc. | Polyethyleneimine matrixes for affinity chromatography |
US5489678A (en) | 1989-06-07 | 1996-02-06 | Affymax Technologies N.V. | Photolabile nucleoside and peptide protecting groups |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5347283A (en) | 1989-06-14 | 1994-09-13 | Hughes Aircraft Company | Frequency agile radar |
US5262772A (en) | 1989-08-16 | 1993-11-16 | Bio Medic Data Systems, Inc. | Transponder scanner |
US4958452A (en) * | 1989-09-27 | 1990-09-25 | Zoecon Corporation | Animal identification ear tag assembly |
US5215899A (en) | 1989-11-09 | 1993-06-01 | Miles Inc. | Nucleic acid amplification employing ligatable hairpin probe and transcription |
US5482867A (en) | 1989-11-13 | 1996-01-09 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5451683A (en) | 1989-11-13 | 1995-09-19 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5252743A (en) | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5120642A (en) | 1989-11-28 | 1992-06-09 | Coulter Corporation | Monoclonal antibody which distinguishes helper inducer and suppressor inducer cd4+ lymphocytes |
US5028918A (en) * | 1989-12-18 | 1991-07-02 | Dairy Equipment Company | Identification transponder circuit |
US5268371A (en) | 1990-01-10 | 1993-12-07 | Cis Bio International | Derivatives of porphyrin and metalloporphyrins optionally coupled to a biologically active molecule and pharmaceutical composition containing them |
US5030807A (en) * | 1990-01-16 | 1991-07-09 | Amtech Corporation | System for reading and writing data from and into remote tags |
US5218343A (en) | 1990-02-05 | 1993-06-08 | Anatoli Stobbe | Portable field-programmable detection microchip |
US5055659A (en) * | 1990-02-06 | 1991-10-08 | Amtech Technology Corp. | High speed system for reading and writing data from and into remote tags |
US5328603A (en) | 1990-03-20 | 1994-07-12 | The Center For Innovative Technology | Lignocellulosic and cellulosic beads for use in affinity and immunoaffinity chromatography of high molecular weight proteins |
US5073703A (en) | 1990-03-30 | 1991-12-17 | Datakey, Inc. | Apparatus for encoding electrical identification devices by means of selectively fusible links |
US5311039A (en) | 1990-04-24 | 1994-05-10 | Seiko Epson Corporation | PROM and ROM memory cells |
US5121748A (en) | 1990-05-12 | 1992-06-16 | Schott Glaswerke | Biocompatible infused absorption glass containing feo |
US5100626A (en) | 1990-05-24 | 1992-03-31 | Levin Andrew E | Binding assay device with removable cassette and manifold |
US5089877A (en) | 1990-06-06 | 1992-02-18 | Sgs-Thomson Microelectronics, Inc. | Zero power ic module |
US5432018A (en) | 1990-06-20 | 1995-07-11 | Affymax Technologies N.V. | Peptide library and screening systems |
US5064767A (en) | 1990-06-21 | 1991-11-12 | The Board Of Trustees Of The Leland Stanford Junior University | Carboxyl-terminal protein sequencing method and kit |
US5119163A (en) | 1990-06-22 | 1992-06-02 | Sharp Kabushiki Kaisha | Semiconductor device |
US5399339A (en) | 1990-07-04 | 1995-03-21 | Cis Bio International | Process for the preparation of nitride complexes of transition metals |
US5422636A (en) | 1990-08-03 | 1995-06-06 | Bio Medic Data Systems, Inc. | System monitoring programmable implantable transponder |
US5252962A (en) | 1990-08-03 | 1993-10-12 | Bio Medic Data Systems | System monitoring programmable implantable transponder |
US5443816A (en) | 1990-08-08 | 1995-08-22 | Rhomed Incorporated | Peptide-metal ion pharmaceutical preparation and method |
US5258289A (en) | 1990-09-05 | 1993-11-02 | Davis Claude G | Method for the selecting of genes encoding catalytic antibodies |
US5136572A (en) | 1990-09-10 | 1992-08-04 | Tacan Corporation | Optical data storage using temperature stabilizer lasers |
US5342772A (en) | 1990-09-21 | 1994-08-30 | E. I. Du Pont De Nemours And Company | Process for enzyme immobilization on a fluorocarbon surface |
US5148404A (en) | 1990-10-09 | 1992-09-15 | Texas Instruments Incorporated | Transponder and method for the production thereof |
US5095362A (en) | 1990-10-23 | 1992-03-10 | Instant Circuit Corporation | Method for reducing resistance for programmed antifuse |
US5308967A (en) | 1990-10-26 | 1994-05-03 | Reinhard Jurisch | Data carrier for identification systems |
US5250944A (en) | 1990-10-29 | 1993-10-05 | Bio Medic Data Systems, Inc. | Antenna and driving circuit for transmitting and receiving images to and from a passive transponder |
US5420579A (en) | 1990-10-29 | 1995-05-30 | Bio Medic Data Systems, Inc. | Antenna and driving circuit for transmitting and receiving signals to and from a passive transponder |
US5556762A (en) | 1990-11-21 | 1996-09-17 | Houghten Pharmaceutical Inc. | Scanning synthetic peptide combinatorial libraries: oligopeptide mixture sets having a one predetermined residue at a single, predetermined position, methods of making and using the same |
US5273927A (en) | 1990-12-03 | 1993-12-28 | Micron Technology, Inc. | Method of making a ferroelectric capacitor and forming local interconnect |
US5389449A (en) | 1991-01-04 | 1995-02-14 | Perseptive Biosystems, Inc. | Sulfonamide bonded hydrophilic coatings |
US5408037A (en) | 1991-01-17 | 1995-04-18 | Zymogenetics, Inc. | Methods for detecting glucagon antagonists |
US5384481A (en) | 1991-01-17 | 1995-01-24 | Crosspoint Solutions, Inc. | Antifuse circuit structure for use in a field programmable gate array and method of manufacture thereof |
US5335219A (en) | 1991-01-18 | 1994-08-02 | Ovshinsky Stanford R | Homogeneous composition of microcrystalline semiconductor material, semiconductor devices and directly overwritable memory elements fabricated therefrom, and arrays fabricated from the memory elements |
US5099226A (en) | 1991-01-18 | 1992-03-24 | Interamerican Industrial Company | Intelligent security system |
US5228001A (en) | 1991-01-23 | 1993-07-13 | Syracuse University | Optical random access memory |
US5572410A (en) | 1991-02-25 | 1996-11-05 | Gustafson; Ake | Integrated circuit device having a winding connected to an integrated circuit solely by a wire |
US5403750A (en) | 1991-03-06 | 1995-04-04 | W. R. Grace & Co.-Conn. | Biocompatible, low protein adsorption affinity matrix |
EP0535242B1 (en) | 1991-03-18 | 1997-09-03 | Institut Molekulyarnoi Biologii Im. V.A.Engelgardta Rossiiskoi Akademii Nauk | Method and device for determining nucleotide sequence of dna |
US5322812A (en) | 1991-03-20 | 1994-06-21 | Crosspoint Solutions, Inc. | Improved method of fabricating antifuses in an integrated circuit device and resulting structure |
US5401378A (en) | 1991-03-27 | 1995-03-28 | Australian Membrane & Biotechnology Research Institute | Ionic reservoir at electrode surface |
US5349173A (en) | 1991-04-23 | 1994-09-20 | Siemens Aktiengesellschaft | Apparatus for contactless data and energy transmission |
US5334880A (en) | 1991-04-30 | 1994-08-02 | International Business Machines Corporation | Low voltage programmable storage element |
US5201728A (en) | 1991-05-03 | 1993-04-13 | Giampapa Vincent C | Subcutaneous implantable multiple-agent delivery system |
US5266926A (en) | 1991-05-31 | 1993-11-30 | Avid Marketing, Inc. | Signal transmission and tag power consumption measurement circuit for an inductive reader |
US5290734A (en) | 1991-06-04 | 1994-03-01 | Vlsi Technology, Inc. | Method for making anti-fuse structures |
US5232831A (en) | 1991-06-28 | 1993-08-03 | Gen-Probe Incorporated | Nucleic acid probes to streptococcus pyogenes |
US5216143A (en) | 1991-06-28 | 1993-06-01 | Gen-Probe Products Company | Nucleic acid probes to mycobacterium gordonae |
US5352579A (en) | 1991-06-28 | 1994-10-04 | Gen Probe, Inc. | Nucleic acid probes to histoplasma capsulatum |
US5223408A (en) | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
US5397939A (en) | 1991-07-31 | 1995-03-14 | Quicklogic Corporation | Programming of antifuses |
US5235326A (en) | 1991-08-15 | 1993-08-10 | Avid Corporation | Multi-mode identification system |
US5457184A (en) | 1991-08-30 | 1995-10-10 | Cis Bio International | Rare earth macrocyclic complexes and use thereof for reduction of disturbances in an assay using fluorescence |
US5251635A (en) | 1991-09-03 | 1993-10-12 | General Electric Company | Stereoscopic X-ray fluoroscopy system using radiofrequency fields |
US5377678A (en) | 1991-09-03 | 1995-01-03 | General Electric Company | Tracking system to follow the position and orientation of a device with radiofrequency fields |
US5265610A (en) | 1991-09-03 | 1993-11-30 | General Electric Company | Multi-planar X-ray fluoroscopy system using radiofrequency fields |
US5211165A (en) | 1991-09-03 | 1993-05-18 | General Electric Company | Tracking system to follow the position and orientation of a device with radiofrequency field gradients |
US5255680A (en) | 1991-09-03 | 1993-10-26 | General Electric Company | Automatic gantry positioning for imaging systems |
US5292874A (en) | 1991-09-04 | 1994-03-08 | Gen-Probe Incorporated | Nucleic acid probes to Staphylococcus aureus |
US5218189A (en) | 1991-09-09 | 1993-06-08 | Checkpoint Systems, Inc. | Binary encoded multiple frequency rf indentification tag |
US5708153A (en) | 1991-09-18 | 1998-01-13 | Affymax Technologies N.V. | Method of synthesizing diverse collections of tagged compounds |
US5639603A (en) | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5248863A (en) | 1991-10-01 | 1993-09-28 | Ncr Corporation | Switch actuator mechanism |
US5338665A (en) | 1991-10-16 | 1994-08-16 | Affymax Technologies N.V. | Peptide library and screening method |
US5498530A (en) | 1991-10-16 | 1996-03-12 | Affymax Technologies, N.V. | Peptide library and screening method |
US5250962A (en) | 1991-10-16 | 1993-10-05 | Xerox Corporation | Movable ink jet priming station |
US5270170A (en) | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
US5272666A (en) | 1991-10-18 | 1993-12-21 | Lattice Semiconductor Corporation | Programmable semiconductor antifuse structure and method of fabricating |
US5442940A (en) | 1991-10-24 | 1995-08-22 | Hewlett-Packard Company | Apparatus and method for evaluating the fetal condition |
US5449941A (en) | 1991-10-29 | 1995-09-12 | Semiconductor Energy Laboratory Co., Ltd. | Semiconductor memory device |
US5348867A (en) | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
US5437277A (en) | 1991-11-18 | 1995-08-01 | General Electric Company | Inductively coupled RF tracking system for use in invasive imaging of a living body |
US5445150A (en) | 1991-11-18 | 1995-08-29 | General Electric Company | Invasive system employing a radiofrequency tracking system |
US5443066A (en) | 1991-11-18 | 1995-08-22 | General Electric Company | Invasive system employing a radiofrequency tracking system |
US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
US5257011A (en) | 1991-12-03 | 1993-10-26 | Avid Corporation | Data altering means for multi-memory electronic identification tag |
US5214409A (en) | 1991-12-03 | 1993-05-25 | Avid Corporation | Multi-memory electronic identification tag |
US5346789A (en) | 1991-12-06 | 1994-09-13 | Cornell Research Foundation, Inc. | Oriented biological material for optical information storage and processing |
US5256469A (en) | 1991-12-18 | 1993-10-26 | General Electric Company | Multi-layered, co-fired, ceramic-on-metal circuit board for microelectronic packaging |
US5284747A (en) | 1991-12-18 | 1994-02-08 | Gen-Probe Incorporated | Nucleic acid probes to Coccidioides immitis |
US5277724A (en) | 1991-12-18 | 1994-01-11 | General Electric Co. | Method of minimizing lateral shrinkage in a co-fired, ceramic-on-metal circuit board |
US5253198A (en) | 1991-12-20 | 1993-10-12 | Syracuse University | Three-dimensional optical memory |
US5326449A (en) | 1991-12-31 | 1994-07-05 | Abbott Laboratories | Composite membrane |
US5400136A (en) | 1992-01-16 | 1995-03-21 | Martin Marietta Energy Systems, Inc. | Surface-enhanced Raman scattering (SERS) dosimeter and probe |
US5217743A (en) | 1992-02-07 | 1993-06-08 | Paradigm Biotechnologies Partnership | Biomaterials of enhanced biocompatibility |
US5435937A (en) | 1992-02-14 | 1995-07-25 | Amersham International Plc | Fluorescent compounds |
US5395750A (en) | 1992-02-28 | 1995-03-07 | Hoffmann-La Roche Inc. | Methods for producing proteins which bind to predetermined antigens |
US5359250A (en) | 1992-03-04 | 1994-10-25 | The Whitaker Corporation | Bulk wave transponder |
US5326696A (en) | 1992-03-09 | 1994-07-05 | Tanox Biosystems, Inc. | Selecting low frequency antigen-specific single B lymphocytes |
US5319181A (en) | 1992-03-16 | 1994-06-07 | Symbol Technologies, Inc. | Method and apparatus for decoding two-dimensional bar code using CCD/CMD camera |
US5389534A (en) | 1992-03-23 | 1995-02-14 | Siemens Aktiengesellschaft | Biosensor containing a biochemical substance immobilized on a layer of an olefinic-unsaturated, epoxyfunctional polyether |
US5359115A (en) | 1992-03-26 | 1994-10-25 | Affymax Technologies, N.V. | Methods for the synthesis of phosphonate esters |
US5389769A (en) | 1992-03-27 | 1995-02-14 | Shinko Electric Co., Ltd. | ID recognizing system in semiconductor manufacturing system |
US5271400A (en) | 1992-04-01 | 1993-12-21 | General Electric Company | Tracking system to monitor the position and orientation of a device using magnetic resonance detection of a sample contained within the device |
US5307808A (en) | 1992-04-01 | 1994-05-03 | General Electric Company | Tracking system and pulse sequences to monitor the position of a device using magnetic resonance |
US5334640A (en) | 1992-04-08 | 1994-08-02 | Clover Consolidated, Ltd. | Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods |
US5329153A (en) | 1992-04-10 | 1994-07-12 | Crosspoint Solutions, Inc. | Antifuse with nonstoichiometric tin layer and method of manufacture thereof |
US5348705A (en) | 1992-04-10 | 1994-09-20 | B.M.L., Inc. | Automatic clinical sample dispensing system |
US5250459A (en) | 1992-04-14 | 1993-10-05 | Micron Technology, Inc. | Electrically programmable low resistive antifuse element |
US5316922A (en) | 1992-04-15 | 1994-05-31 | The United States Of America As Represented By Department Of Health And Human Services | Method for indentifying and expressing proteins that recognize and adhere to specific probes |
US5541061A (en) | 1992-04-29 | 1996-07-30 | Affymax Technologies N.V. | Methods for screening factorial chemical libraries |
US5451896A (en) | 1992-05-13 | 1995-09-19 | Mitsubishi Denki Kabushiki Kaisha | Semiconductor integrated circuit device with an internal voltage-down converter |
US5318354A (en) | 1992-05-20 | 1994-06-07 | C. W. Lisk Company, Inc. | Proportional control valve with differential sensing area |
US5323704A (en) | 1992-07-30 | 1994-06-28 | Heidelberg-Harris Gmbh | Device for the identification of a flexible roller shell |
US5288291A (en) | 1992-08-12 | 1994-02-22 | Datapet, Inc. | Method and apparatus for simultaneously injecting a liquid and a transponder into an animal |
US5282158A (en) | 1992-08-21 | 1994-01-25 | Micron Technology, Inc. | Transistor antifuse for a programmable ROM |
US5374718A (en) | 1992-08-26 | 1994-12-20 | Gen-Probe Incorporated | Nucleic acid probes to chlamydia pneumoniae |
US5361385A (en) | 1992-08-26 | 1994-11-01 | Reuven Bakalash | Parallel computing system for volumetric modeling, data processing and visualization |
US5384028A (en) | 1992-08-28 | 1995-01-24 | Nec Corporation | Biosensor with a data memory |
US5447533A (en) | 1992-09-03 | 1995-09-05 | Pacesetter, Inc. | Implantable stimulation lead having an advanceable therapeutic drug delivery system |
US5420328A (en) | 1992-09-11 | 1995-05-30 | Affymax Technologies, N.V. | Methods for the synthesis of phosphonate esters |
US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
US5316971A (en) | 1992-09-18 | 1994-05-31 | Actel Corporation | Methods for programming antifuses having at least one metal electrode |
US5381035A (en) | 1992-09-23 | 1995-01-10 | Chen; Wenn-Jei | Metal-to-metal antifuse including etch stop layer |
US5351052A (en) | 1992-09-28 | 1994-09-27 | Texas Instruments Incorporated | Transponder systems for automatic identification purposes |
US5565324A (en) | 1992-10-01 | 1996-10-15 | The Trustees Of Columbia University In The City Of New York | Complex combinatorial chemical libraries encoded with tags |
US5324483B1 (en) | 1992-10-08 | 1996-09-24 | Warner Lambert Co | Apparatus for multiple simultaneous synthesis |
US5324483A (en) | 1992-10-08 | 1994-06-28 | Warner-Lambert Company | Apparatus for multiple simultaneous synthesis |
US5324324A (en) | 1992-10-13 | 1994-06-28 | Siemens Pacesetter, Inc. | Coated implantable stimulation electrode and lead |
US5453633A (en) | 1992-10-29 | 1995-09-26 | Samsung Electronics Co., Ltd. | Dynamic random access memory device and a manufacturing method thereof |
US5452311A (en) | 1992-10-30 | 1995-09-19 | Intel Corporation | Method and apparatus to improve read reliability in semiconductor memories |
US5452251A (en) | 1992-12-03 | 1995-09-19 | Fujitsu Limited | Semiconductor memory device for selecting and deselecting blocks of word lines |
US5383873A (en) | 1992-12-09 | 1995-01-24 | Regents Of The University Of Minnesota | Smooth muscle chemical pacemaker |
US5353795A (en) | 1992-12-10 | 1994-10-11 | General Electric Company | Tracking system to monitor the position of a device using multiplexed magnetic resonance detection |
US5314829A (en) | 1992-12-18 | 1994-05-24 | California Institute Of Technology | Method for imaging informational biological molecules on a semiconductor substrate |
US5347263A (en) | 1993-02-05 | 1994-09-13 | Gnuco Technology Corporation | Electronic identifier apparatus and method utilizing a single chip microcontroller and an antenna coil |
US5386024A (en) | 1993-02-10 | 1995-01-31 | Gen-Probe Incorporated | Method to prepare nucleic acids from a biological sample using low pH and acid protease |
US5270251A (en) | 1993-02-25 | 1993-12-14 | Massachusetts Institute Of Technology | Incoherent radiation regulated voltage programmable link |
US5410155A (en) | 1993-03-11 | 1995-04-25 | Packard Instrument, B.V. | Scintillation counting medium and process |
US5491074A (en) | 1993-04-01 | 1996-02-13 | Affymax Technologies Nv | Association peptides |
US5416193A (en) | 1993-04-30 | 1995-05-16 | Pfizer Inc. | Coupling reagent and method |
US5306466A (en) | 1993-05-19 | 1994-04-26 | California South Pacific Investors | Detection of contaminants in food |
US5364797A (en) | 1993-05-20 | 1994-11-15 | Mobil Oil Corp. | Sensor device containing mesoporous crystalline material |
DE9308204U1 (en) | 1993-06-01 | 1993-08-05 | Hecht, Manfred, 90765 Fuerth, De | |
US5440511A (en) | 1993-06-15 | 1995-08-08 | Fujitsu Limited | Semiconductor memory device |
US5300456A (en) | 1993-06-17 | 1994-04-05 | Texas Instruments Incorporated | Metal-to-metal antifuse structure |
US5350645A (en) | 1993-06-21 | 1994-09-27 | Micron Semiconductor, Inc. | Polymer-lithium batteries and improved methods for manufacturing batteries |
US5395587A (en) | 1993-07-06 | 1995-03-07 | Smithkline Beecham Corporation | Surface plasmon resonance detector having collector for eluted ligate |
US5438439A (en) | 1993-08-13 | 1995-08-01 | Mok; Fai | Non-destructive readout mechanism for volume holograms using two wavelengths |
US5442212A (en) | 1993-08-31 | 1995-08-15 | Mitsubishi Denki Kabushiki Kaisha | Semiconductor memory device |
US5362899A (en) | 1993-09-09 | 1994-11-08 | Affymax Technologies, N.V. | Chiral synthesis of alpha-aminophosponic acids |
US5442584A (en) | 1993-09-14 | 1995-08-15 | Goldstar Electron Co., Ltd. | Semiconductor memory device and method for fabricating the same dynamic random access memory device construction |
US5503805A (en) | 1993-11-02 | 1996-04-02 | Affymax Technologies N.V. | Apparatus and method for parallel coupling reactions |
US5416486A (en) | 1993-11-08 | 1995-05-16 | Apti, Inc. | Identification/security tag system employing electronic doppler shifting and/or rectenna structure |
US5443953A (en) | 1993-12-08 | 1995-08-22 | Immunomedics, Inc. | Preparation and use of immunoconjugates |
US5412593A (en) | 1994-01-12 | 1995-05-02 | Texas Instruments Incorporated | Fuse and antifuse reprogrammable link for integrated circuits |
US5549974A (en) | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
US5463564A (en) | 1994-09-16 | 1995-10-31 | 3-Dimensional Pharmaceuticals, Inc. | System and method of automatically generating chemical compounds with desired properties |
US5679773A (en) | 1995-01-17 | 1997-10-21 | Affymax Technologies N.V | Reagants and methods for immobilized polymer synthesis and display |
US5583819A (en) | 1995-01-27 | 1996-12-10 | Single Chip Holdings, Inc. | Apparatus and method of use of radiofrequency identification tags |
US5609826A (en) | 1995-04-17 | 1997-03-11 | Ontogen Corporation | Methods and apparatus for the generation of chemical libraries |
US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
US5552721A (en) | 1995-06-05 | 1996-09-03 | International Business Machines Corporation | Method and system for enhanced drive in programmmable gate arrays |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
GB2306484B (en) | 1995-10-26 | 1997-09-24 | Univ Hertfordshire | Coded particles for process sequence tracking in combinatorial compound library preparation |
US5736332A (en) | 1995-11-30 | 1998-04-07 | Mandecki; Wlodek | Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
Non-Patent Citations (264)
Title |
---|
"IUPAC-IUB Commission on Biochemical Nomenclature,"Biochem., 11(5):942-944 (1972). |
Affinity Techiques. Enzume Purification: Part B. Methods in Enzymology, vol. 34, W. B. Jakoby, et al., Eds., Acad. Press, N.Y. (1974). |
Armstrong et al., Microchip encoded combinatorial libraries: Generation of a spatially encoded library from a pool synthesis, Chimia 50(5):258-260 (1996). |
Article in Scrip, "New US combinatorial Company," Dec. 15, 1995, p. 11. |
Baldwin et al., Synthesis of a small molecule combinatorial library encoded with molecular tags, J. Am. Chem. Soc. 117:5588 (1995). * |
Barany et al., "Solid-phase peptide synthesis: a silver anniversary report," Int. J. Peptide Protein Res. 30:705-739 (1987). |
Basch et al., Cell separation using positive immunoselective techniques, J. Immunol. Meths. 56:269 280 (1983). * |
Basch et al., Cell separation using positive immunoselective techniques, J. Immunol. Meths. 56:269-280 (1983). |
Batra et al., Insertion of constant region domains of human IgG 1 into CD4 PE40 increases its plasma half life, Molecular Immunol. 30(4):379 386 (1993). * |
Batra et al., Insertion of constant region domains of human IgG1 into CD4-PE40 increases its plasma half-life, Molecular Immunol. 30(4):379-386 (1993). |
Baum, "Combinatorial Approaches Provide Fresh Leads for Medicinal Chemistry," C& EN, pp. 20-26 (1994). |
Baum, Combinatorial Approaches Provide Fresh Leads for Medicinal Chemistry, C & EN , pp. 20 26 (1994). * |
Bayer et al., "New polymer and strategy for solid-phase synthesis of protected peptide fragments," Pept.: Chem., Struct. Biol., Proc. Am. Pept. Symp., 13th Hodges, et al., Eds., pp. 156-158 (1994). |
Bayer et al., "New polymer supports for solid-liquid-phase synthesis," Chem. Pept. Proteins 3: 3-8 (1986). |
Bayer et al., "Polystyrene-immobilized Peg Chains," Poly(Ethylene Glycol) Chem. Harris, Ed., pp. 325-345 (1992). |
Bayer et al., in Pept.: Struct. Funct., Proc. Am. Pept. Symp, 8th , Hruby et al., Eds., pp. 87 90 (1983). * |
Bayer et al., in Pept.: Struct. Funct., Proc. Am. Pept. Symp, 8th, Hruby et al., Eds., pp. 87-90 (1983). |
Beck Sickinger, et al., Semiautomated T Bag peptide synthesis using 9 Fluorenyl Methoxyearbonyl strategy and Benzotriazol 1 yl Tetramethyl Uronium Tetrafluoroborate activation, Peptide Research , 4(2):88 94, Mar. 1991 Apr. 1991. * |
Beck-Sickinger, et al., Semiautomated T-Bag peptide synthesis using 9-Fluorenyl-Methoxyearbonyl strategy and Benzotriazol-1-yl-Tetramethyl-Uronium Tetrafluoroborate activation, Peptide Research, 4(2):88-94, Mar. 1991-Apr. 1991. |
Berg et al., "Long-Chain Polystyrene-Grafted Polyethylene Film Matrix: A New Support for Solid-Phase Peptide Synthesis1," J. Am. Chem. Soc., 111:8024-8026 (1989). |
Berg et al., "Peptide Synthesis on Polystyrene-Grafted Polyethylene Sheets," Pept., Proc. Eur. Pept. Symp., 20th, Jung, G. et al. (Eds.), pp. 196-198. |
Berg et al., "Polystyrene-Grafted Polyethylene: Design of Film and Felt Matrices for Solid-Phase Peptide Synthesis," Innovation Perspect. Solid Phase Synth. Collect. Pap., Int. Symp., 1st, Epton, Roger (Ed.), pp. 453-459 (1990). |
Birge, "Photophysics and molecular electronic applications of the rhodpsins," Ann. Rev. Phys. Chem 41:683-733 (1990). |
Bloom "A Memory to Remember," Electronics Systems Design Magazine, pp. 5-9 (1989) (Best Copy Available Supplied). |
Boldt, Fractionation of human lymphocytes with plant lectins. II. Lens culinaris lection and wheat germ agglutinin identify distinct lymphocyte subclasses, J. Immunon. 123(2):808 816 (1979). * |
Boldt, Fractionation of human lymphocytes with plant lectins. II. Lens culinaris lection and wheat germ agglutinin identify distinct lymphocyte subclasses, J. Immunon. 123(2):808-816 (1979). |
Borman, Combinatorial chemists focus on small molecules, molecular recognition, and automation, Chem. & Engin. News , pp. 29 54 (1996). * |
Borman, Combinatorial chemists focus on small molecules, molecular recognition, and automation, Chem. & Engin. News , pp. 29-54 (1996). |
Brenner et al., Encoded combinatorial chemistry, Proc. Natl. Acad. Sci. USA 89 : 5381 5383 (1992). * |
Brenner et al., Encoded combinatorial chemistry, Proc. Natl. Acad. Sci. USA 89: 5381-5383 (1992). |
Brown et al., "Modern machine-aided methods of oligodeoxyribonucleotide synthesis," Oligonucleotides Analogues, Eckstein, Fritz (Ed), IRL, Oxford, UK, pp. 1-24 (1991). |
Buechler et al., "Simultaneous Detection of Seven Drugs of Abuse by the Triage™ Panel for Drugs of Abuse," Clin. Chem., 38(9):1678-1684 (1992). |
Bunin et al., A general method for the solid phase synthesis of 1,4 benzodiazepine derivatives, J. Am. Chem. Soc. 114:10997 10998 (1992). * |
Bunin et al., A general method for the solid-phase synthesis of 1,4-benzodiazepine derivatives, J. Am. Chem. Soc. 114:10997-10998 (1992). |
Bunin et al., The combinatorial synthesis and chemical and biological evaluation of a 1,4 benzodiazepine library, Proc. Natl. Acad. Sci. USA 91:4708 4712 (1994). * |
Bunin et al., The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library, Proc. Natl. Acad. Sci. USA 91:4708-4712 (1994). |
Burgess et al. Combinatorial technologies involving reiterative division/ coupling/ recombination: Statistcal considerations, J. Med. Chem. 37:2985 (1994). * |
Butz, "Immunization and Affinity Purification of Antibodies Using Resin-Immobilized Lysine-Branched Synthetic Peptides," Peptide Res., 7(1):20-23 (1994). |
Campbell et al., A transition state analogue inhibitor combinatorial library, J. Am. Chem. Soc. 117:5381 (1995). * |
Chen et al., `Analogous` organic synthesis of small-compound libraries: Validation of combinatorial chemistry in small-molecule synthesis, J. Am. Chem. Soc. 116:2661-2662 (1994). |
Chen et al., Analogous organic synthesis of small compound libraries: Validation of combinatorial chemistry in small molecule synthesis, J. Am. Chem. Soc. 116:2661 2662 (1994). * |
Clackson et al., "Making antibody fragments using phage display libraries," Nature, 352:624-628 (1991). |
Clackson et al., Making antibody fragments using phage display libraries, Nature , 352:624 628 (1991). * |
Cohen et al., "A Flat-Aluminum Based Voltage-Progarmmable Link for Field-Programmable Devices," IEEE Transactions on Electron Devices, 41(5):721-725 (1994). |
Cook & Keller, "Amorrhous Silicon Antifuse Technology for Bipolar Proms," Proc. IEEE Bipolar Circuits Technol. Meet., pp. 99-100 (1986). |
Cwirla et al., "Peptides on phage: A vast library of peptides for identifying ligands," Proc. Natl. Acad. Sci. USA, 87:6378-6382 (1990). |
Czarnik and Nova, "No static at all", Chemistry in Britain33(10):39-41 (1996). |
Czarnik and Nova, No static at all , Chemistry in Britain 33(10):39 41 (1996). * |
Czarnik et al., Parke Davis Diversomers technology: A practical approach to simultaneous, parallel organic synthesis, Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 35(2):985 (1994). * |
Czarnik et al., Parke-Davis' Diversomers™ technology: A practical approach to simultaneous, parallel organic synthesis, Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 35(2):985 (1994). |
Dave et al., "Sol-Gel Encapsulation Methods for Biosensors," Anal. Chem., 66(22):1120A-1127A (1994). |
Derwent #001509407 WPl Acc. No. 76-H2335X/197633 (citing German Patent No. DE 2503684, published Aug. 5, 1976). |
Devices would detect drugs in sweat, Nasatech (May 1996). * |
Devlin et al., "Random Peptide Libraries: A Source of Specific Protein Binding Molecules," Science, 249:404-406 (1990). |
Devlin et al., Random Peptide Libraries: A Source of Specific Protein Binding Molecules, Science , 249:404 406 (1990). * |
Dewitt et al., "`Diversomers`: An approach to nonpeptide, nonoligomeric chemical diversity," Proc. Natl. Acad. Sci. USA, 90:6909-6913 (1993). |
DeWitt et al., Diversomers technology: Solid phase synthesis, automation, and integration for the generation of chemical diversity, Drug Develop. Res. 33:116 124 (1994). * |
DeWitt et al., Diversomers: An approach to nonpeptide nonoligomeric chemical diversity, Proc. Natl. Acad. Sci. USA 90:6909 6913 (1993). * |
DeWitt et al., Diversomers: An approach to nonpeptide nonoligomeric chemical diversity, Proc. Natl. Acad. Sci. USA 90:6909-6913 (1993). |
DeWitt et al., Diversomers™ technology: Solid phase synthesis, automation, and integration for the generation of chemical diversity, Drug Develop. Res. 33:116-124 (1994). |
Dialog Abstract 000867978, citing: FR 2110030. * |
Dialog Abstract 003812858, citing: FR 2 526 169. * |
Dialog Abstract 004334295, citing: FR 2 555 744. * |
Dialog Abstract 008591601, citing: EP 420 177 A1. * |
Dialog Abstract 009619322, citing: DE 43 10169 A1. * |
Dialog Abstract 009652137, citing: DE 42 13 0659 A1. * |
Dialog Abstract 009659308, citing: DE 43 13807 A1. * |
Dialog Abstract 009968074, citing: DE 43 01401 A1. * |
Dialog Abstract 010012814, citing: DE 43 06 5639 A1. * |
Dialog Abstract 010167274, citing: EP 637 750 A2. * |
Dialog Abstract 010692826, citing: DE 94 16 270 A1. * |
Dorm a n et al., Benzophenone photophores in biochemistry, Biochemistry 33(19):5661 5673 (1994). * |
Dorman et al., Benzophenone photophores in biochemistry, Biochemistry 33(19):5661-5673 (1994). |
Dower & Fodor, "Chapter 28. The Search for Molecular Diversity (II): Recombinant and Synthetic Randomized Peptide Libraries," Annu. Rep. Med. Chem., 26:271-280 (1991). |
Dower & Fodor, Chapter 28. The Search for Molecular Diversity (II): Recombinant and Synthetic Randomized Peptide Libraries, Annu. Rep. Med. Chem. , 26:271 280 (1991). * |
Dulac et al., A novel family of genes encoding putative pheromone receptors in mammals, Cell 83:195 206 (1995), (relevance ). * |
Dulac et al., A novel family of genes encoding putative pheromone receptors in mammals, Cell 83:195-206 (1995), (relevance?). |
Dunlap, ed., Immobilized Biochemicals and Affinity Chromatography, Symposium on Affinity Chromatography and Immobilized Biochemicals, Charleston, SC, 1973, Plenum Press, NY (1974). * |
Dunlap, ed., Immobilized Biochemicals and Affinity Chromatography,Symposium on Affinity Chromatography and Immobilized Biochemicals, Charleston, SC, 1973, Plenum Press, NY (1974). |
Ecker and Crooke, Combinatorial Drug discovery: Which method will produce the greatest value Biotechnology 13: 351 360 (1995). * |
Ecker and Crooke, Combinatorial Drug discovery: Which method will produce the greatest value? Biotechnology 13: 351-360 (1995). |
Eichler and Houghten, "Identification of Substrate-Analog Trypsin Inhibitors through the Screening of Synthetic Peptide Combinatorial Libraries," Biochem., 32:11035-11041 (1993). |
Ekins et al., "Multinalyte Immunoassay: The Immunological 'Compact Disk' of the Future,"J. Clin. Immun., 13(4):169-181 (1990). |
Ekins et al., Multinalyte Immunoassay: The Immunological Compact Disk of the Future, J. Clin. Immun. , 13(4):169 181 (1990). * |
Fodor et al., "Light-Directed, Spatially Addressable Parallel Chemical Synthesis," Science251:767-773 (1991). |
Freshney, Culture of Animal Cells. A Manual of Basic Technique , Alan R. Liss, Inc., New York, pp. 141 143, 217 224 (1983). * |
Freshney, Culture of Animal Cells. A Manual of Basic Technique, Alan R. Liss, Inc., New York, pp. 141-143, 217-224 (1983). |
Furka et al., "General method for rapid synthesis of multicomponent peptide mixtures," Int. J. Pept. Protein Res. 37:487-493 (1991). |
Gallop, et al., "Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries," J. Med. Chem., 37(9):1233-1251 (1994). |
Gallop, et al., Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries, J. Med. Chem. , 37(9):1233 1251 (1994). * |
Geysen et al., Strategies for epitope analysis using peptide synthesis, J. Immunol. Meth. 102:259 274 (1987). * |
Geysen et al., Strategies for epitope analysis using peptide synthesis, J. Immunol. Meth. 102:259-274 (1987). |
Gilham, Immobilized Polynucleotides and Nucleic Acids, pp. 173-185. |
Goldmacher et al., Photoactivation of toxin conjugates, Bioconjugate Chem. 3:104 107 (1992). * |
Goldmacher et al., Photoactivation of toxin conjugates, Bioconjugate Chem. 3:104-107 (1992). |
Gordon et al., "Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies,.and Future Directions,"J. Med. Chem., 37(10):1385-1401 (1994). |
Gordon et al., Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies,.and Future Directions, J. Med. Chem. , 37(10):1385 1401 (1994). * |
Greve, "Programming Mechanism of Polysilicon Resistor Fuses," IEEE Transactions on Electron Devices, Ed-29(4):719-724 (1982). |
Gu et al., Cross talk limited storage capacity of volume holographic memory, Reprinted with permission from J. Optical Soc. Am. , vol. 9(11), pp. 1978 1983 (Nov. 1992), in Selected Papers on Holographic Storage. * |
Gu et al., Cross-talk-limited storage capacity of volume holographic memory, Reprinted with permission from J. Optical Soc. Am., vol. 9(11), pp. 1978-1983 (Nov. 1992), in Selected Papers on Holographic Storage. |
Gu et al., Noise gratings formed during the multiple exposure schedule in photorefractive media, Reprinted with permission from Optics Commnications , vol. 93, pp. 213 218 (1992), in Selected Papers on Holographic Storage. * |
Gu et al., Noise gratings formed during the multiple exposure schedule in photorefractive media, Reprinted with permission from Optics Commnications, vol. 93, pp. 213-218 (1992), in Selected Papers on Holographic Storage. |
Haarer, "Photochemical Hole Burning: A High Density Storage Scheme," Proc. Int. Symp. on Optical Memory, 1987; Japanese Journal of Applied Physics, vol. 26 (1987) Supplement 26-4, pp. 227-232. |
Hale, Irreversible, oriented immobilization of antibodies to cobalt iminodiacetate resin for use as immunoaffinity media, Analytical Biochem. 231:46 49 (1995). * |
Hale, Irreversible, oriented immobilization of antibodies to cobalt-iminodiacetate resin for use as immunoaffinity media, Analytical Biochem. 231:46-49 (1995). |
Harlow et al., Antibodies. A Laboratory Manual, Cold Spring Harbor Laboratory Chap. 14 (1988). |
Hazum et al., A photocleavalble protecting group for the thiol function of cysteine, Pept., Proc. Eur. Pept. Symp., 16th , Brunfeldt, K (Ed), pp. 105 110 (1981). * |
Hazum et al., A photocleavalble protecting group for the thiol function of cysteine, Pept., Proc. Eur. Pept. Symp., 16th, Brunfeldt, K (Ed), pp. 105-110 (1981). |
Hermanson et al., Chaps. 1 and 2, Immobilized Affinity Ligand Techniques, Academic Press, Inc. (1992). |
Hong et al., Volume holographic memory systems: techniques and architectures, Optical Engineering 34(8):2193 2203 (1995). * |
Hong et al., Volume holographic memory systems: techniques and architectures, Optical Engineering 34(8):2193-2203 (1995). |
Houghten et al., "Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery," Nature354:84-86 (1991). |
Houghten et al., "The Use of Synthetic Peptide Combinatorial Libraries for the Identification of Bioactive Peptides," BioTechniques 13(3):412-421 (1992). |
Houghten, General method for the rapid solid phase synthesis of large numbers of peptides; Specificity of antigen antibody interaction at the level of individual amino acids, Proc. Natl. Acad. Sci. USA 82 : 5131 (1985). * |
Houghten, General method for the rapid solid-phase synthesis of large numbers of peptides; Specificity of antigen-antibody interaction at the level of individual amino acids, Proc. Natl. Acad. Sci. USA 82: 5131 (1985). |
Ilg et al., "Investigation of the diffusion process in cross-linked polystyrenes by means of NMR imaging and solid-state NMR spectroscopy," Macromolecules, pp. 2778-2783 (1994). |
Ill et al., "A Cooh-Terminal peptide confers regiospecific orientation and facilitates atomic force microscopy of an IgG,." Biophys J. 64:919 (1993). |
Immobilized Enzyme, Antigens, Antibodies and Peptides. Preparation and Characterization, Howard H. Weetall, Ed., Marcel Dekker, Inc., N.Y. (1975). |
Isailovic, "Optical Memories," Videodisc and Optical Memory Systems, Prentice-Hall, Inc., pp. iii, 292-323 (1985). |
Ishikawa et al., Enzyme labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining, J. Immunoassay 4(3):209 327 (1983). * |
Ishikawa et al., Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining, J. Immunoassay 4(3):209-327 (1983). |
Ito et al., (Eds.), Polymeric Materials for Microelectronic Applications: Science and Technology, ACS Symposium Series No. 579, Chaps. 17, 23, 27-29, 35 and 36 (1995). |
IUPAC IUB Commission on Biochemical Nomenclature, Biochem. , 11(5):942 944 (1972). * |
Janda, "Tagged versus untagged libraries: Methods for the generation and screening of combinatorial chemical libraries," Proc. Natl. Acad. Sci. USA, 91:10779-10785. |
Janda, Tagged versus untagged libraries: Methods for the generation and screening of combinatorial chemical libraries, Proc. Natl. Acad. Sci. USA , 91:10779 10785. * |
Johansson et al., "Immobilized Enzymes in Microcalorimetry," Methods in Enzymology, 44:659-667 (1976). |
Jung et al., "Multiple Peptide Synthesis Methods and Their Applications," Angew. Chem. Int. Ed. Engl., 31(4):367-486 (1992). |
Jung et al., Multiple Peptide Synthesis Methods and Their Applications, Angew. Chem. Int. Ed. Engl. , 31(4):367 486 (1992). * |
Jurisch, Identifikation: kontaktlos via Hochfrequenz, Elektronik 9, pp. 86 92 (1993). * |
Jurisch, Identifikation: kontaktlos via Hochfrequenz, Elektronik 9, pp. 86-92 (1993). |
Kabat and Mayer, "Experimental Imunochemistry," Chapter 40. Equilibrium Dialysis, Charles C. Thomas, Springfield, Illinois., pp. 715-718 (1961). |
Kaji, "Molecular Design of Epoxy Resins for Microelectronics Packaging," Chap. 17, American Chemical Society (1994). |
Kennedy and Cabral, "Immobilized Enzymes," Solid Phase Biochemistry, Analytical and Synthetic Aspects, Scouten, Ed., 7:253-391 (1983). |
Kent and Merrifield, "Preparation and Properties of tert-Butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-(Kel F-g-styrene) Resin, an Insoluble, Noncrosslinked Support for Solid Phase Peptide Synthesis," Isr. J. Chem., 17:243-247 (1978). |
Kessler, "Peptoids--A New Approach to the Development of Pharmaceuticals," Angew. Chem. Int. Ed. Engl., 32(4): 543-544 (1993). |
Ketner & Kelly, "Integrated simian virus 40 sequences in transformed cell DNA: Analysis using restriction endonucleases," Proc. Nat. Acad. Sci. USA, 73(4):1102-1106 (1976). |
Khrapko et al., "An oligonucleotide hybridization approach to DNA sequencing." Febs Lttrs. 256:118-122 (1989). |
Kick et al., Expedient method for the solid phase synthesis of aspartic acid protease inhibitors directed toward the generation of libraries, J. Med. Chem. 38:1427 (1995). * |
Kick et al., Expedient method for the solid-phase synthesis of aspartic acid protease inhibitors directed toward the generation of libraries, J. Med. Chem. 38:1427 (1995). |
Kleine et al., "Lipopeptide-Polyoxyethylene Conjugates as Mitogens and Adjuvants," Immunobiol., 190:53-66 (1994). |
Kleinman et al., Use of extracellular matrix components for cell culture, Analytical Biochem. 166:1 13 (1987). * |
Kleinman et al., Use of extracellular matrix components for cell culture, Analytical Biochem. 166:1-13 (1987). |
Kwoh et al., "Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format," Proc. Natl. Acad. Sci. USA, 86:1173-1177 (1989). |
Lam et al., "A new type of synthetic peptide library for identifying ligand-binding activity," Nature354:82-83. |
Li et al., Three dimensional holographic disks, Applied Optics 33(17):3764 3774 (1994). * |
Li et al., Three-dimensional holographic disks, Applied Optics 33(17):3764-3774 (1994). |
Liskamp, Opportunities for new chemical libraries: Unnatural biopolymers and diversomers, Agnew. Chem. Int. Ed. Engl. 33(6):633 636 (1994). * |
Liskamp, Opportunities for new chemical libraries: Unnatural biopolymers and diversomers, Agnew. Chem. Int. Ed. Engl. 33(6):633-636 (1994). |
Loetscher et al., "Immobilization of monoclonal antibodies for affinity chromatography," J. Chromatography 595:113 (1992). |
Loetscher et al., Immobilization of monoclonal antibodies for affinity chromatography using a chelating peptide, J. Chromatography 595:113 119 (1992). * |
Loetscher et al., Immobilization of monoclonal antibodies for affinity chromatography using a chelating peptide, J. Chromatography 595:113-119 (1992). |
Maeji et al., Grafted supports used with the multipin method of peptide synthesis, Reactive Polymers 22:203 212 (1994). * |
Maeji et al., Grafted supports used with the multipin method of peptide synthesis, Reactive Polymers 22:203-212 (1994). |
Mage et al., Mouse lymphocytes with and without surface immunoglobulin: Preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti immunoglobulin, J. Immunol. Methods 15 :47 56 (1977). * |
Mage et al., Mouse lymphocytes with and without surface immunoglobulin: Preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin, J. Immunol. Methods 15:47-56 (1977). |
Mage et al., Preparative nonlytic separation of Lyt2 and Lyt2 T lymphocytes, functional analyses of the separated cells and demonstration of synergy in graft vs. host reaction of Lyt2 and Lyt2 cells, Eur. J. Immunol. 11 :228 235 (1981). * |
Mage et al., Preparative nonlytic separation of Lyt2+ and Lyt2- T lymphocytes, functional analyses of the separated cells and demonstration of synergy in graft-vs.-host reaction of Lyt2+ and Lyt2- cells, Eur. J. Immunol. 11:228-235 (1981). |
Martin et al., Measuring diversity: Experimental design of combinatorial libraries for drug discovery, J. Med. Chem. 38:1431 (1995). * |
McKeehan et al., Stimulation of clonal growth of normal fibroblasts with substrata coated with basic polymers, J. Cell Biol. 71 :727 734 (1976). * |
McKeehan et al., Stimulation of clonal growth of normal fibroblasts with substrata coated with basic polymers, J. Cell Biol. 71:727-734 (1976). |
Merrifield, "Solid-Phase Peptide Synthesis. III. An Improved Synthesis of Bradykinin," Biochemistry, 3(9):1385-1390 (1964). |
Miles & Hales, "Labelled Antibodies and Immunological Assay Systems," Nature, 219:186-189 (1968). |
Mitchell et al., "A New Synthetic Route to tert-Butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin, an Improved Support for Solid-Phase Peptide Synthesis1," J. Org. Chem., 43(14):2845-2852 (1978). |
Mitchell et al., "Preparation of Aminomethyl-Polystyrene Resin by Direct Amidomethylation," Tetrahedron Lett., 42:3795-3798 (1976). |
Mitchell et al., tert Butyloxycarbonylaminoacyl 4 (oxymethyl)phenylacetamidomethyl resin, an Improved Support for Solid Phase Peptide Synthesis, J. Org. Chem. 43(14):2845 2852 (1978). * |
Mitchell et al., tert-Butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin, an Improved Support for Solid-Phase Peptide Synthesis, J. Org. Chem. 43(14):2845-2852 (1978). |
Mjalli and Toyonaga, Solid support combinatorial chemistry in lead discovery and Sar optimization, NetSci 1(1) (1995). * |
Mok, Angle mutiplexed storage of 5000 holograms in lithium niobate, Optics Lttrs. 18(11):915 917 (1993). * |
Mok, Angle-mutiplexed storage of 5000 holograms in lithium niobate, Optics Lttrs. 18(11):915-917 (1993). |
Moran et al., "Radiofrequency Tag Encoded Combinatorial Library Method for the Discovery of Tripeptide-Substituted Cinnamic Acid Inhibitors of the Protein Tyrosine Phosphatase PTP1B," J. Am. Chem. Soc. 117:10787-10788. |
Moran et al., A radio frequency tag encoding combinatorial library method for the discovery of cinnamite amide inhibitors of the protein tyrosine phosphatase PTP1B, 31st Annual American Chemical Society Western Regional Meeting & 4th Annual San Diego Biotech Exposition. 117 (Oct. 19, 1995). * |
Moran et al., Radiofrequency Tag Encoded Combinatorial Library Method for the Discovery of Tripeptide Substituted Cinnamic Acid Inhibitors of the Protein Tyrosine Phosphatase PTP1B, J. Am. Chem. Soc. 117:10787 10788. * |
Nicolaou et al., "Radiofrequency combinatorial chemistry," Agnew. Chem. 34: 2289-2291 (Oct. 1995). |
Nicolaou et al., Radiofrequency combinatorial chemistry, Agnew. Chem. 34 : 2289 2291 (Oct. 1995). * |
Nikolaiev et al., Peptide encoding for structure determination of nonsequencable polymers within libraries synthesized and tested on solid phase supports, Peptide Research (1992). * |
Nikolaiev et al., Peptide-encoding for structure determination of nonsequencable polymers within libraries synthesized and tested on solid-phase supports, Peptide Research (1992). |
Nogrady, "Pro-Drugs and Soft Drugs," Medicinal Chemistry: A Biochemical Approach, Oxford Univ. Press, N.V., pp. 388-392 (1985). |
Nokihara et al., "Superior support for solid-phase peptide synthesis," Shimadzu Hyoron 50:25-31 (1993). |
P a tek et al., All cis cyclopentane scaffolding for combinatorial solid phase synthesis of small non peptide compounds, Tetrahedron Lett. 35:9169 9172 (1994). * |
P a tek et al., Solid phase synthesis of small organic molecules based on thiazolidine scaffold, Tetrahedron Lett. 36(13):2227 2230 (1995). * |
Padwa et al., Intramolecular reorganization of some unsaturated 2H azirines, J. Org. Chem. 41(3):543 549 (1976). * |
Padwa et al., Intramolecular reorganization of some unsaturated 2H-azirines, J. Org. Chem. 41(3):543-549 (1976). |
Padwa et al., Photocycloaddition of arylazirenes with electron deficient olefins, J. Am. Chem. Soc. 93(2):548 550 (1971). * |
Padwa et al., Photocycloaddition of arylazirenes with electron-deficient olefins, J. Am. Chem. Soc. 93(2):548-550 (1971). |
Padwa et al., Thermal arrangement of allyl substituted 2H azirines to 3 azabicyclo 3.1.0 hex 2 enes, J. Org. Chem. 41(1):180 182 (1976). * |
Padwa et al., Thermal arrangement of allyl substituted 2H-azirines to 3-azabicyclo 3.1.0!hex-2-enes, J. Org. Chem. 41(1):180-182 (1976). |
Patek et al., All-cis cyclopentane scaffolding for combinatorial solid phase synthesis of small non-peptide compounds, Tetrahedron Lett. 35:9169-9172 (1994). |
Patek et al., Solid-phase synthesis of "small" organic molecules based on thiazolidine scaffold, Tetrahedron Lett. 36(13):2227-2230 (1995). |
Pavia et al., "The Generation of Molecular Diversity," Bioorg. & Med. Chem. Lett., 3(3):387-396 (1993). |
Pavia et al., The Generation of Molecular Diversity, Bioorg. & Med. Chem. Lett. , 3(3):387 396 (1993). * |
Pein and Plummer, "A 3-D Sidewall Flash EPROM Cell and Memory Array," IEEE Transactions on Electron Devices, 40(11) (1993). |
Pidgeon et al., "Solid phase membrane mimetics," Enzyme Microb. Technol. 12:149 (1990). |
Pierce Chemical Co. Catalog & Handbook, selected pages which describe the preparation of and use of such reagents and provides a commercial source for such reagents, (1994). |
Piskin et al., Diagnostic Biosensor Polymers, ACS Symposium Series No. 556, Chap. 18 (1994). |
Pokrowsky et al., "Reading and writing of photochemical holes using GaAlAs-diode lasers," Optics Lett., 8(5):280-282 (1983). |
Powers et al., "Protein Purification by Affinity Binding to Unilamellar Vesicles," Biotech. & Bioeng., 33:173-182 (1989). |
Prabhu et al., Co fired ceramic on metal multilayer circuit board technology for multichip module packaging, Proc.Spie Int. Soc. Opt. Eng. (Proc. 1992 Intl. Symposium on Microelectronics) 1847:601 606 (1992). * |
Prabhu et al., Co-fired ceramic on metal multilayer circuit board technology for multichip module packaging, Proc.Spie-Int. Soc. Opt. Eng. (Proc. 1992 Intl. Symposium on Microelectronics) 1847:601-606 (1992). |
Psaltis et al., Holographic memories, Scientific American pp. 70 76 (Nov. 1995). * |
Psaltis et al., Holographic memories, Scientific American pp. 70-76 (Nov. 1995). |
Psaltis, Parallel optical memories, Byte pp. 179 182 (Sep. 1992). * |
Psaltis, Parallel optical memories, Byte pp. 179-182 (Sep. 1992). |
Qiao et al., Electrical fixing of photorefractive holograms in Sr 0.75 Ba 0.25 Nb 2 O 6 , Reprinted with permission from Optics Lttrs. , vol. 18(12), pp. 1004 1006 (Jun. 1993), in Selected Papers on Holographic Storage. * |
Qiao et al., Electrical fixing of photorefractive holograms in Sr0.75 Ba0.25 Nb2 O6, Reprinted with permission from Optics Lttrs., vol. 18(12), pp. 1004-1006 (Jun. 1993), in Selected Papers on Holographic Storage. |
Qiao et al., Sampled dynamic holographic memory, Reprinted with permission from Optics Lttrs. , vol 17(19), pp. 1376 1378 (Oct. 1992), in Selected Papers on Holographic Storage. * |
Qiao et al., Sampled dynamic holographic memory, Reprinted with permission from Optics Lttrs., vol 17(19), pp. 1376-1378 (Oct. 1992), in Selected Papers on Holographic Storage. |
Radio frequency encoded combinatorial chemistry (RECC) kit (available at http://www.irori.com/products.html on May 24, 1996). * |
Randolph et al., Major simplications in oligosaccharide syntheses arising from a solid phase based method: An application to the synthesis of the Lewis b antigen, J. Am. Chem. Soc. 117:5712 5719 (1995). * |
Randolph et al., Major simplications in oligosaccharide syntheses arising from a solid-phase based method: An application to the synthesis of the Lewis b antigen, J. Am. Chem. Soc. 117:5712-5719 (1995). |
Rapp et al., "Peptide screening and optimization by using monosized 25-μm tentacle microspheres," in Pept. Chem. 1992, Proc. Jpn. Symp., 2nd, Smith et al., eds., pp. 529-530 (1992). |
Rapp et al., "Polystyrene-polyoxyethylene graftcopolymers for high speed peptide synthesis," Pept., Proc. Eur. Pept. Symp., 20th, Jung et al., eds., pp. 199-201 (1989). |
Rapp et al.,"Continuous flow peptide synthesis on PSPOE-graft copolymers," Innovation Perspect. Solid Phase Synth. Collect. Pap., Int. Symp., 1st, Epton, ed., pp. 205-210 (1990). |
Saha, et al., "Diisopropylsilyl-linked oligonucleotide analogs: Solid-phase synthesis and physicochemical properties", J.Org.Chem. 58:7827-7831 (1993). |
Saha, et al., Diisopropylsilyl linked oligonucleotide analogs: Solid phase synthesis and physicochemical properties , J.Org.Chem . 58:7827 7831 (1993). * |
Sakakibara, The Use of Hydrogen Fluoride in Peptide Chemistry, Chap. 3, Institute for Protein Research, Osaka Univ., Osaka, Japan. |
Scott and Craig, "Random peptide libraries," Biotech., 5:40-48 (1994). |
Scott et al., "Searching for Peptide Ligands with an Epitope Library," Science, 249:386-390 (1990). |
Scott et al., Random peptide libraries, Current Biology 5:40 48 (1994). * |
Scott et al., Random peptide libraries, Current Biology 5:40-48 (1994). |
Scott et al., Searching for Peptide Ligands with an Epitope Library, Science , 249:386 390 (1990). * |
Sebestyen et al., "Chemical synthesis of peptide libraries," Bioorg. Med. Chem. Lett. 3:413-418 (1993). |
Senter et al., Novel photocleavable protein crosslinking reagents and thier use in the preparation of antibody toxin conjugates, Photochem. Photobiol. 42(3):231 237 (1985). * |
Senter et al., Novel photocleavable protein crosslinking reagents and thier use in the preparation of antibody-toxin conjugates, Photochem. Photobiol. 42(3):231-237 (1985). |
Sherwood et al., "Controlled antibody delivery systems," Bio/Technology 10:1446-1449 (1992). |
Simon, et al., "Peptoids: A modular approach to drug discovery," Proc. Natl. Acad. Sci. USA, 89:9367-9371 (1992). |
Smith et al., "Kinetically Inert Co(lll) Linkage through an Engineered Metal Binding Site: Specific Orientation of Recombinant Human Papillomavirus Type 16 E7 Protein on a Solid Support," Methods: A Companion to Methods in Enzymology, 4:73-78 (1992). |
Snacham-Diamand et al., "IPEL--A Novel Ion-Implanted Electrically Programmable Element," IEEE Electron Device Lett., 10(5):1080-182 (1989). |
Southern, "Detection of Specific Sequences Among DNA Fragments Separated by Gel Electrophoresis," J. Mol. Biol., 98:503-517 (1975). |
Spatola, "Peptide backbone modifications: A structure-activity analysis of peptides containing amide bond surrogates. Conformation constraints, and related backbone replacements," Chem. Biochem. Amino Acids, Pept. Proteins, 7:267-357 (1983). |
Stankovic et al., Diversomers libraries: A novel appraoch to chemical diversity, in Innovation and Perspectives in Solid Phase Synthesis , R. Epton, ed. (SPCC Ltd. Birmingham, 1993) pp. 391 396. * |
Stankovic et al., Diversomers™ libraries: A novel appraoch to chemical diversity, in Innovation and Perspectives in Solid Phase Synthesis, R. Epton, ed. (SPCC Ltd. Birmingham, 1993) pp. 391-396. |
Stewart and Young, Solid Phase Peptide Synthesis, 2d Ed., Pierce Chemical Co., pp. 53-73 (1984). |
Sucholeiki, Solid phase photochemical C S Bond cleavage of thioethers A New approach to the solid phase production of non peptide molecules, Tetrahedron Lttrs. 35:7307 (1994). * |
Sucholeiki, Solid-phase photochemical C-S Bond cleavage of thioethers--A New approach to the solid-phase production of non-peptide molecules, Tetrahedron Lttrs. 35:7307 (1994). |
Szelke et al., "Novel Transition-state Analogue Inhibitors of Renin," In Peptides: Structure and Function. Proceedings of the Eighth American Peptide Symposium, pp. 579-582 (1983). |
Tanimoto et al., "A Novel MOS Prom Using a Highly Resistive Poly-Si Resistor," IEEE Transactions on Electron Devices, Ed-27(3):517-520 (1980). |
Thiele et al., The immunosuppressive activity of L leucyl L leucine methyl ester: Selective ablation of cytotoxic lymphocytes and monocytes, J. Immunoassay 136 ( 3 ):1038 1048 (1986). * |
Thiele et al., The immunosuppressive activity of L-leucyl-L-leucine methyl ester: Selective ablation of cytotoxic lymphocytes and monocytes, J. Immunoassay 136(3):1038-1048 (1986). |
Towbin et al., "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications," Proc. Natl. Acad. Sci. USA, 76(9):4350-4354 (1979). |
Toyanaga et al., Application of Solid Phase Synthesized Small Molecules Libraries in Drug Discovery. Abstract presented Tues., Nov. 7, 1995, at the First Annual Conference of The Society for BioMolecular Screening. * |
Tsao et al., Clonal growth of normal human epidermal keratinocytes in a defined medium, J. Cell. Physiol. 110 :219 229 (1982). * |
Tsao et al., Clonal growth of normal human epidermal keratinocytes in a defined medium, J. Cell. Physiol. 110:219-229 (1982). |
Usmani, Diagnostic Biosensor Polymers, ACS Symposium Series No. 556, pp. vii-x, 2-19 (1994). |
Vedejs et al., A method for mild photochemical oxidation: Conversion of phenacyl sulfides into carbonyl compounds, J. Org. Chem. 49:573 575 (1984). * |
Vedejs et al., A method for mild photochemical oxidation: Conversion of phenacyl sulfides into carbonyl compounds, J. Org. Chem. 49:573-575 (1984). |
Wang, Solid phase synthesis of protected peptides via photolytic cleavage of the methylphenacyl ester anchoring linkage, J. Org. Chem. 41(20):3258 3261 (1976). * |
Wang, Solid phase synthesis of protected peptides via photolytic cleavage of the α-methylphenacyl ester anchoring linkage, J. Org. Chem. 41(20):3258-3261 (1976). |
Wild et al., "Hole Burning, Stark-Effect and Holographic Image Storage," Proc. Int. Symp. on Optical Memory (1987), Japanese Journal of Applied Physics, vol. 26 (1987) Supplement 26-4, pp. 233-236. |
Winquist and Danielsson, "Semiconductor field effect devices," Biosensors. A Practical Approach, Chap. 7, Cass, Ed., IRL Press at Oxford University Press (1990). |
Wong, "Conjugation of Proteins to Solid Matrices," Chemistry of Protein Conjugation and Cross Linking, 12:295-317 (1993). |
Wright et al., "Large scale synthesis of oligonucleotides via phosphoramidite nucleosides and a high loaded polystyrene support," Tetrahedron Lett. 34:3373-3376 (1993). |
Wysocki et al., `Panning`for lymphocytes: A method for cell seclection, Proc. Natl. Acad. Sci. USA 75(6): 2844-2848 (1978). |
Wysocki et al., Panning for lymphocytes: A method for cell seclection, Proc. Natl. Acad. Sci. USA 75(6): 2844 2848 (1978). * |
Xiang et al., A combinatorial approach to materials discovery, Science 268:1738 1740 (1995). * |
Xiang et al., A combinatorial approach to materials discovery, Science 268:1738-1740 (1995). |
Yen et al., Optically controlled ligand delivery, 1. Synthesis of water soluble copolymers containing photocleavable bonds, Makromol. Chem. 190:69 82 (1989). * |
Yen et al., Optically controlled ligand delivery, 1. Synthesis of water-soluble copolymers containing photocleavable bonds, Makromol. Chem. 190:69-82 (1989). |
Yoshimura et al., "Ultra-High Density Optical Memory by Photochemical Hole Burning (PHB) and Multi-Layered PHB System," Spie vol. 1078, Optical Data Storage Topical Meeting (1989). |
Zeppezauer et al., "Hydrophilic polystyrene-polyoxyethylene graft polymer beads as carrier of antigenic peptides for in vivo and in vitro immunization techniques," Z. Naturforsch., B: Chem. Sci. 48:1801-1806 (1993). |
Zhang et al., "Scale-up continuous-flow peptide synthesis of a partial sequence of tyrosine kinase using tentacle polymers," Pept. 1992, Proc. Eur. Pept. Symp., 22nd, Schneider, et al., Eds., pp. 432-433 (1993). |
Zuckerman et al., "Discovery of Nanomolar Ligands for 7-Transmembrane G-Protein-Coupled Receptors from a Diverse N-(Substituted)glycine Peptoid Library," J. Med. Chem. 37:2678-2685 (1994). |
Zuckerman et al., Efficient Method for the Preparation of Peptoids Oligo(N-substituted glycines)! by Submonomer Solid-Phase Synthesis, J. Am. Chem. Soc. 114:10646-10647 (1992). |
Zuckermann et al., "Identification of highest-affinity ligands by affinity selection from equimolar peptide mixtures generated by robotic synthesis," Proc. Natl. Acad. Sci. USA, 89:4505-4509 (1992). |
Zuckermann et al., Identification of highest affinity ligands by affinity selection from equimolar peptide mixtures generated by robotic synthesis, Proc. Natl. Acad. Sci. USA , 89:4505 4509 (1992). * |
Cited By (268)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6652808B1 (en) * | 1991-11-07 | 2003-11-25 | Nanotronics, Inc. | Methods for the electronic assembly and fabrication of devices |
US6340588B1 (en) | 1995-04-25 | 2002-01-22 | Discovery Partners International, Inc. | Matrices with memories |
US20110237459A1 (en) * | 1995-04-25 | 2011-09-29 | Nexus Biosystems, Inc. | Multiplexed Assay Using Encoded Solid Support Matrices |
US7935659B2 (en) | 1995-04-25 | 2011-05-03 | Nexus Biosystems, Inc. | Multiplexed assays using encoded solid supports |
US8219327B2 (en) * | 1995-04-25 | 2012-07-10 | Irori Technologies, Inc. | Multiplexed assay using encoded solid support matrices |
US6372428B1 (en) | 1995-04-25 | 2002-04-16 | Discovery Partners International, Inc. | Remotely programmable matrices with memories |
US6319668B1 (en) | 1995-04-25 | 2001-11-20 | Discovery Partners International | Method for tagging and screening molecules |
US6352854B1 (en) | 1995-04-25 | 2002-03-05 | Discovery Partners International, Inc. | Remotely programmable matrices with memories |
US20030203390A1 (en) * | 1995-10-26 | 2003-10-30 | Kaye Paul H. | Coded particles for process sequence tracking in combinatorial compound library preparation |
US6361950B1 (en) | 1995-11-30 | 2002-03-26 | Pharmaseq, Inc. | Multiplex assay for nucleic acids employing transponders |
US6376187B1 (en) * | 1995-11-30 | 2002-04-23 | Pharmaseq, Inc. | Electronically-indexed solid-phase assay for biomolecules |
US6387623B1 (en) | 1995-11-30 | 2002-05-14 | Pharmaseq | Screening of drugs from chemical combinatorial libraries employing transponders |
US6686158B2 (en) | 1995-11-30 | 2004-02-03 | Pharma Seg, Inc. | Electronically-indexed solid-phase assay for biomolecules |
US6706473B1 (en) | 1996-12-06 | 2004-03-16 | Nanogen, Inc. | Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides |
US20040115696A1 (en) * | 1996-12-06 | 2004-06-17 | Nanotronics, Inc. | Affinity based self-assembly systems and devices for photonic and electronic applications |
US20010048895A1 (en) * | 1997-02-28 | 2001-12-06 | Jorma Virtanen | Laboratory in a disk |
US6030581A (en) * | 1997-02-28 | 2000-02-29 | Burstein Laboratories | Laboratory in a disk |
US6873593B1 (en) * | 1997-05-21 | 2005-03-29 | Eugen Pavel | Three-Dimensional optical memory with fluorescent photosensitive vitreous material read and written to by laser |
US6506342B1 (en) * | 1997-06-19 | 2003-01-14 | Robert D. Frankel | Tracking apparatus and method for use with combinatorial synthesis processes |
US20020084329A1 (en) * | 1997-07-16 | 2002-07-04 | Kaye Paul H. | Coded items for labeling objects |
US20100304404A1 (en) * | 1997-09-15 | 2010-12-02 | Annegret Boge | Molecular modification assays |
US20050227294A1 (en) * | 1997-09-15 | 2005-10-13 | Molecular Devices Corporation | Molecular modification assays involving lipids |
US7745142B2 (en) | 1997-09-15 | 2010-06-29 | Molecular Devices Corporation | Molecular modification assays |
US20040249586A1 (en) * | 1997-09-15 | 2004-12-09 | Annegret Boge | Molecular modification assays |
US20060121544A1 (en) * | 1997-09-15 | 2006-06-08 | Annegret Boge | Molecular modification assays |
US20060008923A1 (en) * | 1998-02-03 | 2006-01-12 | Anderson Emory V | Point of care diagnostic systems |
US20060014302A1 (en) * | 1998-02-03 | 2006-01-19 | Martinez Ricardo R | Point of care diagnostic systems |
US20040241752A1 (en) * | 1998-02-03 | 2004-12-02 | Anderson Emory V. | Point of care diagnostic systems |
US6297018B1 (en) | 1998-04-17 | 2001-10-02 | Ljl Biosystems, Inc. | Methods and apparatus for detecting nucleic acid polymorphisms |
US20030162296A1 (en) * | 1998-05-13 | 2003-08-28 | Lawandy Nabil M. | Micro-lasing beads and structures for combinatorial chemistry and other applications, and techniques for fabricating the structures and for detecting information encoded by the structures |
US20030127609A1 (en) * | 1998-08-31 | 2003-07-10 | Amer El-Hage | Sample analysis systems |
US6500609B1 (en) | 1999-02-11 | 2002-12-31 | Scynexis Chemistry & Automation, Inc. | Method and apparatus for synthesizing characterizing and assaying combinatorial libraries |
US6245511B1 (en) | 1999-02-22 | 2001-06-12 | Vialogy Corp | Method and apparatus for exponentially convergent therapy effectiveness monitoring using DNA microarray based viral load measurements |
US20040111219A1 (en) * | 1999-02-22 | 2004-06-10 | Sandeep Gulati | Active interferometric signal analysis in software |
US6464687B1 (en) * | 1999-03-09 | 2002-10-15 | Ball Semiconductor, Inc. | Implantable drug delivery system |
US20030129654A1 (en) * | 1999-04-15 | 2003-07-10 | Ilya Ravkin | Coded particles for multiplexed analysis of biological samples |
US20040096911A1 (en) * | 1999-04-15 | 2004-05-20 | Oleg Siniaguine | Particles with light-polarizing codes |
US6908737B2 (en) | 1999-04-15 | 2005-06-21 | Vitra Bioscience, Inc. | Systems and methods of conducting multiplexed experiments |
US20030166015A1 (en) * | 1999-04-15 | 2003-09-04 | Zarowitz Michael A. | Multiplexed analysis of cell-substrate interactions |
US20030036096A1 (en) * | 1999-04-15 | 2003-02-20 | Ilya Ravkin | Chemical-library composition and method |
US20030134330A1 (en) * | 1999-04-15 | 2003-07-17 | Ilya Ravkin | Chemical-library composition and method |
US20030008323A1 (en) * | 1999-04-15 | 2003-01-09 | Ilya Ravkin | Chemical-library composition and method |
US20030207249A1 (en) * | 1999-04-15 | 2003-11-06 | Beske Oren E. | Connection of cells to substrates using association pairs |
US7253435B2 (en) | 1999-04-15 | 2007-08-07 | Millipore Corporation | Particles with light-polarizing codes |
GB2385850B (en) * | 1999-04-30 | 2004-05-19 | Agilent Technologies Inc | Polynucleotide array fabrication |
GB2385850A (en) * | 1999-04-30 | 2003-09-03 | Agilent Technologies Inc | Biopolymer array fabrication and use |
US20040203047A1 (en) * | 1999-04-30 | 2004-10-14 | Caren Michael P. | Polynucleotide array fabrication |
US20040197817A1 (en) * | 1999-04-30 | 2004-10-07 | Caren Michael P. | Polynucleotide array fabrication |
US20040203138A1 (en) * | 1999-04-30 | 2004-10-14 | Caren Michael P. | Polynucleotide array fabrication |
WO2000075664A1 (en) * | 1999-06-09 | 2000-12-14 | Ljl Biosystems, Inc. | Improvements in luminescence polarization assays |
US7276336B1 (en) | 1999-07-22 | 2007-10-02 | Agilent Technologies, Inc. | Methods of fabricating an addressable array of biopolymer probes |
US6846635B1 (en) | 1999-07-30 | 2005-01-25 | Large Scale Proteomics Corp. | Microarrays and their manufacture |
US7179638B2 (en) | 1999-07-30 | 2007-02-20 | Large Scale Biology Corporation | Microarrays and their manufacture by slicing |
US6713309B1 (en) | 1999-07-30 | 2004-03-30 | Large Scale Proteomics Corporation | Microarrays and their manufacture |
US6887701B2 (en) | 1999-07-30 | 2005-05-03 | Large Scale Proteomics Corporation | Microarrays and their manufacture |
US6653151B2 (en) | 1999-07-30 | 2003-11-25 | Large Scale Proteomics Corporation | Dry deposition of materials for microarrays using matrix displacement |
US6524863B1 (en) | 1999-08-04 | 2003-02-25 | Scynexis Chemistry & Automation, Inc. | High throughput HPLC method for determining Log P values |
US6413431B1 (en) | 1999-08-10 | 2002-07-02 | Scynexis Chemistry & Automation, Inc. | HPLC method for purifying organic compounds |
US6660832B1 (en) | 1999-08-20 | 2003-12-09 | Isis Pharmaceuticals, Inc. | Macrocyclic compounds and preparation methods thereof |
US6387273B1 (en) | 1999-08-27 | 2002-05-14 | Scynexis Chemistry & Automation, Inc. | Sample preparation for high throughput purification |
US20070178094A1 (en) * | 1999-09-14 | 2007-08-02 | Humphreys Robert E | Hybrid peptides modulate the immune response |
US9289487B2 (en) | 1999-09-14 | 2016-03-22 | Antigen Express, Inc. | II-key/antigenic epitope hybrid peptide vaccines |
US7541334B2 (en) | 1999-09-14 | 2009-06-02 | Antigen Express, Inc. | Hybrid peptides modulate the immune response |
US20060002947A1 (en) * | 1999-09-14 | 2006-01-05 | Robert Humphreys | Ii-key/antigenic epitope hybrid peptide vaccines |
US20030235594A1 (en) * | 1999-09-14 | 2003-12-25 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
US20030146095A1 (en) * | 1999-11-08 | 2003-08-07 | Nanogen, Inc. | Methods for the electronic, Homogeneous assembly and fabrication of devices |
US7060224B2 (en) | 1999-11-08 | 2006-06-13 | Nanogen, Inc. | Methods for the electronic, homogeneous assembly and fabrication of devices |
US20010022279A1 (en) * | 2000-02-11 | 2001-09-20 | Denyer Jonathan Stanley Harold | Controlling drug delivery apparatus |
US7151456B2 (en) | 2000-02-26 | 2006-12-19 | Glaxo Group Limited | Medicament dispenser |
US20030011476A1 (en) * | 2000-02-26 | 2003-01-16 | Godfrey James William | Medicament dispenser |
US6454759B2 (en) * | 2000-02-28 | 2002-09-24 | The Regents Of The University Of California | Microfabricated injectable drug delivery system |
US7732628B2 (en) | 2000-03-22 | 2010-06-08 | Solulink Incorporated | Functional biopolymer modification reagents and uses thereof |
US20050203289A1 (en) * | 2000-03-22 | 2005-09-15 | Schwartz David A. | Functional biopolymer modification reagents and uses thereof |
US6686461B1 (en) | 2000-03-22 | 2004-02-03 | Solulink Bioscience, Inc. | Triphosphate oligonucleotide modification reagents and uses thereof |
US10829541B2 (en) | 2000-04-17 | 2020-11-10 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
US20030153092A1 (en) * | 2000-04-19 | 2003-08-14 | Skinner Nigel Guy | Method of fabricating coded particles |
US7009517B2 (en) | 2000-05-24 | 2006-03-07 | Glaxo Group Limited | Method for monitoring objects with transponders |
WO2001094016A1 (en) * | 2000-06-06 | 2001-12-13 | Glaxo Group Limited | Sample container with radiofrequency identifier tag |
US20070075141A1 (en) * | 2000-06-06 | 2007-04-05 | Glaxo Group Limited | Sample container with radiofrequency identifier tag |
US7091864B2 (en) | 2000-06-06 | 2006-08-15 | Glaxo Group Limited | Sample container with radiofrequency identifier tag |
US7191777B2 (en) | 2000-07-15 | 2007-03-20 | Glaxo Group Limited | Medicament dispenser |
US20070163583A1 (en) * | 2000-07-15 | 2007-07-19 | Brand Peter J | Medicament dispenser |
US7819116B2 (en) | 2000-07-15 | 2010-10-26 | Glaxo Group Limited | Medicament dispenser |
US20030183226A1 (en) * | 2000-07-15 | 2003-10-02 | Brand Peter John | Medicament dispenser |
US7102024B1 (en) | 2000-08-01 | 2006-09-05 | Schwartz David A | Functional biopolymer modification reagents and uses thereof |
US7173125B2 (en) | 2000-08-01 | 2007-02-06 | Schwartz David A | Triphosphate oligonucleotide modification reagents and uses thereof |
USRE46171E1 (en) | 2000-08-01 | 2016-10-04 | Solulink, Incorporated | Functional biopolymer modification reagents and uses thereof |
US7999098B2 (en) | 2000-08-01 | 2011-08-16 | Solulink Biosciences, Inc. | Triphosphate oligonucleotide modification reagents and uses thereof |
US20030059764A1 (en) * | 2000-10-18 | 2003-03-27 | Ilya Ravkin | Multiplexed cell analysis system |
US7557070B2 (en) | 2000-10-18 | 2009-07-07 | Millipore Corporation | Multiplexed cell analysis system |
US20060147977A1 (en) * | 2000-12-29 | 2006-07-06 | Labcyte, Inc. | Device and methods for tracking conditions in an assay |
US20020094537A1 (en) * | 2000-12-29 | 2002-07-18 | Ellson Richard N. | Device and method for tracking conditions in an assay |
US20020155490A1 (en) * | 2001-04-18 | 2002-10-24 | Skinner Nigel G. | Particle based assay system |
US7572642B2 (en) | 2001-04-18 | 2009-08-11 | Ambrigen, Llc | Assay based on particles, which specifically bind with targets in spatially distributed characteristic patterns |
US20030119021A1 (en) * | 2001-07-16 | 2003-06-26 | Hubert Koster | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
EP2053406A2 (en) | 2001-07-16 | 2009-04-29 | caprotec bioanalytics GmbH | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US7858560B2 (en) | 2001-07-16 | 2010-12-28 | Caprotec Bioanalytics Gmbh | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US20030143612A1 (en) * | 2001-07-18 | 2003-07-31 | Pointilliste, Inc. | Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening |
US20100262379A1 (en) * | 2001-08-24 | 2010-10-14 | Applied Biosystems, Llc | Sequencing System With Memory |
US8697004B2 (en) | 2001-08-24 | 2014-04-15 | Applied Biosystems, Llc | Sequencing system with memory |
US20080288178A1 (en) * | 2001-08-24 | 2008-11-20 | Applera Corporation | Sequencing system with memory |
US20100307921A1 (en) * | 2001-09-19 | 2010-12-09 | Life Technologies Corporation | Microdevice with integrated memory |
US20030219800A1 (en) * | 2001-10-18 | 2003-11-27 | Beske Oren E. | Multiplexed cell transfection using coded carriers |
US20030081574A1 (en) * | 2001-10-25 | 2003-05-01 | Ntt Docomo, Inc. | Radio base station and method of controlling radio communications |
US20040048311A1 (en) * | 2002-01-24 | 2004-03-11 | Dana Ault-Riche | Use of collections of binding sites for sample profiling and other applications |
US20040209255A1 (en) * | 2002-03-11 | 2004-10-21 | Hk Pharmaceuticals, Inc. | Compounds and methods for analyzing the proteome |
US7338811B2 (en) | 2002-03-26 | 2008-03-04 | Vincogen Corporation | Integrated circuit chip for bioassays |
WO2003083905A3 (en) * | 2002-03-26 | 2004-07-15 | Derhsing Lai | Novel integrated circuit chip for bioassays_____________________ |
US20040029109A1 (en) * | 2002-03-26 | 2004-02-12 | Derhsing Lai | Novel integrated circuit chip for bioassays |
WO2003083905A2 (en) * | 2002-03-26 | 2003-10-09 | Derhsing Lai | Novel integrated circuit chip for bioassays_____________________ |
US20040126773A1 (en) * | 2002-05-23 | 2004-07-01 | Beske Oren E. | Assays with coded sensor particles to sense assay conditions |
US20040132005A1 (en) * | 2002-09-10 | 2004-07-08 | Jing-Hsiang Hsu | Method of forming biochip and application thereof |
WO2004030616A2 (en) | 2002-09-17 | 2004-04-15 | Antigen Express, Inc. | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES |
US7179645B2 (en) | 2002-09-24 | 2007-02-20 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
US20080305122A1 (en) * | 2002-09-24 | 2008-12-11 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
US8791053B2 (en) | 2002-09-27 | 2014-07-29 | Mpm-Holding Aps | Spatially encoded polymer matrix |
US20060127369A1 (en) * | 2002-09-27 | 2006-06-15 | Carlsberg A/S | Spatially encoded polymer matrix |
US20050042623A1 (en) * | 2002-10-30 | 2005-02-24 | Dana Ault-Riche | Systems for capture and analysis of biological particles and methods using the systems |
US20040209282A1 (en) * | 2002-10-30 | 2004-10-21 | Dana Ault-Riche | Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
US9034798B2 (en) | 2003-01-16 | 2015-05-19 | Caprotec Bioanalytics Gmbh | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US20050042771A1 (en) * | 2003-01-16 | 2005-02-24 | Hubert Koster | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US20060051879A9 (en) * | 2003-01-16 | 2006-03-09 | Hubert Koster | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US20100248264A1 (en) * | 2003-01-16 | 2010-09-30 | Koster Hubert | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US20100298168A1 (en) * | 2003-01-16 | 2010-11-25 | Koester Hubert | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
US20040241748A1 (en) * | 2003-02-10 | 2004-12-02 | Dana Ault-Riche | Self-assembling arrays and uses thereof |
US20040191770A1 (en) * | 2003-02-17 | 2004-09-30 | Midwest Research Institute, Inc. | Biological particulate matter analogue |
US20060257855A1 (en) * | 2003-02-17 | 2006-11-16 | Page Andrew E | Biological particulate matter analogue |
US7291497B2 (en) | 2003-09-11 | 2007-11-06 | Theranos, Inc. | Medical device for analyte monitoring and drug delivery |
US9131884B2 (en) | 2003-09-11 | 2015-09-15 | Theranos, Inc. | Medical device for analyte monitoring and drug delivery |
US20050100937A1 (en) * | 2003-09-11 | 2005-05-12 | Holmes Elizabeth A. | Medical device for analyte monitoring and drug delivery |
US10130283B2 (en) | 2003-09-11 | 2018-11-20 | Theranos, IP Company, LLC | Medical device for analyte monitoring and drug delivery |
US20110166553A1 (en) * | 2003-09-11 | 2011-07-07 | Holmes Elizabeth A | Medical device for analyte monitoring and drug delivery |
US8202697B2 (en) | 2003-09-11 | 2012-06-19 | Theranos, Inc. | Medical device for analyte monitoring and drug delivery |
US8101402B2 (en) | 2003-09-11 | 2012-01-24 | Theranos, Inc. | Medical device for analyte monitoring and drug delivery |
US20050208468A1 (en) * | 2003-09-15 | 2005-09-22 | Beske Oren E | Assays with primary cells |
US20050084914A1 (en) * | 2003-09-15 | 2005-04-21 | Foulkes J. G. | Assays with primary cells |
US7488451B2 (en) | 2003-09-15 | 2009-02-10 | Millipore Corporation | Systems for particle manipulation |
US20050084423A1 (en) * | 2003-09-15 | 2005-04-21 | Zarowitz Michael A. | Systems for particle manipulation |
US20050280811A1 (en) * | 2003-09-19 | 2005-12-22 | Donald Sandell | Grooved high density plate |
US20050225751A1 (en) * | 2003-09-19 | 2005-10-13 | Donald Sandell | Two-piece high density plate |
US20050095648A1 (en) * | 2003-10-30 | 2005-05-05 | Mario Geysen | Method for designing linear epitopes and algorithm therefor and polypeptide epitopes |
US20060018911A1 (en) * | 2004-01-12 | 2006-01-26 | Dana Ault-Riche | Design of therapeutics and therapeutics |
US20080284602A1 (en) * | 2004-03-19 | 2008-11-20 | Applera Corporation | Methods and systems for using rfid in biological field |
US9019079B2 (en) | 2004-03-19 | 2015-04-28 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US8669848B2 (en) | 2004-03-19 | 2014-03-11 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US8669849B2 (en) | 2004-03-19 | 2014-03-11 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US8665071B2 (en) | 2004-03-19 | 2014-03-04 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US7663487B2 (en) | 2004-03-19 | 2010-02-16 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US8400304B2 (en) | 2004-03-19 | 2013-03-19 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US8049623B2 (en) | 2004-03-19 | 2011-11-01 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US7187286B2 (en) | 2004-03-19 | 2007-03-06 | Applera Corporation | Methods and systems for using RFID in biological field |
US20110115633A1 (en) * | 2004-03-19 | 2011-05-19 | Applied Biosystems, Llc | Methods and systems for using rfid in biological field |
US9530035B2 (en) | 2004-03-19 | 2016-12-27 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US7880617B2 (en) | 2004-03-19 | 2011-02-01 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US7382258B2 (en) | 2004-03-19 | 2008-06-03 | Applera Corporation | Sample carrier device incorporating radio frequency identification, and method |
US20050205673A1 (en) * | 2004-03-19 | 2005-09-22 | Applera Corporation | Methods and systems for using RFID in biological field |
US20110001609A1 (en) * | 2004-03-19 | 2011-01-06 | Life Technologies Corporation | Sample carrier device incorporating radio frequency identification, and method |
US20050242963A1 (en) * | 2004-03-19 | 2005-11-03 | Applera Corporation | Sample carrier device incorporating radio frequency identification, and method |
US10369573B2 (en) | 2004-03-19 | 2019-08-06 | Applied Biosystems, Llc | Methods and systems for using RFID in biological field |
US20090291427A1 (en) * | 2004-04-08 | 2009-11-26 | Judy Muller-Cohn | Integration of sample storage and sample management for life science |
US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US8900856B2 (en) | 2004-04-08 | 2014-12-02 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US20050276728A1 (en) * | 2004-04-08 | 2005-12-15 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US9078426B2 (en) | 2004-04-08 | 2015-07-14 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
WO2006002641A1 (en) * | 2004-07-02 | 2006-01-12 | Versamatrix A/S | Spherical radiofrequency-encoded beads |
US20060053005A1 (en) * | 2004-09-02 | 2006-03-09 | Sandeep Gulati | Detecting events of interest using quantum resonance interferometry |
US8484000B2 (en) | 2004-09-02 | 2013-07-09 | Vialogy Llc | Detecting events of interest using quantum resonance interferometry |
US20060058099A1 (en) * | 2004-09-09 | 2006-03-16 | Soukup Thomas E | System and method for awarding an incentive award |
US7828954B2 (en) | 2004-09-21 | 2010-11-09 | Gamida For Life B.V. | Electrode based patterning of thin film self-assembled nanoparticles |
US20070138024A1 (en) * | 2004-09-21 | 2007-06-21 | Swanson Paul D | Electrode based patterning of thin film self-assembled nanoparticles |
US20060098745A1 (en) * | 2004-11-09 | 2006-05-11 | Yu-Pin Chou | Apparatus and method for evaluating data transmission |
US20080311681A1 (en) * | 2004-12-23 | 2008-12-18 | Ib Johannsen | Antibody Binding Affinity Ligands |
US20080238627A1 (en) * | 2005-03-22 | 2008-10-02 | Applera Corporation | Sample carrier device incorporating radio frequency identification, and method |
US8841076B2 (en) | 2005-05-09 | 2014-09-23 | Theranos, Inc. | Systems and methods for conducting animal studies |
US9772291B2 (en) | 2005-05-09 | 2017-09-26 | Theranos, Inc. | Fluidic medical devices and uses thereof |
US10761030B2 (en) | 2005-05-09 | 2020-09-01 | Labrador Diagnostics Llc | System and methods for analyte detection |
US20110104826A1 (en) * | 2005-05-09 | 2011-05-05 | Ian Gibbons | Calibration of fluidic devices |
US20060264782A1 (en) * | 2005-05-09 | 2006-11-23 | Holmes Elizabeth A | Point-of-care fluidic systems and uses thereof |
US20100081144A1 (en) * | 2005-05-09 | 2010-04-01 | Theranos, Inc. | Point-of-care fluidic systems and uses thereof |
US8679407B2 (en) | 2005-05-09 | 2014-03-25 | Theranos, Inc. | Systems and methods for improving medical treatments |
US20060264779A1 (en) * | 2005-05-09 | 2006-11-23 | Kemp Timothy M | Fluidic medical devices and uses thereof |
US20080009766A1 (en) * | 2005-05-09 | 2008-01-10 | Holmes Elizabeth A | Systems and methods for improving medical treatments |
US9075046B2 (en) | 2005-05-09 | 2015-07-07 | Theranos, Inc. | Fluidic medical devices and uses thereof |
US20060264783A1 (en) * | 2005-05-09 | 2006-11-23 | Holmes Elizabeth A | Systems and methods for monitoring pharmacological parameters |
US20060264780A1 (en) * | 2005-05-09 | 2006-11-23 | Holmes Elizabeth A | Systems and methods for conducting animal studies |
US8283155B2 (en) | 2005-05-09 | 2012-10-09 | Theranos, Inc. | Point-of-care fluidic systems and uses thereof |
US7888125B2 (en) | 2005-05-09 | 2011-02-15 | Theranos, Inc. | Calibration of fluidic devices |
US20100074799A1 (en) * | 2005-05-09 | 2010-03-25 | Kemp Timothy M | Fluidic Medical Devices and Uses Thereof |
US10908093B2 (en) | 2005-05-09 | 2021-02-02 | Labrador Diagnostics, LLC | Calibration of fluidic devices |
US7635594B2 (en) | 2005-05-09 | 2009-12-22 | Theranos, Inc. | Point-of-care fluidic systems and uses thereof |
US9182388B2 (en) | 2005-05-09 | 2015-11-10 | Theranos, Inc. | Calibration of fluidic devices |
US11630069B2 (en) | 2005-05-09 | 2023-04-18 | Labrador Diagnostics Llc | Fluidic medical devices and uses thereof |
US20080233341A1 (en) * | 2005-08-26 | 2008-09-25 | Evonik Degussa Gmbh | Special Aminoalkylsilane Compounds as Binders for Composite Materials |
WO2007044711A1 (en) * | 2005-10-07 | 2007-04-19 | University Of Florida Research Foundation, Inc. | Multiple component nanoparticles for multiplexed signaling and optical encoding |
US8168447B2 (en) | 2005-10-07 | 2012-05-01 | University Of Florida Research Foundation, Inc. | Multiple component nanoparticles for multiplexed signaling and optical encoding |
US20090017476A1 (en) * | 2005-10-07 | 2009-01-15 | Weihong Tan | Multiple Component Nanoparticles for Multiplexed Signaling and Optical Encoding |
EP2384811A1 (en) * | 2006-01-11 | 2011-11-09 | Novo Nordisk A/S | A spherical encoded bead with an ultrasonic identification chip |
WO2007079752A2 (en) * | 2006-01-11 | 2007-07-19 | Novo Nordisk A/S | Improved spherical encoded beads |
WO2007079752A3 (en) * | 2006-01-11 | 2008-02-21 | Novo Nordisk As | Improved spherical encoded beads |
US20090032592A1 (en) * | 2006-01-11 | 2009-02-05 | Novo Nordisk A/S | Spherical encoded beads |
US8741230B2 (en) | 2006-03-24 | 2014-06-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
US20070224084A1 (en) * | 2006-03-24 | 2007-09-27 | Holmes Elizabeth A | Systems and Methods of Sample Processing and Fluid Control in a Fluidic System |
US10533994B2 (en) | 2006-03-24 | 2020-01-14 | Theranos Ip Company, Llc | Systems and methods of sample processing and fluid control in a fluidic system |
US9176126B2 (en) | 2006-03-24 | 2015-11-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
US11287421B2 (en) | 2006-03-24 | 2022-03-29 | Labrador Diagnostics Llc | Systems and methods of sample processing and fluid control in a fluidic system |
US20070266826A1 (en) * | 2006-04-28 | 2007-11-22 | Angel Sanjurjo | Methods for producing consolidated materials |
US7959707B2 (en) | 2006-04-28 | 2011-06-14 | Sri International | Methods for producing consolidated materials |
US8669047B2 (en) | 2006-05-10 | 2014-03-11 | Theranos, Inc. | Real-time detection of influenza virus |
US11162947B2 (en) | 2006-05-10 | 2021-11-02 | Labrador Diagnostics Llc | Real-time detection of influenza virus |
US9885715B2 (en) | 2006-05-10 | 2018-02-06 | Theranos IP Comany, LLC | Real-time detection of influenza virus |
US8007999B2 (en) | 2006-05-10 | 2011-08-30 | Theranos, Inc. | Real-time detection of influenza virus |
US10156579B2 (en) | 2006-11-14 | 2018-12-18 | Theranos Ip Company, Llc | Methods for the detection of analytes in small-volume blood samples |
US20100248277A1 (en) * | 2006-11-14 | 2010-09-30 | Ian Gibbons | Detection and quantification of analytes in bodily fluids |
US9303286B2 (en) * | 2006-11-14 | 2016-04-05 | Theranos, Inc. | Detection and quantification of analytes in bodily fluids |
US20140308689A1 (en) * | 2006-11-14 | 2014-10-16 | Theranos, Inc. | Detection and Quantification of Analytes in Bodily Fluids |
US11802882B2 (en) | 2006-11-14 | 2023-10-31 | Labrador Diagnostics Llc | Methods for the detection of analytes in small-volume blood samples |
US8778665B2 (en) | 2006-11-14 | 2014-07-15 | Theranos, Inc. | Detection and quantification of analytes in bodily fluids |
US20160245759A1 (en) * | 2007-06-30 | 2016-08-25 | Shane M. Popp | Pharmaceutical dosage forms fabricated with nanomaterials |
US10060860B2 (en) * | 2007-06-30 | 2018-08-28 | Smp Logic Systems | Pharmaceutical dosage forms fabricated with nanomaterials |
US11754554B2 (en) | 2007-08-06 | 2023-09-12 | Labrador Diagnostics Llc | Systems and methods of fluidic sample processing |
US8883518B2 (en) | 2007-08-06 | 2014-11-11 | Theranos, Inc. | Systems and methods of fluidic sample processing |
US9575058B2 (en) | 2007-08-06 | 2017-02-21 | Theranos, Inc. | Systems and methods of fluidic sample processing |
US8158430B1 (en) | 2007-08-06 | 2012-04-17 | Theranos, Inc. | Systems and methods of fluidic sample processing |
US20110118147A1 (en) * | 2008-03-13 | 2011-05-19 | Ladner Robert C | Libraries of genetic packages comprising novel hc cdr3 designs |
US9873957B2 (en) | 2008-03-13 | 2018-01-23 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR3 designs |
US10718066B2 (en) | 2008-03-13 | 2020-07-21 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR3 designs |
US11926926B2 (en) | 2008-03-13 | 2024-03-12 | Takeda Pharmaceutical Company Limited | Libraries of genetic packages comprising novel HC CDR3 designs |
US20110172125A1 (en) * | 2008-04-24 | 2011-07-14 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs |
US11598024B2 (en) | 2008-04-24 | 2023-03-07 | Takeda Pharmaceutical Company Limited | Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs |
US10683342B2 (en) | 2008-04-24 | 2020-06-16 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs |
US9388510B2 (en) | 2008-04-24 | 2016-07-12 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs |
US20100310591A1 (en) * | 2009-01-28 | 2010-12-09 | Robert Humphreys | Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA |
US20130006479A1 (en) * | 2009-07-30 | 2013-01-03 | Anderson Gerald G | Microchip System and Method for Operating a Locking Mechanism and for Cashless Transactions |
WO2011032181A2 (en) | 2009-09-14 | 2011-03-17 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr3 designs |
US20110082054A1 (en) * | 2009-09-14 | 2011-04-07 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr3 designs |
US20110093249A1 (en) * | 2009-10-19 | 2011-04-21 | Theranos, Inc. | Integrated health data capture and analysis system |
US8862448B2 (en) | 2009-10-19 | 2014-10-14 | Theranos, Inc. | Integrated health data capture and analysis system |
US9460263B2 (en) | 2009-10-19 | 2016-10-04 | Theranos, Inc. | Integrated health data capture and analysis system |
US11195624B2 (en) | 2009-10-19 | 2021-12-07 | Labrador Diagnostics Llc | Integrated health data capture and analysis system |
US11158429B2 (en) | 2009-10-19 | 2021-10-26 | Labrador Diagnostics Llc | Integrated health data capture and analysis system |
US11139084B2 (en) | 2009-10-19 | 2021-10-05 | Labrador Diagnostics Llc | Integrated health data capture and analysis system |
US9999217B2 (en) | 2010-07-26 | 2018-06-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
US9376709B2 (en) | 2010-07-26 | 2016-06-28 | Biomatrica, Inc. | Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures |
US9845489B2 (en) | 2010-07-26 | 2017-12-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
US9376907B2 (en) | 2011-08-23 | 2016-06-28 | Harris Corporation | Method of hydrocarbon resource recovery including actuator operated positioning of an RF sensor and related apparatus |
US8997864B2 (en) | 2011-08-23 | 2015-04-07 | Harris Corporation | Method for hydrocarbon resource recovery including actuator operated positioning of an RF applicator and related apparatus |
US8967248B2 (en) | 2011-08-23 | 2015-03-03 | Harris Corporation | Method for hydrocarbon resource recovery including actuator operated positioning of an RF sensor and related apparatus |
US10543503B1 (en) | 2011-10-27 | 2020-01-28 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
US9610597B1 (en) | 2011-10-27 | 2017-04-04 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
US11691165B2 (en) | 2011-10-27 | 2023-07-04 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
US9725703B2 (en) | 2012-12-20 | 2017-08-08 | Biomatrica, Inc. | Formulations and methods for stabilizing PCR reagents |
US9626620B2 (en) | 2013-06-05 | 2017-04-18 | Haemonetics Corporation | Frangible RFID tag and method of producing same |
US9928457B2 (en) | 2013-06-18 | 2018-03-27 | Haemonetics Corporation | RFID tag and method of securing same to object |
US10064404B2 (en) | 2014-06-10 | 2018-09-04 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
US11672247B2 (en) | 2014-06-10 | 2023-06-13 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
US10772319B2 (en) | 2014-06-10 | 2020-09-15 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
US10568317B2 (en) | 2015-12-08 | 2020-02-25 | Biomatrica, Inc. | Reduction of erythrocyte sedimentation rate |
US11116205B2 (en) | 2015-12-08 | 2021-09-14 | Biomatrica, Inc. | Reduction of erythrocyte sedimentation rate |
US20190139603A1 (en) * | 2016-04-29 | 2019-05-09 | Johannes Kepler Universität Linz | Storage of codes in molecularly imprinted polymers |
US10790018B1 (en) | 2016-04-29 | 2020-09-29 | Johannes Kepler Universität Linz | Storage of codes in molecularly imprinted polymers |
US10734072B2 (en) * | 2016-04-29 | 2020-08-04 | Johannes Kepler Universitäat Linz | Storage of codes in molecularly imprinted polymers |
US10700273B2 (en) * | 2017-09-20 | 2020-06-30 | Research & Business Foundation Sungkyunkwan University | Protein-based nonvolatile memory device and method for manufacturing the same |
US11112416B2 (en) | 2018-01-30 | 2021-09-07 | Life Technologies Corporation | Instruments, devices and consumables for use in a workflow of a smart molecular analysis system |
US11252956B2 (en) | 2018-10-05 | 2022-02-22 | TMRW Life Sciences, Inc. | Apparatus to preserve and identify biological samples at cryogenic conditions |
US10973226B2 (en) | 2018-10-05 | 2021-04-13 | TMRW Life Sciences, Inc. | Apparatus to preserve and identify biological samples at cryogenic conditions |
USD951481S1 (en) | 2020-09-01 | 2022-05-10 | TMRW Life Sciences, Inc. | Cryogenic vial |
USD963194S1 (en) | 2020-12-09 | 2022-09-06 | TMRW Life Sciences, Inc. | Cryogenic vial carrier |
USD1002868S1 (en) | 2020-12-09 | 2023-10-24 | TMRW Life Sciences, Inc. | Cryogenic vial carrier |
Also Published As
Publication number | Publication date |
---|---|
US6372428B1 (en) | 2002-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5874214A (en) | Remotely programmable matrices with memories | |
US6025129A (en) | Remotely programmable matrices with memories and uses thereof | |
US8219327B2 (en) | Multiplexed assay using encoded solid support matrices | |
US5751629A (en) | Remotely programmable matrices with memories | |
US6416714B1 (en) | Remotely programmable matrices with memories | |
US6352854B1 (en) | Remotely programmable matrices with memories | |
US5925562A (en) | Remotely programmable matrices with memories | |
US6100026A (en) | Matrices with memories and uses thereof | |
US5741462A (en) | Remotely programmable matrices with memories | |
US6319668B1 (en) | Method for tagging and screening molecules | |
US6017496A (en) | Matrices with memories and uses thereof | |
US6331273B1 (en) | Remotely programmable matrices with memories | |
US6284459B1 (en) | Solid support matrices with memories and combinatorial libraries therefrom | |
US5961923A (en) | Matrices with memories and uses thereof | |
US6329139B1 (en) | Automated sorting system for matrices with memory | |
US6340588B1 (en) | Matrices with memories | |
WO1997012680A9 (en) | Matrices with memories, sensors with memories and uses thereof | |
US6306975B1 (en) | Radiation-grafted solid supports for chemical synthesis | |
EP0931259B1 (en) | System for synthesizing a library of compounds and use thereof | |
US20020143144A1 (en) | Screening of drugs from chemical combinatorial libraries employing transponders | |
WO1997049653A2 (en) | Solid phase tyrphostin library linked to matrices with memories | |
WO1997049653A9 (en) | Solid phase tyrphostin library linked to matrices with memories |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: IRORI, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NOVA, MICHAEL PHILLIP;SENYEI, ANDREW E.;DAVID, GARY S.;REEL/FRAME:007903/0368;SIGNING DATES FROM 19951020 TO 19951215 |
|
CC | Certificate of correction | ||
AS | Assignment |
Owner name: DISCOVERY PARTNERS INTERNATIONAL, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IRORI, INC.;REEL/FRAME:011874/0755 Effective date: 20010522 |
|
CC | Certificate of correction | ||
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
REMI | Maintenance fee reminder mailed | ||
AS | Assignment |
Owner name: IRORI DISCOVERY, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DISCOVERY PARTNERS INTERNATIONAL, INC.;REEL/FRAME:016662/0417 Effective date: 20051007 |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
REFU | Refund |
Free format text: REFUND - PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: R1552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
AS | Assignment |
Owner name: NEXUS BIOSYSTEMS, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:IRORI DISCOVERY, INC.;REEL/FRAME:016722/0313 Effective date: 20051013 |
|
AS | Assignment |
Owner name: NEXUS BIOSYSTEMS, INC., CALIFORNIA Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:DISCOVERY PARTNERS INTERNATIONAL, INC.;REEL/FRAME:017366/0939 Effective date: 20060323 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20110223 |